Processing 00000000.tx.1: Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays Herv Husson, Elizabeth G. 

Phrase: "Gene expression profiling of follicular lymphoma"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0752248:Gene Expression Profiling [Laboratory Procedure,Molecular Biology Research Technique]
   833   C1449575:Gene Expression Profiling [Laboratory Procedure]
   816 E C1956267:Profile, Gene Expression [Quantitative Concept]
   790   C1513400:Expression Profiling [Molecular Biology Research Technique]
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "normal germinal center B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   881   C0007634:Normal cell [Cell]
           Cells
   881   C1268443:Normal cell [Cell]
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cDNA arrays Herv Husson,"

Phrase: "Elizabeth G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.2: Carideo, Donna Neuberg, Joachim Schultze, Olivier Munoz, Peter W. 

Phrase: "Carideo,"

Phrase: "Donna Neuberg,"

Phrase: "Joachim Schultze,"

Phrase: "Olivier Munoz,"

Phrase: "Peter W."
Processing 00000000.tx.3: Marks, John W. 

Phrase: "Marks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:marks [Qualitative Concept]
   916 E C1706089:Marked [Qualitative Concept]

Phrase: "John W."
Processing 00000000.tx.4: Donovan, Antoinette C. 

Phrase: "Donovan,"

Phrase: "Antoinette C."
Processing 00000000.tx.5: Chillemi, Peter O'Connell, and Arnold S. 

Phrase: "Chillemi,"

Phrase: "Peter O'Connell,"

Phrase: "and"

Phrase: "Arnold S."
Processing 00000000.tx.6: Freedman From the Department of Medicine, Harvard Medical School, and the Department of Adult Oncology and Department of Biostatistical Science, Dana-Farber Cancer Institute, Boston, MA; 

Phrase: "Freedman From the Department of Medicine,"

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "the Department of Adult Oncology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Department of Biostatistical Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Dana-Farber Cancer Institute,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1511716:Dana-Farber Cancer Institute [Health Care Related Organization]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ";"
Processing 00000000.tx.7: and the Breast Center, Baylor College of Medicine, Houston, TX.  

Phrase: "and"

Phrase: "the Breast Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205099:Center [Spatial Concept]

Phrase: "Baylor College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: "Houston,"

Phrase: "TX."
Processing 00000000.tx.8: Abstract Top Abstract Introduction Materials and methods Results Discussion References Follicular lymphomas (FLs) are neoplastic counterparts of normal germinal center (GC) B cells. 

Phrase: "Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Follicular lymphomas (FLs)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0024301:Lymphomas, Follicular [Neoplastic Process]
   861   C0024299:Lymphomas [Neoplastic Process]
   861   C0439682:Follicular [Qualitative Concept]
   861   C1571705:Follicular [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "neoplastic counterparts of normal germinal center (GC) B cells."
Processing 00000000.tx.9: FLs are characterized by t(14;18) with deregulation of the Bcl-2 (BCL2) gene. 

Phrase: "FLs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0024301:Lymphomas, Follicular [Neoplastic Process]
   861   C0024299:Lymphomas [Neoplastic Process]
   861   C0439682:Follicular [Qualitative Concept]
   861   C1571705:Follicular [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "characterized by t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterized [Activity]

Phrase: ";18"

Phrase: ")"

Phrase: "with deregulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880287:Deregulation [Activity]

Phrase: "of the Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "(BCL2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376515:BCL2 [Gene or Genome]
  1000   C0597712:BCL2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.10: The presence of t(14;18) and overexpression of Bcl-2 is necessary, but not sufficient, to cause this disease. 

Phrase: "The presence of t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: ";18"

Phrase: ")"

Phrase: "and"

Phrase: "overexpression of Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "necessary,"

Phrase: "but"

Phrase: "not sufficient, to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "this disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.11: An array containing 588complementary DNAs (cDNAs) was used to compare the gene expression between GC B cells and FL cells. 

Phrase: "An array containing 588complementary DNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the gene expression between GC B cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017262:Gene Expression [Genetic Function]
   750   C1861886:CELL Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "FL cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.12: To specifically monitor genes expressed in normal GC B and FL cells and not the entire tissue compartment, normal and malignant B cells were purified from tissues. 

Phrase: "To specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "expressed in normal GC B"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0282491:Germinal Center [Tissue]
   753   C0205099:Center [Spatial Concept]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the entire tissue compartment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]

Phrase: "normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "malignant B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0334227:Malignant cells [Cell]
   913   C2698007:Malignant Cells, NOS [Laboratory Procedure]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "purified from tissues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0040300:Tissues [Tissue]
   790   C1998793:Purified [Functional Concept]
   756 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.13: Using the array, 37genes were up-regulated and 28were down-regulated in FL cells as compared to normal GC B cells. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the array,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510941:Array [Spatial Concept]

Phrase: "37genes"

Phrase: "were"

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "and"

Phrase: "28were"

Phrase: "down-regulated in FL cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "as"

Phrase: "compared to normal GC B cells."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   778   C0004561:B-Cells [Cell]
   778   C0282491:Germinal Center [Tissue]
   757   C0007634:Normal cell [Cell]
           Cells
   757   C1268443:Normal cell [Cell]
   748   C0205099:Center [Spatial Concept]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C1707455:Compared [Activity]
   748   C2347086:% Normal [Quantitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.14: The expression level of each differentially expressed gene was verified by quantitative polymerase chain reaction. 

Phrase: "The expression level of each differentially expressed gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C3244092:expression level [Idea or Concept]
   767   C0017262:Gene Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "verified by quantitative polymerase chain reaction."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0337112:Chain [Manufactured Object]
   753   C0392762:Quantitative [Quantitative Concept]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1524075:Chain [Idea or Concept]
   753   C1711411:Verified [Functional Concept]
Processing 00000000.tx.15: Following these studies 24genes were up-regulated and 8genes down-regulated with a P value less than .1.

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "these studies 24genes"

Phrase: "were"

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "and"

Phrase: "8genes"

Phrase: "down-regulated with a P value less"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1709380:P-Value [Quantitative Concept]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C1522609:Value [Quantitative Concept]

Phrase: "than .1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.16: Included among the genes that were up-regulated in FLs were cell cycle regulator proteins CDK10, p120, p21CIP1, and p16INK4A; 

Phrase: "Included among the genes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0017337:Genes [Gene or Genome]
   770   C0332257:included [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "that"

Phrase: "were"

Phrase: "up-regulated in FLs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0024301:Lymphomas, Follicular [Neoplastic Process]
   760   C0024299:Lymphomas [Neoplastic Process]
   760   C0439682:Follicular [Qualitative Concept]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1571705:Follicular [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "cell cycle regulator proteins CDK10,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1332730:CDK10 [Gene or Genome]
   804   C1333180:CDK10 [Amino Acid, Peptide, or Protein,Enzyme]
   722   C0243021:Cell Cycle Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1325288:cell cycle regulator [Cell Function]

Phrase: "p120,"

Phrase: "p21CIP1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0249197:p21CIP1 [Gene or Genome]

Phrase: "and"

Phrase: "p16INK4A"

Phrase: ";"
Processing 00000000.tx.17: transcription factors/regulators Pax-5 and Id-2, which are involved in normal B-cell development; 

Phrase: "transcription factors/regulators Pax-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   894   C0209548:Transcription Factor 5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   894   C1413323:TRANSCRIPTION FACTOR 5 [Gene or Genome]
   804   C3542477:PAX [Gene or Genome]

Phrase: "and"

Phrase: "Id-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   861   C0600091:ID [Intellectual Product]

Phrase: "which"

Phrase: "are"

Phrase: "involved in normal B-cell development"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   833   C1511002:B-Cell Development [Cell Function]
   833   C3158362:B cell development [Cell Function]
   790   C0004561:B-cell [Cell]
   790   C0815089:cell development [Cell Function]
   783   C0007634:Normal cell [Cell]
           Cell
   783   C1268443:Normal cell [Cell]
   783   C1821244:Normal development [Finding]
   753   C0205307:Normal [Qualitative Concept]
   753   C0243107:development [Physiologic Function]
   753   C0439166:% normal [Quantitative Concept]
   753   C0678723:Development [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1314939:Involved [Functional Concept]
   753   C1527148:Development [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.18: and genes involved in cell-cell interactions, tumor necrosis factor, interleukin-2R (IL-2R), and IL-4R. 

Phrase: "and"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell-cell interactions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C0007582:cell-cell interaction [Cell Function]
           Interactions, Cell
   779   C1704675:Interaction [Functional Concept]

Phrase: "tumor necrosis factor,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "interleukin-2R (IL-2R),"

Phrase: "and"

Phrase: "IL-4R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1149207:IL-4R [Molecular Function]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]
Processing 00000000.tx.19: Among the genes that were down-regulated in FLs were MRP8 and MRP14, which are involved in adhesion. 

Phrase: "Among the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "were"

Phrase: "down-regulated in FLs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0024301:Lymphomas, Follicular [Neoplastic Process]
   760   C0024299:Lymphomas [Neoplastic Process]
   760   C0439682:Follicular [Qualitative Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1571705:Follicular [Body Part, Organ, or Organ Component]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "were"

Phrase: "MRP8"

Phrase: "and"

Phrase: "MRP14,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054505:MRP14 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1335798:MRP14 [Gene or Genome]
  1000   C1704874:MRP14 [Gene or Genome]

Phrase: "which"

Phrase: "are"

Phrase: "involved in adhesion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001511:Adhesion [Pathologic Function]
   790   C0175633:Adhesion [Natural Phenomenon or Process]
   790   C1314939:Involved [Functional Concept]
Processing 00000000.tx.20: Interestingly, several of these genes are localized within chromosomal regions already described to be altered in FLs. 

Phrase: "Interestingly,"

Phrase: "several of these genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439064:Several [Quantitative Concept]
   770   C0443302:Several [Quantitative Concept]

Phrase: "are"

Phrase: "localized within chromosomal regions already"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C1953345:Chromosomal region [Cell]
   760   C0008633:Chromosomal [Cell Component]
   760   C0392752:Localized [Spatial Concept]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "altered in FLs."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0024301:Lymphomas, Follicular [Neoplastic Process]
   770   C0024299:Lymphomas [Neoplastic Process]
   770   C0392747:Altered [Functional Concept]
   770   C0439682:Follicular [Qualitative Concept]
   770   C1571705:Follicular [Body Part, Organ, or Organ Component]
Processing 00000000.tx.21: These findings provide a basis for future studies into the pathogenesis and pathophysiology of FL and may lead to the identification of potential therapeutic targets as well as antigens for immunotherapeutic strategies. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a basis for future studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "into the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "and"

Phrase: "pathophysiology of FL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031847:pathophysiology [Functional Concept]
   790   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "and"

Phrase: "may"

Phrase: "lead to the identification of potential therapeutic targets"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0020792:Identification [Mental Process]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   744   C0205396:Identification [Qualitative Concept]
   744   C0302350:Therapeutic [Functional Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3245505:Potential [Qualitative Concept]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   711   C1521840:Target [Functional Concept]
   711   C2986546:TARGET [Diagnostic Procedure]

Phrase: "as well as"

Phrase: "antigens for immunotherapeutic strategies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003320:Antigens [Immunologic Factor]
Processing 00000000.tx.22: (Blood. 

Phrase: "(Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.23: 2002;99:282-289)  2002 by The American Society of Hematology.  

Phrase: "2002"

Phrase: ";99"

Phrase: ":"

Phrase: "282-289"

Phrase: ")"

Phrase: "2002 by The American Society of Hematology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1515949:American Society of Hematology [Professional Society]
   748   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   748   C0037455:society [Organization]
   748   C0200627:HEMATOLOGY [Laboratory Procedure]
   748   C0596070:American [Population Group]
Processing 00000000.tx.24: Introduction Top Abstract Introduction Materials and methods Results Discussion References Follicular lymphomas (FLs) are characterized by the t(14;18) (q32;q21) translocation in virtually all patients. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Follicular lymphomas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0024301:Lymphomas, Follicular [Neoplastic Process]
   861   C0024299:Lymphomas [Neoplastic Process]
   861   C0439682:Follicular [Qualitative Concept]
   861   C1571705:Follicular [Body Part, Organ, or Organ Component]

Phrase: "(FLs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0024301:Lymphomas, Follicular [Neoplastic Process]
   861   C0024299:Lymphomas [Neoplastic Process]
   861   C0439682:Follicular [Qualitative Concept]
   861   C1571705:Follicular [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "are"

Phrase: "characterized by the t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterized [Activity]

Phrase: ";18"

Phrase: ")"

Phrase: "(q32"

Phrase: ";q21"

Phrase: ")"

Phrase: "translocation in virtually"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040715:Translocation [Cell or Molecular Dysfunction]
   790   C2987521:Translocation [Activity]

Phrase: "all patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.25: This translocation involves the Bcl-2 gene (BCL2) on chromosome 18juxtaposed with the immunoglobulin heavy chain (IGHG1) joining region on chromosome 14(Bcl-2/IgH).1 This leads to deregulation of the BCL2 gene, with overproduction of the antiapoptotic Bcl-2 protein. 

Phrase: "This translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040715:Translocation [Cell or Molecular Dysfunction]
  1000   C2987521:Translocation [Activity]

Phrase: "involves"

Phrase: "the Bcl-2 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0376515:bcl-2 Gene [Gene or Genome]
           Bcl-2
  1000   C1704467:BCL-2 Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "(BCL2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376515:BCL2 [Gene or Genome]
  1000   C0597712:BCL2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "on chromosome 18juxtaposed"

Phrase: "with the immunoglobulin heavy chain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0021034:Immunoglobulin Heavy Chain [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C1302674:Immunoglobulin chain [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1420192:heavy chain [Gene or Genome]
   827   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C0439539:Heavy [Qualitative Concept]
   827   C1524075:Chain [Idea or Concept]
   827   C1621846:immunoglobulin [Molecular Function]

Phrase: "(IGHG1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415978:IGHG1 [Gene or Genome]
  1000   C3273768:IGHG1 [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "joining region on chromosome 14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1953345:Chromosome region [Cell]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "(Bcl-2/IgH).1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376515:Bcl-2 [Gene or Genome]
   812   C0017351:IGH [Gene or Genome]

Phrase: "This"

Phrase: "leads to deregulation of the BCL2 gene,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0376515:BCL2 gene [Gene or Genome]
           BCL2
   778   C1704467:BCL-2 Gene [Gene or Genome]
   774   C1518576:Gene Deregulation [Cell or Molecular Dysfunction]
   748   C0017337:Gene [Gene or Genome]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C0597712:BCL2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1880287:Deregulation [Activity]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "with overproduction"

Phrase: "of the antiapoptotic Bcl-2 protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0597712:BCL-2 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.26: A substantial body of evidence supports the hypothesis that the Bcl-2/IgH translocation is necessary, but not sufficient, to cause FL. 

Phrase: "A substantial body of evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the Bcl-2/IgH translocation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1516130:BCL-2 Translocation [Cell or Molecular Dysfunction]
   812   C0040715:Translocation [Cell or Molecular Dysfunction]
   812   C2987521:Translocation [Activity]

Phrase: "is"

Phrase: "necessary,"

Phrase: "but"

Phrase: "not sufficient, to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "FL."
Processing 00000000.tx.27: Compelling evidence comes from studies of transgenic mice that bear a Bcl-2/IgH fusion gene to mimic the t(14;18) translocation in humans. 

Phrase: "Compelling evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "comes from studies of transgenic mice"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0025936:Mice, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "bear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004897:Bear [Mammal]

Phrase: "a Bcl-2/IgH fusion gene to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0376515:bcl-2 Gene [Gene or Genome]
   885   C1704467:BCL-2 Gene [Gene or Genome]
   839   C0017351:IGH gene [Gene or Genome]
   827   C1533585:Fusion Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]

Phrase: "mimic"

Phrase: "the t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";18"

Phrase: ")"

Phrase: "translocation in humans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040715:Translocation [Cell or Molecular Dysfunction]
   790   C2987521:Translocation [Activity]
Processing 00000000.tx.28: These mice developed polyclonal B-cell hyperplasia in lymph nodes and spleen with IgM/IgD+ mature B cells, but not a monoclonal lymphoproliferative disorder.2,3 Similar to the progression seen in human FL, a minor subset of these transgenic mice go on to develop a monoclonal diffuse large B-cell lymphoma that is associated with a rearranged c-Myc (MYC) gene in about 50% of cases.3 Further evidence that the Bcl-2/IgH translocation alone is not causative for follicular non-Hodgkin lymphoma (NHL) is that B cells with t(14;18) are present in a substantial number of healthy individuals. 

Phrase: "These mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "developed"

Phrase: "polyclonal B-cell hyperplasia in lymph nodes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   788   C2987486:Lymph node hyperplasia [Finding]
   769 E C0340782:hyperplastic lymph nodes [Acquired Abnormality]
   748   C0020507:Hyperplasia [Pathologic Function]

Phrase: "and"

Phrase: "spleen with IgM/IgD+ mature B cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037993:Spleen [Body Part, Organ, or Organ Component]
   748   C0771377:SPLEEN [Tissue]
   748   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a monoclonal lymphoproliferative disorder.2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024314:Lymphoproliferative disorder [Neoplastic Process]
   812   C0012634:Disorder [Disease or Syndrome]
   812   C0746619:monoclonal [Finding]

Phrase: "3 Similar to the progression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "seen in human FL,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "a minor subset of these transgenic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515021:Subset [Classification]

Phrase: "go on to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1822658:GO [Gene or Genome]

Phrase: "develop"

Phrase: "a monoclonal diffuse large B-cell lymphoma"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   947   C0079744:Diffuse Large B-Cell Lymphoma [Neoplastic Process]
           Lymphoma, Large-Cell, Diffuse
           Lymphoma, Large-Cell
   947   C2699777:Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [Neoplastic Process]
   876   C0079734:Lymphoma, Diffuse [Neoplastic Process]
   867   C0024302:Large cell lymphoma [Neoplastic Process]
   861   C0079731:Lymphoma, B-Cell [Neoplastic Process]
   827   C0004561:B-cell [Cell]
   827   C0883208:cell lymphoma [Cell]
   799   C0007634:Cell [Cell]
   799   C0024299:Lymphoma [Neoplastic Process]
   799   C0205219:Diffuse [Qualitative Concept]
   799   C0549177:Large [Quantitative Concept]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "associated with a rearranged c-Myc"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(MYC) gene in about 50% of cases.3 Further evidence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0026902:MYC Gene [Gene or Genome]
   760   C0079068:myc gene [Gene or Genome]
   760   C0086661:MYC gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]

Phrase: "that"

Phrase: "the Bcl-2/IgH translocation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1516130:BCL-2 Translocation [Cell or Molecular Dysfunction]
   812   C0040715:Translocation [Cell or Molecular Dysfunction]
   812   C2987521:Translocation [Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "not causative for follicular non-Hodgkin lymphoma (NHL)"

Phrase: "is"

Phrase: "that B cells with t(14"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0004561:B-Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: ";18"

Phrase: ")"

Phrase: "are"

Phrase: "present in a substantial number of healthy individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]
Processing 00000000.tx.29: In peripheral blood, t(14;18)+ cells have been reported in 8% to 88% of healthy subjects using polymerase chain reaction (PCR). 

Phrase: "In peripheral blood,"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0229664:peripheral blood [Body Substance]
           Blood
   958 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0205100:Peripheral [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";18"

Phrase: ")"

Phrase: "+ cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "reported in 8%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "to 88%"

Phrase: "of healthy subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1708335:HEALTHY SUBJECTS [Population Group]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polymerase chain reaction (PCR)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.30: Similarly using fluorescein in situ hybridization (FISH), B cells with t(14;18) have been detected in hyperplastic lymphoid tissues (tonsil, lymph nodes) of 12% to 54% of healthy individuals.4-6 Similar to the risk of FL increasing with age, the detection of t(14;18) in peripheral blood of healthy humans appears to increase with age.7 Cells with t(14;18)+ have also been detected by PCR in peripheral blood of patients with localized FL who are in long-term remission (>10 years) after radiation therapy.8 One interpretation of these finding is that these cells lack other genetic changes necessary for transformation into recurrent lymphoma. 

Phrase: "Similarly"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescein in situ hybridization (FISH),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]

Phrase: "B cells with t(14"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0004561:B-Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: ";18"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "detected in hyperplastic lymphoid tissues"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0024296:Tissues, Lymphoid [Tissue]
   800   C0949039:tissue lymphoid hyperplasia [Disease or Syndrome]
   762   C0333997:LYMPHOID HYPERPLASIAS [Disease or Syndrome]
   760   C0020507:Hyperplastic [Pathologic Function]
   760   C0040300:Tissues [Tissue]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1518071:Lymphoid [Qualitative Concept]
   726 E C1547928:Tissue [Intellectual Product]

Phrase: "(tonsil,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040421:Tonsil [Body Part, Organ, or Organ Component]
  1000   C0836921:Tonsil [Body Part, Organ, or Organ Component]
  1000   C1280736:Tonsil [Body Part, Organ, or Organ Component]
  1000   C1519547:TONSIL [Tissue]

Phrase: "lymph nodes"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
  1000   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   966 E C0440747:LYMPH NODE [Tissue]
   966 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   861   C0024202:Lymph [Body Substance]
   861   C0746922:nodes [Body Part, Organ, or Organ Component]
   827 E C1706163:Node [Conceptual Entity]
   827 E C2697524:Node [Conceptual Entity]
   827 E C2700445:Node [Plant]
   777 E C0443268:Nodal [Spatial Concept]
   777 E C1417752:NODAL [Gene or Genome]
   755 E C0449725:Nodality [Spatial Concept]

Phrase: ")"

Phrase: "of 12%"

Phrase: "to 54%"

Phrase: "of healthy individuals.4-6 Similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2348205:Similar [Qualitative Concept]

Phrase: "to the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of FL increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   861   C0442808:Increasing [Functional Concept]
   827 E C0442805:Increase [Functional Concept]
   789 E C1517378:Gain [Quantitative Concept]
   768 E C0205217:Increased [Quantitative Concept]
   768 E C0439661:Acquired [Temporal Concept]
   768 E C1301820:Obtain [Functional Concept]
   768 E C1706701:Acquire [Activity]
   768 E C3245488:acquired [Intellectual Product]

Phrase: "with age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "the detection of t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: ";18"

Phrase: ")"

Phrase: "in peripheral blood"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0229664:peripheral blood [Body Substance]
           Blood
   958 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0205100:Peripheral [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "of healthy humans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086418:Humans [Human]
   789   C0018684:Health [Idea or Concept]
   789   C0031206:healthiness [Finding]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase with age.7 Cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   797   C0178537:age cells [Temporal Concept]
   760   C0001779:Age [Organism Attribute]
   760   C0007634:Cells [Cell]
   760   C0442805:Increase [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "with t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";18"

Phrase: ")"

Phrase: "+"

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "detected by PCR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0442726:Detected [Finding]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1524075:Chain [Idea or Concept]

Phrase: "in peripheral blood"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0229664:peripheral blood [Body Substance]
           Blood
   958 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0205100:Peripheral [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with localized FL"

Phrase: "who"

Phrase: "are in long-term remission"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0443252:Long-term [Temporal Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C0544452:Remission [Finding]
   760   C0687702:remission [Neoplastic Process]
   760   C1515273:Term [Temporal Concept]
   760   C1551058:Are [Quantitative Concept]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C2826302:TERM [Intellectual Product]

Phrase: "("

Phrase: ">10 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "after"

Phrase: "radiation therapy.8 One interpretation of these finding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0459471:Interpretation [Intellectual Product]
   744   C3173575:Interpretation [Clinical Attribute]

Phrase: "is"

Phrase: "that"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "other genetic changes"
Meta Candidates (Total=20; Excluded=15; Pruned=0; Remaining=5)
   966   C1705285:Genetic Change [Cell or Molecular Dysfunction]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "necessary for transformation"

Phrase: "into recurrent lymphoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024299:Lymphoma [Neoplastic Process]
Processing 00000000.tx.31: One approach to understand neoplastic transformation is by comparing gene expression of normal cells to their malignant counterparts. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "neoplastic transformation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0007621:neoplastic transformation [Neoplastic Process]
   861   C0040682:Transformation [Cell Function]
   861   C1510411:Transformation [Pathologic Function]
   861   C1705163:Transformation [Research Activity]
   861   C1709160:Neoplastic [Qualitative Concept]
   789 E C0027651:Neoplasia [Neoplastic Process]

Phrase: "is by comparing gene expression of normal cells"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   770   C0017262:Gene Expression [Genetic Function]
   767   C0314622:Is gene [Gene or Genome]
   750   C1861886:CELL Gene [Gene or Genome]
   744   C0007634:Cells [Cell]
           Normal cell
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205307:Normal [Qualitative Concept]
   744   C0439166:% normal [Quantitative Concept]
   744   C2347086:% Normal [Quantitative Concept]
   744   C3282337:Cells [Cell]
   737   C1268443:Normal cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711   C1707455:Compare [Activity]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "to their malignant counterparts."
Processing 00000000.tx.32: The development of complementary DNA (cDNA) array technology allows one to simultaneously quantify the expression of a very large number of genes.9-18 The application of DNA array technology to studies of human malignancies includes identifying the gene profile of malignancies of different cell types or lineages; 

Phrase: "The development of complementary DNA (cDNA) array technology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0599834:Technology Development [Intellectual Product]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "one to simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "the expression of a very large number of genes.9-18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   737   C0017262:Gene Expression [Genetic Function]

Phrase: "The application of DNA array technology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185125:Application [Health Care Activity]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]

Phrase: "to studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "of human malignancies"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0006826:MALIGNANCIES [Neoplastic Process]
   827 E C1306459:Malignancy [Finding]
   777 E C0205282:Malignant [Qualitative Concept]
   777 E C0334590:MALIGNANT [Neoplastic Process]
   777 E C1533592:MALIGNANT [Neoplastic Process]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "identifying"

Phrase: "the gene profile of malignancies of different cell types"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1979963:Profile [Laboratory Procedure]
   742   C2003903:Profile [Functional Concept]

Phrase: "or"

Phrase: "lineages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881379:Lineage [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.33: genes involved in pathogenesis, progression, and metastasis; 

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in pathogenesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0543483:pathogenesis [Functional Concept]
   790   C0699748:Pathogenesis [Pathologic Function]
   790   C1314939:Involved [Functional Concept]

Phrase: "progression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "metastasis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027627:Metastasis [Neoplastic Process]
  1000   C2939420:metastasis [Neoplastic Process]
   928 E C0036525:Metastatic [Functional Concept]
   928 E C1522484:metastatic [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.34: genetically determined risk groups; 

Phrase: "genetically determined risk groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0035647:Risk [Qualitative Concept]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: ";"
Processing 00000000.tx.35: genes involved in resistance; 

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in resistance"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0237834:Resistance [Mental Process]
   790   C1314939:Involved [Functional Concept]
   790   C1514892:Resistance [Physiologic Function]
   718 E C0332325:Resistant [Functional Concept]
   718 E C1550464:resistent [Idea or Concept]
   718 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: ";"
Processing 00000000.tx.36: and ultimately potential molecular targets of therapy. 

Phrase: "and"

Phrase: "ultimately potential molecular targets of therapy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   719   C1521840:Target [Functional Concept]
   719   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.37: To date, gene profiling studies of NHL have identified clinically relevant subgroups, related histologic subgroups to normal cellular counterparts, and molecules that are specific to certain disease entities.10,13 In the present report, we have used a cDNA microarray to compare the expression of 588genes in FL cells with their normal cellular counterparts, germinal center (GC) B cells isolated from hyperplastic tonsils. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "gene profiling studies of NHL"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   774   C1273305:Gene studies [Laboratory Procedure]
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "clinically relevant subgroups,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1079230:subgroups [Virus]
   793 E C1515021:Subgroup [Classification]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "histologic subgroups to normal cellular counterparts,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1079230:subgroups [Virus]
   719 E C1515021:Subgroup [Classification]

Phrase: "and"

Phrase: "molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "specific to certain disease entities.10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "13 In the present report,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cDNA microarray to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600596:DNA Microarray [Research Device]
   861   C1522053:DNA Microarray [Molecular Biology Research Technique]
   812   C1709016:Microarray [Manufactured Object]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the expression of 588genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with their normal cellular counterparts,"

Phrase: "germinal center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Center [Tissue]
   861   C0205099:Center [Spatial Concept]

Phrase: "(GC) B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "isolated from hyperplastic tonsils."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0020507:Hyperplastic [Pathologic Function]
   770   C0040421:Tonsils [Body Part, Organ, or Organ Component]
   770   C0205409:Isolated [Functional Concept]
   770   C0836921:tonsils [Body Part, Organ, or Organ Component]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1280736:Tonsil [Body Part, Organ, or Organ Component]
   737 E C1519547:TONSIL [Tissue]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.38: The levels of differentially expressed genes were verified by real-time quantitative reverse transcription PCR (RT-PCR). 

Phrase: "The levels of differentially expressed genes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "verified by real-time quantitative reverse transcription PCR (RT-PCR)."
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   837   C3179034:Quantitative Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   833   C0814037:reverse transcription polymerase chain reaction [Genetic Function]
   820   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   782   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0035380:Reverse Transcription [Genetic Function]
   760   C1550177:Real Time [Idea or Concept]
   757   C0034746:Reaction Time [Temporal Concept]
   739   C0040223:Time [Temporal Concept]
   739   C0040649:Transcription [Genetic Function]
   739   C0237400:Real [Qualitative Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C0392762:Quantitative [Quantitative Concept]
   739   C0443286:Reaction [Functional Concept]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1524075:Chain [Idea or Concept]
   739   C1555029:Reverse [Idea or Concept]
   739   C1711411:Verified [Functional Concept]
   739   C3272377:REAL [Intellectual Product]
   739   C3541383:Time [Temporal Concept]
Processing 00000000.tx.39: Our data suggest that there is differential expression of a large number of genes between normal GC B cells and FL cells. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "is"

Phrase: "differential expression of a large number of genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1519516:Differential Gene Expression [Genetic Function]
   750   C0017262:Gene Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "between normal GC B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   881   C0007634:Normal cell [Cell]
           Cells
   881   C1268443:Normal cell [Cell]
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "FL cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.40: Among these are transcription factors, cell cycle regulators, signal transduction molecules, and molecules involved in cell-cell interactions. 

Phrase: "Among these"

Phrase: "are"

Phrase: "transcription factors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "cell cycle regulators,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   983   C1325288:cell cycle regulator [Cell Function]
   827   C0182953:regulators [Medical Device]
   793 E C1704734:Regulator [Medical Device]
   793 E C1704735:Regulator [Conceptual Entity]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "signal transduction molecules,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]
   734   C0037083:Signal Transduction [Cell Function]

Phrase: "and"

Phrase: "molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell-cell interactions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C0007582:cell-cell interaction [Cell Function]
           Interactions, Cell
   779   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.41: These studies may provide further understanding of the pathogenesis and pathophysiology of FL.  

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "further understanding of the pathogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162340:Understanding [Mental Process]

Phrase: "and"

Phrase: "pathophysiology of FL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031847:pathophysiology [Functional Concept]
   790   C0277785:Pathophysiology [Qualitative Concept]
Processing 00000000.tx.42: Materials and methods Top Abstract Introduction Materials and methods Results Discussion References Cells Single-cell suspensions were prepared from tissues after mincing with a scalpel blade in the presence of collagenase IV and DNAse I, followed by passage through a fine wire mesh as previously described.19 Mononuclear cells were then isolated by Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) density gradient centrifugation. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cells Single-cell suspensions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0038960:Suspensions [Biomedical or Dental Material]
   779 E C1382107:Suspension [Substance]
   779 E C1705537:Suspension [Functional Concept]

Phrase: "were"

Phrase: "prepared from tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0040300:Tissues [Tissue]
   756   C1521827:Prepare [Functional Concept]
   756 E C1547928:Tissue [Intellectual Product]

Phrase: "after mincing"

Phrase: "with a scalpel blade"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0179326:BLADE, SCALPEL [Medical Device]
   861   C0179323:blade [Medical Device]
   861   C2700402:Blade [Plant]
   861   C2948008:Blade [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of collagenase IV"

Phrase: "and"

Phrase: "DNAse I,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
           DNase
  1000   C1148702:DNase I [Genetic Function]
   861   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "followed by passage"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0439799:Passage [Spatial Concept]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "through a fine wire mesh"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0181805:Mesh [Medical Device]
   827   C1135584:MeSH [Intellectual Product]
   827   C1552983:Mesh [Quantitative Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described.19 Mononuclear cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0806987:Mononuclear cells [Cell]
   812   C0007634:Cells [Cell]
   812   C1513475:Mononuclear [Clinical Attribute]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "isolated by Ficoll-Hypaque"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0016071:Ficoll [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   770   C0205409:Isolated [Functional Concept]
   770   C0813724:Hypaque [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(Pharmacia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: "density gradient centrifugation."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0007704:Centrifugation, Density Gradient [Laboratory Procedure]
   827   C0007703:Centrifugation [Laboratory Procedure]
   827   C0178587:density [Quantitative Concept]
   827   C0439182:% gradient [Quantitative Concept]
   827   C0812409:Gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.43: Normal GC B cells were enriched from single-cell suspensions of tonsils by immunomagnetic bead depletion of T cells, monocytes, natural killer (NK) cells, naive B cells, and non-GC B cells using anti-CD4, -CD8, -CD14, -CD56, -IgD, and -CD44, respectively.19 FL cells were isolated from single-cell suspensions from lymph nodes or spleen that were histologically involved with FL. 

Phrase: "Normal GC B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   881   C0007634:Normal cell [Cell]
           Cells
   881   C1268443:Normal cell [Cell]
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "enriched from single-cell suspensions of tonsils"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   748   C0007634:Cell [Cell]
   748   C0037179:Single [Population Group]
   748   C0038960:Suspensions [Biomedical or Dental Material]
   748   C0040421:Tonsils [Body Part, Organ, or Organ Component]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0359583:enriched [Food]
   748   C0836921:tonsils [Body Part, Organ, or Organ Component]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C1280736:Tonsil [Body Part, Organ, or Organ Component]
   714 E C1382107:Suspension [Substance]
   714 E C1519547:TONSIL [Tissue]
   714 E C1705537:Suspension [Functional Concept]

Phrase: "by immunomagnetic bead depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333668:Depletion [Functional Concept]

Phrase: "of T cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "monocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026473:Monocytes [Cell]

Phrase: "natural killer (NK) cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
  1000   C2363836:Natural Killer Cells [Laboratory Procedure]
   901   C0022686:Killer Cells [Cell]
   901   C2709199:Natural killer [Cell]
   827   C0007634:Cells [Cell]
   827   C0205296:Natural [Functional Concept]
   827   C1336644:KILLER [Gene or Genome]
   827   C1705132:KILLER [Gene or Genome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "naive B cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "non-GC B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-CD4, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541261:CD4 [Laboratory Procedure]

Phrase: "CD8, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538720:CD8 [Laboratory Procedure]
  1000   C3540595:CD8 [Gene or Genome]

Phrase: "CD14, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367477:CD14 [Gene or Genome]
  1000   C3538991:CD14 [Laboratory Procedure]

Phrase: "CD56, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539926:CD56 [Laboratory Procedure]

Phrase: "IgD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020843:IgD [Amino Acid, Peptide, or Protein]
  1000   C0577612:IGD [Laboratory Procedure]

Phrase: "and -"

Phrase: "CD44,"

Phrase: "respectively.19 FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "isolated from single-cell suspensions"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   760   C0007634:Cell [Cell]
   760   C0037179:Single [Population Group]
   760   C0038960:Suspensions [Biomedical or Dental Material]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0205409:Isolated [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1548221:Isolated [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1382107:Suspension [Substance]
   726 E C1705537:Suspension [Functional Concept]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "from lymph nodes"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
  1000   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   966 E C0440747:LYMPH NODE [Tissue]
   966 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   861   C0024202:Lymph [Body Substance]
   861   C0746922:nodes [Body Part, Organ, or Organ Component]
   827 E C1706163:Node [Conceptual Entity]
   827 E C2697524:Node [Conceptual Entity]
   827 E C2700445:Node [Plant]
   777 E C0443268:Nodal [Spatial Concept]
   777 E C1417752:NODAL [Gene or Genome]
   755 E C0449725:Nodality [Spatial Concept]

Phrase: "or"

Phrase: "spleen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "that"

Phrase: "were"

Phrase: "histologically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205462:Histologically [Functional Concept]

Phrase: "involved with FL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]
Processing 00000000.tx.44: These populations of cells were depleted of T cells, monocytes, and NK cells as described above. 

Phrase: "These populations of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "were"

Phrase: "depleted of T cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0039194:T-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0333668:Depleted [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "monocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026473:Monocytes [Cell]

Phrase: "and"

Phrase: "NK cells as described above."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   833   C2363836:Natural Killer Cells [Laboratory Procedure]
   790   C0022686:Killer Cells [Cell]
   790   C2709199:Natural killer [Cell]
   753   C0007634:Cells [Cell]
   753   C0205296:Natural [Functional Concept]
   753   C1336644:KILLER [Gene or Genome]
   753   C1705132:KILLER [Gene or Genome]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.45: Normal GC B cells were obtained from tonsils from 6different individuals and FL cells isolated from 6individuals with relapsed FL who had not received any therapy for at least 6months before biopsy. 

Phrase: "Normal GC B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   881   C0007634:Normal cell [Cell]
           Cells
   881   C1268443:Normal cell [Cell]
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "obtained from tonsils"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0040421:Tonsils [Body Part, Organ, or Organ Component]
   790   C0836921:tonsils [Body Part, Organ, or Organ Component]
   790   C1301820:Obtained [Functional Concept]
   756 E C1280736:Tonsil [Body Part, Organ, or Organ Component]
   756 E C1519547:TONSIL [Tissue]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "from 6different individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "and"

Phrase: "FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "isolated from 6individuals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "with relapsed FL"

Phrase: "who"

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "any therapy for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0039798:therapy [Functional Concept]
   790   C0087111:Therapy [Therapeutic or Preventive Procedure]
   790   C1363945:Therapy [Finding]

Phrase: "at least 6months"

Phrase: "before biopsy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005558:Biopsy [Diagnostic Procedure]
  1000   C0220797:biopsy [Functional Concept]
Processing 00000000.tx.46: All samples were obtained according to appropriate Human Protection Committee validation and informed patient consent. 

Phrase: "All samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained according to appropriate Human Protection Committee validation"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0086418:Human [Human]
   744   C0680240:according [Social Behavior]
   744   C1301820:Obtained [Functional Concept]
   744   C1519941:Validation [Research Activity]
   744   C1545588:Protection [Finding]
   744   C1548787:Appropriate [Qualitative Concept]
   744   C2699414:Committee [Group]
   711 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "informed patient consent."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0021430:Informed Consent [Regulation or Law]
   827   C1511481:Consent [Functional Concept]
   827   C1554192:consent [Idea or Concept]
   734   C0588446:informed patient [Health Care Activity]
Processing 00000000.tx.47: Following immunomagnetic bead treatment, a small aliquot of cells was phenotyped by flow cytometry and the remainder quickly frozen before RNA extraction. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "immunomagnetic bead treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "a small aliquot of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510844:Aliquot [Quantitative Concept]

Phrase: "was"

Phrase: "phenotyped by flow cytometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   737   C0031437:Phenotype [Organism Attribute]
   737   C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "the remainder quickly"

Phrase: "frozen before RNA extraction."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0185115:Extraction [Therapeutic or Preventive Procedure]
   770   C0677542:Frozen [Functional Concept]
   770   C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.48: Flow cytofluorometric analysis and antibodies Cells were washed once in phosphate-buffered saline (PBS) and resuspended in PBS containing 1% bovine serum albumin (BSA; w/v; PBS-A). 

Phrase: "Flow cytofluorometric analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "antibodies Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once in phosphate-buffered saline (PBS)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C1720092:Once [Intellectual Product]
   760   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "resuspended in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   861   C0728877:serum albumin [Laboratory or Test Result]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0007452:Bovine [Mammal]
   812   C0229671:Serum [Body Substance]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "(BSA"

Phrase: "; w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: "; PBS-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "A"

Phrase: ")."
Processing 00000000.tx.49: Immunophenotyping was performed as previously described19 using monoclonal antibodies (mAbs) directed against CD4, CD8, CD14, CD20, CD38, CD44, CD56, IgD, or light chains (Southern Biotechnology Associates, Birmingham, AL). 

Phrase: "Immunophenotyping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079611:Immunophenotyping [Laboratory Procedure]

Phrase: "was"

Phrase: "performed as previously described19"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "monoclonal antibodies (mAbs)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against CD4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3541261:CD4 [Laboratory Procedure]
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "CD8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538720:CD8 [Laboratory Procedure]
  1000   C3540595:CD8 [Gene or Genome]

Phrase: "CD14,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367477:CD14 [Gene or Genome]
  1000   C3538991:CD14 [Laboratory Procedure]

Phrase: "CD20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540684:CD20 [Laboratory Procedure]

Phrase: "CD38,"

Phrase: "CD44,"

Phrase: "CD56,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539926:CD56 [Laboratory Procedure]

Phrase: "IgD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020843:IgD [Amino Acid, Peptide, or Protein]
  1000   C0577612:IGD [Laboratory Procedure]

Phrase: "or"

Phrase: "light chains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0337112:chains [Manufactured Object]
   861   C1306462:Light [Functional Concept]
   861   C1524075:Chains [Idea or Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "(Southern Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: ","

Phrase: "Birmingham,"

Phrase: "AL"

Phrase: ")."
Processing 00000000.tx.50: An irrelevant isotype-matched control mAb was used in all experiments. 

Phrase: "An irrelevant isotype-matched control mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "used in all experiments."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.51: The secondary antibody was a phycoerythrin R-conjugated goat F(ab')2 antimouse IgG (Southern Biotechnology Associates) diluted at 2g/mL. 

Phrase: "The secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "a phycoerythrin R-conjugated goat F(ab')2 antimouse IgG (Southern Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: "diluted at 2g/mL."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439526:/mL [Quantitative Concept]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]
Processing 00000000.tx.52: Flow cytometry was carried out within 2hours using an EPICS XL (Beckman-Coulter, Hialeah, FL). 

Phrase: "Flow cytometry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out within 2hours"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an EPICS XL"

Phrase: "(Beckman-Coulter,"

Phrase: "Hialeah,"

Phrase: "FL)."
Processing 00000000.tx.53: Cells were gated using forward versus side scatter to exclude dead cells and debris. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "gated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "versus"

Phrase: "side scatter to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439742:scatter [Spatial Concept]
   827   C0441987:Side [Spatial Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "dead cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "debris."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0440266:Debris [Substance]
Processing 00000000.tx.54: Poly(A)+ RNAs extraction and cDNA labeling Cells were resuspended in TRIzol reagent (Gibco BRL, Grand Island, NY) according to the manufacturer's procedures. 

Phrase: "Poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "+ RNAs extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "cDNA labeling Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in TRIzol reagent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   770   C0916178:trizol [Organic Chemical]

Phrase: "(Gibco BRL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: "Grand Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "according to the manufacturer's procedures."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.55: Contaminating DNA was removed by treatment with RNAse-free DNase I (Boehringer Mannheim, Indianapolis, IN) as described in the manufacturer's manual (Clontech, Palo Alto, CA). 

Phrase: "Contaminating DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "removed by treatment"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0849355:Removed [Qualitative Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "with RNAse-free DNase I"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C0035541:RNase I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
           DNase
   861   C1148702:DNase I [Genetic Function]
   812   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Boehringer Mannheim,"

Phrase: "Indianapolis,"

Phrase: "IN) as"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]

Phrase: "described in the manufacturer's"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1705426:Manufacturer [Population Group]

Phrase: "manual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024763:Manual [Intellectual Product,Manufactured Object]
  1000   C0175674:Manual [Functional Concept]

Phrase: "(Clontech,"

Phrase: "Palo Alto,"

Phrase: "CA)."
Processing 00000000.tx.56: After 1hour of incubation, the samples were extracted with phenol/chloroform/isoamylalcohol (25:24:1) and chloroform/isoamyl-alcohol (24:1). 

Phrase: "After 1hour"

Phrase: "of incubation,"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "extracted with phenol/chloroform/isoamylalcohol"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   760   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "(25"

Phrase: ":"

Phrase: "24"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "chloroform/isoamyl-alcohol"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0064032:Isoamyl alcohol [Organic Chemical]
   827   C0001962:ALCOHOL [Organic Chemical]
   827   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   755 E C0687725:Alcoholic [Patient or Disabled Group]

Phrase: "(24"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.57: Total RNAs were finally precipitated with 1:5 (v/v) 7.5M ammonium acetate and 1:2.5 (v/v) 100% ethanol. 

Phrase: "Total RNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "finally"

Phrase: "precipitated with 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: ":"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(v/v) 7.5M ammonium acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0051704:ammonium acetate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   799   C0002611:Ammonium [Inorganic Chemical]

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(v/v) 100% ethanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0001962:Ethanol [Organic Chemical]
Processing 00000000.tx.58: Poly(A)+ RNA was purified using Oligotex messenger RNA (mRNA) isolation kit (Qiagen, Valencia, CA) according to the manufacturer's protocol. 

Phrase: "Poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "+ RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Oligotex messenger RNA (mRNA) isolation kit (Qiagen,"

Phrase: "Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1217267:Valencia [Fish]
   928 E C1553365:Valencian [Population Group]

Phrase: "CA) according to the manufacturer's protocol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0050385:CA protocol [Therapeutic or Preventive Procedure]
Processing 00000000.tx.59: The cDNA probes were synthesized either from 1g mRNA extracted from normal GC B cells or FL cells by reverse transcription according to the Atlas cDNA Expression Array manufacturer's protocol (Clontech) using 35Ci (1.295KBq) [32P]dATP (3.000Ci/mmol; 111TBq/mmol) (NEN, Boston, MA). 

Phrase: "The cDNA probes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0012893:DNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0182400:Probes [Medical Device]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]
   734   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "either from 1g mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0335218:Messenger [Professional or Occupational Group]

Phrase: "extracted from normal GC B cells"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   778   C0004561:B-Cells [Cell]
   778   C0282491:Germinal Center [Tissue]
   757   C0007634:Normal cell [Cell]
           Cells
   757   C1268443:Normal cell [Cell]
   748   C0185115:Extracted [Therapeutic or Preventive Procedure]
   748   C0205099:Center [Spatial Concept]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C2347086:% Normal [Quantitative Concept]
   748   C3282337:Cells [Cell]
   748   C3541890:EXTRACTED [Finding]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714 E C2828366:Extract [Substance]

Phrase: "or"

Phrase: "FL cells by reverse transcription"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "according to the Atlas cDNA Expression Array manufacturer's protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0442711:Protocol [Intellectual Product]
   795   C1507394:Protocol [Intellectual Product]
   795   C1522729:Protocol [Intellectual Product]
   795   C2348563:Protocol [Intellectual Product]

Phrase: "(Clontech"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "35Ci"

Phrase: "(1.295KBq"

Phrase: ")"

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]dATP (3.000Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439190:MMOLE [Quantitative Concept]

Phrase: "; 111TBq/mmol) (NEN,"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.60: Probe purification and hybridization Reverse transcribed products were purified using CHROMA SPIN-200 DEPC-H2O columns as described by the manufacturer (Clontech). 

Phrase: "Probe purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243114:purification [Functional Concept]
   861   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "hybridization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020202:Hybridisation [Genetic Function]
  1000   C1300517:Hybridization [Laboratory Procedure]

Phrase: "Reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CHROMA SPIN-200 DEPC-H2O columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C1185738:Column [Body Part, Organ, or Organ Component]
   766   C1706132:Column [Idea or Concept]

Phrase: "as"

Phrase: "described by the manufacturer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1705426:Manufacturer [Population Group]

Phrase: "(Clontech"

Phrase: ")."
Processing 00000000.tx.61: Incorporation of 32P into the probes was determined after counting an aliquot in a liquid scintillation counter (Packard, Meridien, CT). 

Phrase: "Incorporation of 32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0243126:incorporation [Functional Concept]

Phrase: "into the probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "determined after counting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]

Phrase: "an aliquot in a liquid scintillation counter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510844:Aliquot [Quantitative Concept]

Phrase: "(Packard,"

Phrase: "Meridien,"

Phrase: "CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.62: The fractions corresponding to the peak were pooled and denatured (Clontech). 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "corresponding to the peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0444505:Peak [Quantitative Concept]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "denatured"

Phrase: "(Clontech"

Phrase: ")."
Processing 00000000.tx.63: The Atlas cDNA Expression Array membranes containing 588cDNAs (Clontech) were prehybridized in ExpressHyb buffer (Clontech) containing 100g/mL heat-denatured salmon sperm (Sigma, St Louis, MO) for 3hours in a rotating oven at 68C. 

Phrase: "The Atlas cDNA Expression Array membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   799   C0025255:Membranes [Tissue]
   766 E C0596901:Membrane [Cell Component]
   766 E C1706182:Membrane [Manufactured Object]
   716 E C0205287:Membranous [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "588cDNAs"

Phrase: "(Clontech"

Phrase: ")"

Phrase: "were"

Phrase: "prehybridized in ExpressHyb buffer"

Phrase: "(Clontech"

Phrase: ")"

Phrase: "containing 100g/mL heat-denatured salmon sperm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0037868:Sperm [Cell]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO) for 3hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3538743:MO [Idea or Concept]

Phrase: "in a rotating oven"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0336755:Oven [Manufactured Object]
   861   C1706357:Oven [Medical Device]

Phrase: "at 68C."
Processing 00000000.tx.64: The denatured probes were added directly into the hybridization buffer and further incubated for 18hours at 68C. 

Phrase: "The denatured probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "directly into the hybridization buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0020202:Hybridisation [Genetic Function]
   760   C1300517:Hybridization [Laboratory Procedure]
   760   C1947931:Directly [Qualitative Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "incubated for 18hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 68C."
Processing 00000000.tx.65: The membranes were washed 4times 30minutes at 68C with 2 standard sodium citrate (SSC)-1% sodium dodecyl sulfate (SDS), twice 30minutes at 68C with 0.1 SSC-0.5% SDS, and finally at room temperature for 5minutes in 2 SSC. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "4times 30minutes at 68C"

Phrase: "with 2 standard sodium citrate (SSC)-1% sodium dodecyl sulfate (SDS),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   869   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   864   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   793   C0038720:Sulfate [Inorganic Chemical]
   793   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   793   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "twice 30minutes at 68C"

Phrase: "with 0.1 SSC-0.5% SDS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   857   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   790   C0038720:Sulfate [Inorganic Chemical]
   790   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   790   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "finally at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1547703:Room [Spatial Concept]

Phrase: "for 5minutes"

Phrase: "in 2 SSC."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0142825:sodium citrate [Organic Chemical,Pharmacologic Substance]
   812   C0008857:Citrate [Organic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1442989:Standard [Qualitative Concept]
   812   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.66: Hybridizations were performed in duplicate. 

Phrase: "Hybridizations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0020202:Hybridization [Genetic Function]
   966   C1300517:Hybridization [Laboratory Procedure]

Phrase: "were"

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.67: Duplicate measurements were analyzed for reproducibility. 

Phrase: "Duplicate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205173:Duplicate [Functional Concept]
  1000   C3539942:Duplicate [Intellectual Product]

Phrase: "measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "analyzed for reproducibility."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0936012:Analyzed [Research Activity]
   790   C1514863:Reproducibility [Qualitative Concept]
Processing 00000000.tx.68: Quantitation was assessed and transformed by the logarithm (base 10). 

Phrase: "Quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "and"

Phrase: "transformed by the logarithm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1510411:Transformed [Pathologic Function]
   770   C2986775:Logarithm [Occupational Activity]

Phrase: "(base 10"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.69: The ratios of the measurements had a median of 0.036; 

Phrase: "The ratios of the measurements"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   764   C1261161:Ratio measurement [Laboratory Procedure]
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C1547037:Ratio [Intellectual Product]

Phrase: "had"

Phrase: "a median of 0.036"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0549183:Median [Spatial Concept]
   760   C0876920:Median [Quantitative Concept]
   760   C2347635:Median [Quantitative Concept]
   760   C2348144:Median [Quantitative Concept]
   760   C2939193:Median [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.70: 17% of the measurements were either above 0.10or below 0.10 on the log scale, suggesting that 83% of the genes could be replicated with no more than 10% error. 

Phrase: "17% of the measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "either above 0.10or"

Phrase: "below 0.10"

Phrase: "on the log scale,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0175659:Scale [Medical Device]
   861   C0349674:Scale [Intellectual Product]
   861   C1947916:Scale [Activity]
   861   C3536777:Scale [Manufactured Object]
   789 E C1710017:Scalar [Qualitative Concept]
   777 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that 83% of the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Genes [Gene or Genome]

Phrase: "could"

Phrase: "be"

Phrase: "replicated with no more"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205173:replicated [Functional Concept]
   737 E C0205341:Replicate [Functional Concept]
   737 E C1883725:Replicate [Qualitative Concept]

Phrase: "than 10% error."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0743559:error [Qualitative Concept]
   861   C1608199:Error [Functional Concept]
Processing 00000000.tx.71: Image acquisition and DNA array analysis The membranes were exposed to phosphorimager screens at room temperature for 2days (Molecular Dynamics, Sunnyvale, CA). 

Phrase: "Image acquisition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708464:Image Acquisition [Machine Activity]
   861   C1706701:Acquisition [Activity]

Phrase: "and"

Phrase: "DNA array analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0200898:DNA analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0600596:DNA Array [Research Device]

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to phosphorimager screens at room temperature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0220908:screen [Health Care Activity]
   719   C1305399:screen [Functional Concept]
   719   C1705053:Screen [Medical Device]

Phrase: "for 2days"

Phrase: "(Molecular Dynamics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: "Sunnyvale,"

Phrase: "CA)."
Processing 00000000.tx.72: The screens were scanned on a Storm 860Phosphorimager (Molecular Dynamics) at a resolution of 50m. 

Phrase: "The screens"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "were"

Phrase: "scanned on a Storm 860Phosphorimager"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0441633:scanned [Diagnostic Procedure]
   760   C2905612:Storm NOS [Injury or Poisoning]
   726 E C0034606:Scan [Diagnostic Procedure]
   726 E C2826292:SCAN [Finding]

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")"

Phrase: "at a resolution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514893:Resolution [Idea or Concept]
  1000   C1706463:Resolution [Quantitative Concept]
  1000   C2699488:Resolution [Conceptual Entity]

Phrase: "of 50m."
Processing 00000000.tx.73: Scans were imported and arrayed using the AtlasImage 1.5software (Clontech). 

Phrase: "Scans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034606:Scan [Diagnostic Procedure]
  1000   C0441633:Scan [Diagnostic Procedure]
  1000   C2826292:SCAN [Finding]

Phrase: "were"

Phrase: "imported"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699788:Imported [Occupational Activity]

Phrase: "and"

Phrase: "arrayed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510941:Array [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the AtlasImage 1.5software"

Phrase: "(Clontech"

Phrase: ")."
Processing 00000000.tx.74: The arrays from the 6different normal GC B-cell samples were averaged after normalization of their intensities using the sum method as described in the AtlasImage 1.5user manual. 

Phrase: "The arrays from the 6different normal GC B-cell samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C1510941:Array [Spatial Concept]

Phrase: "were"

Phrase: "averaged after normalization of their intensities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0522510:intensities [Qualitative Concept]
   753   C1882115:Normalization [Research Activity]
   719   C1510992:Average [Quantitative Concept]
   719   C2825518:AVERAGE [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the sum method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "as"

Phrase: "described in the AtlasImage 1.5user"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1552738:described [Idea or Concept]

Phrase: "manual."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024763:Manual [Intellectual Product,Manufactured Object]
  1000   C0175674:Manual [Functional Concept]
Processing 00000000.tx.75: The same procedure was applied to the arrays from the 6different FL samples. 

Phrase: "The same procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "applied to the arrays"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0185125:Applied [Health Care Activity]
   737   C1510941:Array [Spatial Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "from the 6different FL samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.76: Using this methodology -actin (GenBank accession no. X00351, Human Genome Organization (HUGO) nomenclature ACTB) and ribosomal protein S9 (GenBank accession no. U14971, HUGO nomenclature RPS9) were equally expressed in all the samples. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this methodology -actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "(GenBank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1510755:Accession [Intellectual Product]
   861   C1706078:Accession [Activity]

Phrase: "no. X00351,"

Phrase: "Human Genome Organization (HUGO) nomenclature ACTB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1384510:ACTB [Gene or Genome]
   804   C3542398:ACTB [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1705051:Human Genome Organisation [Organization]

Phrase: ")"

Phrase: "and"

Phrase: "ribosomal protein S9"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0073341:ribosomal protein S9 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419753:RIBOSOMAL PROTEIN S9 [Gene or Genome]
           S9
   901   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0035553:Ribosomal [Cell Component]
   827   C1419029:S9 [Gene or Genome]
   827   C1861421:S9 [Gene or Genome]
   755 E C2984240:Ribosome [Functional Concept]

Phrase: "(GenBank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1510755:Accession [Intellectual Product]
   861   C1706078:Accession [Activity]

Phrase: "no. U14971,"

Phrase: "HUGO nomenclature RPS9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1419753:RPS9 [Gene or Genome]
   717   C1705051:Human Genome Organisation [Organization]

Phrase: ")"

Phrase: "were"

Phrase: "equally"

Phrase: "expressed in all"

Phrase: "the samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.77: Two composite arrays were generated, respectively. 

Phrase: "Two composite arrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1510941:Array [Spatial Concept]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.78: These 2composite arrays were finally compared using the AtlasImage 1.5software. 

Phrase: "These 2composite arrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510941:Array [Spatial Concept]

Phrase: "were"

Phrase: "finally"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the AtlasImage 1.5software."
Processing 00000000.tx.79: Intensity of the genes ranged from 0to 65280 arbitrary units (AU). 

Phrase: "Intensity of the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "ranged from 0to 65280 arbitrary units (AU)."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   756   C0439183:Arbitrary unit [Quantitative Concept]
   753   C0439148:Units [Quantitative Concept]
   753   C1264693:*Arbitrary [Quantitative Concept]
   753   C1519795:Units [Quantitative Concept]
   719   C1514721:Range [Quantitative Concept]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]
   719   C2348147:Range [Quantitative Concept]
   719   C3542016:Range [Intellectual Product]
Processing 00000000.tx.80: For a given gene, positive ratio corresponded to the normalized value of the intensity of a gene in FL cells divided by the normalized value in normal GC B cells. 

Phrase: "For a given gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "positive ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "corresponded to the normalized value of the intensity of a gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0017337:Gene [Gene or Genome]
   738   C0522510:Intensity [Qualitative Concept]
   738   C1522609:Value [Quantitative Concept]
   738   C1882115:Normalized [Research Activity]

Phrase: "in FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "divided by the normalized value"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332849:Divided [Functional Concept]
   760   C1522609:Value [Quantitative Concept]
   760   C1882115:Normalized [Research Activity]

Phrase: "in normal GC B cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   881   C0007634:Normal cell [Cell]
           Cells
   881   C1268443:Normal cell [Cell]
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.81: Negative ratios are the negative value of the ratio of the normalized gene intensities of normal GC B cells divided by the one of FL cells. 

Phrase: "Negative ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: "the negative value of the ratio of the normalized gene intensities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C1532109:Ratio value [Quantitative Concept]
   738   C1522609:Value [Quantitative Concept]

Phrase: "of normal GC B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   881   C0007634:Normal cell [Cell]
           Cells
   881   C1268443:Normal cell [Cell]
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "divided by the one of FL cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0007634:Cells [Cell]
   748   C0205447:One [Quantitative Concept]
   748   C0332849:Divided [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.82: Ratios greater than or equal to 2and less than or equal to 2 were identified for further investigation. 

Phrase: "Ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0456603:Ratios [Quantitative Concept]
  1000   C1610540:*Ratios [Quantitative Concept]
   966 E C1547037:Ratio [Intellectual Product]

Phrase: "greater than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439093:Greater Than [Quantitative Concept]
   833   C0443228:greater [Quantitative Concept]
   833   C1704243:Greater [Quantitative Concept]
   799 E C0549177:Great [Quantitative Concept]

Phrase: "or"

Phrase: "equal to 2and less"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0205163:Equal To [Qualitative Concept]
           Equal
   770   C1549782:Equal [Idea or Concept]

Phrase: "than"

Phrase: "or"

Phrase: "equal to 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0205163:Equal To [Qualitative Concept]
           Equal
   790   C1549782:Equal [Idea or Concept]

Phrase: "were"

Phrase: "identified for further investigation."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0205396:Identified [Qualitative Concept]
   770   C1261322:Investigation [Health Care Activity]
   770   C1517331:Further [Spatial Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1552578:investigation [Idea or Concept]
   737 E C0205108:far [Spatial Concept]
Processing 00000000.tx.83: To include genes for which the value was below background level (ie, 0for the AtlasImage 1.5software), we took into consideration differences in intensities (FL minus GC) greater than or equal to 2000and less than or equal to 2000 AU. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "genes for which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017337:Genes [Gene or Genome]

Phrase: "the value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "was below background level"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1421478:WAS [Gene or Genome]
   770   C1547707:Level [Geographic Area]
   770   C1706907:Background [Conceptual Entity]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "ie"

Phrase: ","

Phrase: "0for"

Phrase: "the AtlasImage 1.5software"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "took into consideration differences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0518609:consideration [Finding]
   737   C1515187:Take [Health Care Activity]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in intensities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522510:intensities [Qualitative Concept]

Phrase: "(FL minus GC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282491:Germinal Center [Tissue]
   812   C0205099:Center [Spatial Concept]

Phrase: ")"

Phrase: "greater than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439093:Greater Than [Quantitative Concept]
   833   C0443228:greater [Quantitative Concept]
   833   C1704243:Greater [Quantitative Concept]
   799 E C0549177:Great [Quantitative Concept]

Phrase: "or"

Phrase: "equal to 2000and less"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0205163:Equal To [Qualitative Concept]
           Equal
   770   C1549782:Equal [Idea or Concept]

Phrase: "than"

Phrase: "or"

Phrase: "equal to 2000 AU."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0205163:Equal To [Qualitative Concept]
           Equal
   760   C1549782:Equal [Idea or Concept]
Processing 00000000.tx.84: All the expressed genes that did not meet these criteria are available at http://dfciwww.dfci.harvard.edu/AO/Freedman_Lab/cDNA_array/not_different_expressed.html. 

Phrase: "All"

Phrase: "the expressed genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "meet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Meet [Idea or Concept]

Phrase: "these criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "are"

Phrase: "available at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ":"

Phrase: "//dfciwww.dfci.harvard.edu/AO/Freedman_Lab/cDNA_array/not_different_"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   787   C1705242:Different [Qualitative Concept]
   716 E C1705241:*Difference [Quantitative Concept]

Phrase: "expressed.html."
Processing 00000000.tx.85: Real-time quantitative PCR analysis Real-time quantitative RT-PCR analysis was performed using an ABI PRISM 7700Sequence Detection System instrument using the SYBR Green I dye (PE Biosystems, Foster City, CA). 

Phrase: "Real-time quantitative PCR analysis Real-time quantitative RT-PCR analysis"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ABI PRISM 7700Sequence Detection System instrument"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0348000:Instrument [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SYBR Green I dye"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   756   C0386577:SYBR Green I [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(PE Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)."
Processing 00000000.tx.86: Briefly, direct detection of PCR product was monitored by measuring the increase in fluorescence caused by the binding of SYBR Green I dye to double-stranded DNA by the Sequence Detection System directly into the reaction tube. 

Phrase: "Briefly,"

Phrase: "direct detection of PCR product"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "monitored by measuring"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   756   C0030695:monitor [Health Care Activity]
   756 E C0079809:Measure [Quantitative Concept]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756 E C0242485:Measure [Functional Concept]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "the increase in fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "caused by the binding of SYBR Green I dye to double-stranded DNA"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   780   C1148741:double-stranded DNA binding [Genetic Function]
   766   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   766   C0386577:SYBR Green I [Indicator, Reagent, or Diagnostic Aid]
   749   C1148673:DNA Binding [Genetic Function]
   735   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   735   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   735   C0021966:I- [Inorganic Chemical]
   735   C0205173:Double [Functional Concept]
   735   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   735   C0243122:binding [Functional Concept]
   735   C0332583:Green [Qualitative Concept]
   735   C1145667:Binding [Activity]
   735   C1167622:Binding [Molecular Function]
   735   C1705764:Double [Activity]
   735   C1705765:Double [Qualitative Concept]
   714   C1979882:Double strand [Qualitative Concept]
   702   C0015127:cause [Functional Concept]
   702   C1524003:Cause [Conceptual Entity]

Phrase: "by the Sequence Detection System directly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "into the reaction tube."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0175730:Tube [Medical Device]
   861   C1547937:Tube NOS [Intellectual Product]
   861   C1561954:tube [Conceptual Entity]
   861   C1704730:TUBE [Medical Device]
Processing 00000000.tx.87: The sequence detector software 1.7calculates the threshold cycle number (CT) when signals reach 10times the SD of the baseline. 

Phrase: "The sequence detector software 1.7calculates"

Phrase: "the threshold cycle number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]

Phrase: "(CT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "when"

Phrase: "signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "10times"

Phrase: "the SD of the baseline."
Processing 00000000.tx.88: It was previously demonstrated that the calculated CT values are a quantitative measurement for the mRNA levels of various genes tested.20,21 DNase I-treated total RNA (1g) was reverse transcribed using the Advantage RT-for-PCR kit (Clontech) following the manufacturer's instructions, resuspended in 100L final volume, and aliquoted to avoid freezing and thawing procedures. 

Phrase: "It"

Phrase: "was"

Phrase: "previously"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the calculated CT values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "a quantitative measurement for the mRNA levels of various genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0242485:Measurement [Functional Concept]

Phrase: "tested.20,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0392366:tested [Intellectual Product]
   827 E C0022885:Test [Laboratory Procedure]
   827 E C0039593:Test [Functional Concept]

Phrase: "21 DNase I-treated total RNA (1g"

Phrase: ")"

Phrase: "was"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Advantage"

Phrase: "RT-for-PCR kit (Clontech"

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturer's instructions,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "resuspended in 100L final volume,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205088:Final [Temporal Concept]
   760   C0449468:*Volume [Quantitative Concept]
   760   C1546485:Final [Idea or Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "aliquoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "freezing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016701:Freezing [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "thawing procedures."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.89: RT reaction (2.5L), or water as control, was amplified in triplicate by real-time PCR in a final volume of 50L using the SYBR Green Master Mix reagent at a final concentration of 1 (PE Biosystems). 

Phrase: "RT reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "(2.5L"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "water as control,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "was"

Phrase: "amplified in triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205174:Triplicate [Quantitative Concept]

Phrase: "by real-time PCR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   875   C0034746:time reaction [Temporal Concept]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]

Phrase: "in a final volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 50L"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SYBR Green Master Mix reagent at a final concentration of 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(PE Biosystems"

Phrase: ")."
Processing 00000000.tx.90: The appropriate primers were designed with the Primer Express 1.0software (PE Biosystems). 

Phrase: "The appropriate primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed with the Primer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   737   C1707689:Design [Activity]
   737   C2983265:DESIGN [Intellectual Product]

Phrase: "Express"

Phrase: "1.0software"

Phrase: "(PE Biosystems"

Phrase: ")."
Processing 00000000.tx.91: To ensure that any DNA contamination was removed by DNAse I treatment, real-time RT-PCR was performed on non-reverse-transcribed RNA. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "any DNA contamination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2936628:DNA Contamination [Human-caused Phenomenon or Process]
   861   C0259846:contamination [Human-caused Phenomenon or Process]
   861   C1881659:CONTAMINATION [Event]
   861   C2349974:Contamination [Idea or Concept]

Phrase: "was"

Phrase: "removed by DNAse I treatment,"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   806   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
           DNase
   806   C1148702:DNase I [Genetic Function]
   760   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0021966:I- [Inorganic Chemical]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0849355:Removed [Qualitative Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]

Phrase: "real-time RT-PCR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   929   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   876   C0034746:time reaction [Temporal Concept]
   861   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   799   C0337112:Chain [Manufactured Object]
   799   C0443286:Reaction [Functional Concept]
   799   C1114821:Reaction [Clinical Attribute]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1524075:Chain [Idea or Concept]

Phrase: "was"

Phrase: "performed on non-reverse-transcribed RNA."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0884358:Performed [Functional Concept]
   753   C1518422:Non [Functional Concept]
   753   C1555029:Reverse [Idea or Concept]
   719 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.92: No amplification was observed in these conditions for all 65genes that were differentially expressed. 

Phrase: "No amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "observed in these conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1441672:Observed [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "for all 65genes"

Phrase: "that"

Phrase: "were"

Phrase: "differentially"

Phrase: "expressed."
Processing 00000000.tx.93: Due to the nonspecific binding of SYBR Green I to double-stranded DNA, the optimal primer concentrations were defined after verifying that no amplification was observed in the no template controls (NTCs) for a given set of forward and reverse primer concentrations. 

Phrase: "Due to the nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "of SYBR Green I to double-stranded DNA,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   845   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0205173:Double [Functional Concept]
   795   C1705764:Double [Activity]
   795   C1705765:Double [Qualitative Concept]
   782   C1979882:Double strand [Qualitative Concept]
   724   C1704972:Strand [Spatial Concept]
   724   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the optimal primer concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "after"

Phrase: "verifying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1553511:Verifying [Intellectual Product]
   966 E C1711411:Verify [Functional Concept]

Phrase: "that"

Phrase: "no amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "observed in the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "no template controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(NTCs"

Phrase: ")"

Phrase: "for a given set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "of forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "reverse primer concentrations."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.94: To ensure the specificity of the reaction, the size of the PCR product for each gene was verified by gel electrophoresis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "the specificity of the reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "the size of the PCR product"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0456389:size [Spatial Concept]

Phrase: "for each gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "verified by gel electrophoresis."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0596607:Gel Electrophoresis [Laboratory Procedure]
   819 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   770   C0013855:Electrophoresis [Laboratory Procedure]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C1382104:Gel [Substance]
   770   C1711411:Verified [Functional Concept]
Processing 00000000.tx.95: The sequences and the concentrations of the primers are available at http://dfciwww.dfci.harvard.edu/AO/Freedman_Lab/cDNA_array/sequences.html. 

Phrase: "The sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "the concentrations of the primers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "are"

Phrase: "available at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ":"

Phrase: "//dfciwww.dfci.harvard.edu/AO/Freedman_Lab/cDNA_array/sequences.html."
Processing 00000000.tx.96: Conditions were as follows: 1cycle at 50C for 2minutes, 1cycle at 95C for 10minutes, 40cycles at 95C for 15seconds, and 60C for 1minute. 

Phrase: "Conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "1cycle at 50C"

Phrase: "for 2minutes,"

Phrase: "1cycle at 95C"

Phrase: "for 10minutes,"

Phrase: "40cycles at 95C"

Phrase: "for 15seconds,"

Phrase: "and"

Phrase: "60C for 1minute."
Processing 00000000.tx.97: Validation experiments to verify the efficiencies of amplification of the primers of target and reference genes were approximately equal. 

Phrase: "Validation experiments to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the efficiencies of amplification of the primers of target"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0013682:efficiencies [Quantitative Concept]

Phrase: "and"

Phrase: "reference genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "approximately equal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205163:Equal [Qualitative Concept]
   861   C1549782:Equal [Idea or Concept]
Processing 00000000.tx.98: For each sample, CT values for -actin and ribosomal protein S9 genes were generated for normalization purposes. 

Phrase: "For each sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "CT values for -actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "ribosomal protein S9 genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Genes [Gene or Genome]
   756   C0073341:ribosomal protein S9 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1419753:RIBOSOMAL PROTEIN S9 [Gene or Genome]

Phrase: "were"

Phrase: "generated for normalization purposes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1285529:purposes [Functional Concept]
   770   C1882115:Normalization [Research Activity]
   770   C3146294:Generated [Activity]
Processing 00000000.tx.99: For each run of each sample, a correction factor was calculated by dividing by the minimum -actin and ribosomal protein S9 values, and then averaging the adjusted control values for the sample. 

Phrase: "For each run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "of each sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "a correction factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "was"

Phrase: "calculated by"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0444686:Calculated [Functional Concept]
   833   C1441506:Calculated [Activity]
   833   C1443182:Calculated [Laboratory Procedure]

Phrase: "dividing by the minimum -actin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332849:dividing [Functional Concept]
   760   C1524031:Minimum [Qualitative Concept]
   760   C1552614:minimum [Idea or Concept]
   760   C2826545:MINIMUM [Quantitative Concept]

Phrase: "and"

Phrase: "ribosomal protein S9 values,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0042295:Values [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]
   756   C0073341:ribosomal protein S9 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1419753:RIBOSOMAL PROTEIN S9 [Gene or Genome]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "averaging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "the adjusted control values for the sample."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0042295:Values [Qualitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.100: This value was used to correct each sample for differences in RNA content. 

Phrase: "This value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "used to correct"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   790   C2349182:Correct [Qualitative Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "each"

Phrase: "sample for differences"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0370003:Sample [Substance]
   790   C2347026:Sample [Conceptual Entity]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in RNA content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.101: Statistical analysis Genes were identified from the Clontech array as described above. 

Phrase: "Statistical analysis Genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017337:Genes [Gene or Genome]
   734   C0871424:statistical analysis [Research Activity]

Phrase: "were"

Phrase: "identified from the Clontech array"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205396:Identified [Qualitative Concept]
   760   C1510941:Array [Spatial Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "as described above."
Processing 00000000.tx.102: Results of quantitative RT-PCR were assessed by the 2-sample t test; 

Phrase: "Results of quantitative RT-PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1709795:Quantitative Result [Finding]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "were"

Phrase: "assessed by the 2-sample t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0370003:Sample [Substance]
   748   C0392366:test [Intellectual Product]
   748   C1516048:Assessed [Activity]
   748   C2347026:Sample [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.103: nominal P values are presented without correction for multiple comparisons.  

Phrase: "nominal P values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   896   C1264625:Nominal value [Quantitative Concept]
   867   C1709380:P-Value [Quantitative Concept]
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "presented without correction"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449450:Presented [Idea or Concept]
   790   C1705565:CORRECTION [Intellectual Product]
   790   C1947976:Correction [Functional Concept]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "for multiple comparisons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]
Processing 00000000.tx.104: Results Top Abstract Introduction Materials and methods Results Discussion References Cell surface analysis of purified GC B cells and FL cells To try to better understand the differences in gene expression between normal GC B cells and FL cells we used purified cell populations. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell surface analysis of purified GC B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "FL cells To"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "try"

Phrase: "to better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the differences in gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1519516:Differential Gene Expression [Genetic Function]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "between normal GC B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   881   C0007634:Normal cell [Cell]
           Cells
   881   C1268443:Normal cell [Cell]
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "purified cell populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.105: Single mononuclear cell suspensions of tonsil and tissues biopsies involved with FL contain significant numbers of T cells, NK cells, and monocytes and in the case of tonsil, naive and memory B cells. 

Phrase: "Single mononuclear cell suspensions of tonsil"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0038960:Suspensions [Biomedical or Dental Material]
   719 E C1382107:Suspension [Substance]
   719 E C1705537:Suspension [Functional Concept]

Phrase: "and"

Phrase: "tissues biopsies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0005558:biopsies [Diagnostic Procedure]
   827 E C0220797:biopsy [Functional Concept]

Phrase: "involved with FL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "significant numbers of T cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "NK cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
  1000   C2363836:Natural Killer Cells [Laboratory Procedure]
   901   C0022686:Killer Cells [Cell]
   901   C2709199:Natural killer [Cell]
   827   C0007634:Cells [Cell]
   827   C0205296:Natural [Functional Concept]
   827   C1336644:KILLER [Gene or Genome]
   827   C1705132:KILLER [Gene or Genome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "monocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026473:Monocytes [Cell]

Phrase: "and in the case of tonsil,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0040421:Tonsil [Body Part, Organ, or Organ Component]
   753   C0836921:Tonsil [Body Part, Organ, or Organ Component]
   753   C0868928:Case [Functional Concept]
   753   C1280736:Tonsil [Body Part, Organ, or Organ Component]
   753   C1515981:And [Idea or Concept]
   753   C1519547:TONSIL [Tissue]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]

Phrase: "naive"

Phrase: "and"

Phrase: "memory B cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0682638:Memory B Cell [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.106: To limit the interference of any genes from the microenvironment in our study, we used immunomagnetic bead depletion to remove these cells from our preparations. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "the interference of any genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0521102:Interference [Qualitative Concept]

Phrase: "from the microenvironment"

Phrase: "in our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunomagnetic bead depletion to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0333668:Depletion [Functional Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "these cells from our preparations."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   764   C0920433:cell preparation [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.107: Normal GC B cells were purified from single-cell suspensions of tonsils. 

Phrase: "Normal GC B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   881   C0007634:Normal cell [Cell]
           Cells
   881   C1268443:Normal cell [Cell]
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "purified from single-cell suspensions of tonsils."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   748   C0007634:Cell [Cell]
   748   C0037179:Single [Population Group]
   748   C0038960:Suspensions [Biomedical or Dental Material]
   748   C0040421:Tonsils [Body Part, Organ, or Organ Component]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0836921:tonsils [Body Part, Organ, or Organ Component]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C1998793:Purified [Functional Concept]
   714 E C1280736:Tonsil [Body Part, Organ, or Organ Component]
   714 E C1382107:Suspension [Substance]
   714 E C1519547:TONSIL [Tissue]
   714 E C1705537:Suspension [Functional Concept]
Processing 00000000.tx.108: The immunophenotype of GC B cells has been previously described to be CD20+/CD38+ and IgD/CD44.19,22 Following immunomagnetic bead depletion of T cells, monocytes, NK cells, and IgD+/CD44+ cells, the population of cells were phenotyped and analyzed by flow cytometry. 

Phrase: "The immunophenotype of GC B cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0079611:Immunophenotype [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "CD20+/CD38+"

Phrase: "and"

Phrase: "IgD/CD44.19,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020843:IgD [Amino Acid, Peptide, or Protein]
   827   C0577612:IGD [Laboratory Procedure]

Phrase: "22"

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "immunomagnetic bead depletion of T cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0677960:T-Cell Depletion [Therapeutic or Preventive Procedure]
   753   C0333668:Depletion [Functional Concept]

Phrase: "monocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026473:Monocytes [Cell]

Phrase: "NK cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
  1000   C2363836:Natural Killer Cells [Laboratory Procedure]
   901   C0022686:Killer Cells [Cell]
   901   C2709199:Natural killer [Cell]
   827   C0007634:Cells [Cell]
   827   C0205296:Natural [Functional Concept]
   827   C1336644:KILLER [Gene or Genome]
   827   C1705132:KILLER [Gene or Genome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "IgD+/CD44+ cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "the population of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "were"

Phrase: "phenotyped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0031437:Phenotype [Organism Attribute]
   966   C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "analyzed by flow cytometry."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.109: The preparation of GC B cells was more than 98% CD20+/CD38+, with no detectable CD4+, CD8+, CD56+, CD14+, CD44+, and IgD+ cells. 

Phrase: "The preparation of GC B cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0920433:cell preparation [Laboratory Procedure]
   748   C0455052:Preparation [Health Care Activity]
   748   C1521827:Preparation [Functional Concept]

Phrase: "was"

Phrase: "more than 98% CD20+/CD38+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205172:More [Functional Concept]
   760   C3540684:CD20 [Laboratory Procedure]

Phrase: "with no detectable CD4+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541261:CD4 [Laboratory Procedure]

Phrase: "CD8+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538720:CD8 [Laboratory Procedure]
  1000   C3540595:CD8 [Gene or Genome]

Phrase: "CD56+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539926:CD56 [Laboratory Procedure]

Phrase: "CD14+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367477:CD14 [Gene or Genome]
  1000   C3538991:CD14 [Laboratory Procedure]

Phrase: "CD44+,"

Phrase: "and"

Phrase: "IgD+ cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.110: Similarly, immunomagnetic depletion of T cells, NK cells, and monocytes was performed with single-cell suspensions of tissues involved with FL. 

Phrase: "Similarly,"

Phrase: "immunomagnetic depletion of T cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0677960:T-Cell Depletion [Therapeutic or Preventive Procedure]
   760   C0333668:Depletion [Functional Concept]

Phrase: "NK cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
  1000   C2363836:Natural Killer Cells [Laboratory Procedure]
   901   C0022686:Killer Cells [Cell]
   901   C2709199:Natural killer [Cell]
   827   C0007634:Cells [Cell]
   827   C0205296:Natural [Functional Concept]
   827   C1336644:KILLER [Gene or Genome]
   827   C1705132:KILLER [Gene or Genome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "monocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026473:Monocytes [Cell]

Phrase: "was"

Phrase: "performed with single-cell suspensions of tissues"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   748   C0007634:Cell [Cell]
   748   C0037179:Single [Population Group]
   748   C0038960:Suspensions [Biomedical or Dental Material]
   748   C0040300:Tissues [Tissue]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0884358:Performed [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C1382107:Suspension [Substance]
   714 E C1547928:Tissue [Intellectual Product]
   714 E C1705537:Suspension [Functional Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "involved with FL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]
Processing 00000000.tx.111: Cell surface marker analysis of FL cells showed a monoclonal population CD20+ B cells.23-25 cDNA array analysis In an attempt to further understand differences between FL and normal GC B cells, we compared the gene expression between these 2cell types by cDNA microarray. 

Phrase: "Cell surface marker analysis of FL cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0430297:Cell marker analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a monoclonal population CD20+ B cells.23-25 cDNA array analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   880   C1514228:Population Analysis [Research Activity]
   841   C1449653:Cell Array Analysis [Laboratory Procedure]
   809   C0200898:DNA analysis [Laboratory Procedure]
   788   C0002778:Analysis [Laboratory Procedure]
   788   C0936012:Analysis [Research Activity]
   788   C1524024:analysis [Functional Concept]

Phrase: "In an attempt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "differences between FL"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "normal GC B cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   881   C0007634:Normal cell [Cell]
           Cells
   881   C1268443:Normal cell [Cell]
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the gene expression between these 2cell types"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0017262:Gene Expression [Genetic Function]
   774   C0314611:GENE TYPES [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by cDNA microarray."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0600596:DNA Microarray [Research Device]
   901   C1522053:DNA Microarray [Molecular Biology Research Technique]
   827   C1709016:Microarray [Manufactured Object]
   734   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.112: In the Clontech array the randomly selected cDNA represented all known sequences spotted onto a nylon membrane as amplified products of 200to 600base pairs (bp) in length. 

Phrase: "In the Clontech"

Phrase: "array"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510941:Array [Spatial Concept]

Phrase: "the randomly"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "all known sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "spotted onto a nylon membrane"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0025255:Membrane [Tissue]
   760   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   760   C0596901:Membrane [Cell Component]
   760   C0740034:Nylon [Biomedical or Dental Material]
   760   C1706182:Membrane [Manufactured Object]
   726   C0329155:Spot [Fish]
   726   C1427618:SPOT [Gene or Genome]
   726   C1705203:Spot [Conceptual Entity]

Phrase: "as amplified products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "of 200to 600base pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709450:Pair [Qualitative Concept]

Phrase: "(bp) in length."
Processing 00000000.tx.113: These fragments have been carefully selected from gene regions that lack the poly-A tail, repetitive elements, or other highly homologous sequences. 

Phrase: "These fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "carefully"

Phrase: "selected from gene regions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017337:Gene [Gene or Genome]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]
   737   C1707391:Select [Activity]

Phrase: "that"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the poly-A tail,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242494:POLY A TAIL [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0039259:Tail [Body Part, Organ, or Organ Component]
   734   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "repetitive elements,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0086908:Repetitive Element [Nucleotide Sequence]
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "or"

Phrase: "other highly homologous sequences."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   901   C0162774:Homologous Sequences [Molecular Sequence]
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C1334043:Homologous [Gene or Genome]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.114: The array is organized in 6different quadrants each containing one or several gene families. 

Phrase: "The array"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510941:Array [Spatial Concept]

Phrase: "is"

Phrase: "organized in 6different quadrants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1300196:Organized [Functional Concept]
   737   C1631280:Quadrant [Spatial Concept]

Phrase: "each"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "several gene families."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1517488:Gene Family [Gene or Genome]
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.115: The families include oncogenes, tumor suppressors, cell cycle control proteins (Figure 1A); 

Phrase: "The families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "oncogenes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogenes [Gene or Genome]

Phrase: "tumor suppressors,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0079427:Tumor Suppressors [Gene or Genome]
   966 E C1325410:tumor suppressor [Cell Function]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   827   C1710252:Suppressor [Manufactured Object]
   827   C2954564:Suppressor [Pharmacologic Substance]

Phrase: "cell cycle control proteins"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   923   C0243021:Cell Cycle Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1155872:Cell Cycle Control [Cell Function]
   861   C0007586:Cell Cycle [Cell Function]
   861   C1155839:Cell Cycle [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243148:control [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1511572:Cycle [Temporal Concept]
   812   C1550141:Control [Substance]
   812   C1704653:Cell [Medical Device]
   812   C1882979:Control [Conceptual Entity]
   812   C1948049:Cell [Spatial Concept]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "(Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.116: ion channels and transport, intracellular signal transduction modulators and effectors, stress response proteins (Figure 1B); 

Phrase: "ion channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "transport,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "intracellular signal transduction modulators"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1709060:Modulator [Manufactured Object]
   756   C1155494:intracellular signal transduction [Molecular Function]

Phrase: "and"

Phrase: "effectors,"

Phrase: "stress response proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0018850:Stress Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0149784:stress response [Physiologic Function]

Phrase: "(Figure 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.117: apoptosis, DNA synthesis, repair and recombination proteins (Figure 1C); 

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "DNA synthesis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598312:DNA Synthesis [Genetic Function]
  1000   C1328870:DNA synthesis [Laboratory Procedure]
  1000   C1817262:DNA synthesis [Genetic Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "repair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "recombination proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Figure 1C"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.118: transcription factors, general DNA-binding proteins (Figure 1D); 

Phrase: "transcription factors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "general DNA-binding proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C0012940:DNA-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   906 E C0812382:DNA-binding protein [Gene or Genome]
   875   C0058610:dna proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Figure"

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.119: receptors, cell surface antigens, cell adhesion (Figure 1E); 

Phrase: "receptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "cell surface antigens,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0003339:Cell Surface Antigens [Immunologic Factor]
           Surface Antigens
   901   C0699040:Cell surface [Cell Component]
   827   C0003320:Antigens [Immunologic Factor]
   827   C0007634:Cell [Cell]
   827   C0205148:Surface [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cell Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "(Figure 1E"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.120: and cell-cell communication factors (Figure 1F). 

Phrase: "and"

Phrase: "cell-cell communication factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
   708   C0007582:Cell Communication [Cell Function]

Phrase: "(Figure 1F"

Phrase: ")."
Processing 00000000.tx.121: View larger version (88K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(88K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.122: Gene expression patterns in FLs. 

Phrase: "Gene expression patterns in FLs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Patterns [Spatial Concept]
Processing 00000000.tx.123: Gene expression profiles generated from 6healthy individuals (GC B cells) and 6patients with relapsed FL were analyzed using cDNA arrays. 

Phrase: "Gene expression profiles"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1956267:Gene Expression Profiles [Quantitative Concept]
   983 E C1449575:gene expression profile [Laboratory Procedure]
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]
   734   C0017262:Gene Expression [Genetic Function]

Phrase: "generated from 6healthy individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C3146294:Generated [Activity]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "(GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "6patients with relapsed FL"

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cDNA arrays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0600596:DNA Arrays [Research Device]
   793   C1510941:Array [Spatial Concept]
   734   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.124: The mRNA from purified cells were reverse transcribed and hybridized as described in "Materials and methods." 

Phrase: "The mRNA from purified cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0335218:Messenger [Professional or Occupational Group]

Phrase: "were"

Phrase: "reverse transcribed"

Phrase: "and"

Phrase: "hybridized"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "in ""Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.125: The 6arrays obtained after hybridization of 6GC B-cell probes were averaged, as well as 6arrays from 6FL-cell probes to create 2composite arrays, respectively. 

Phrase: "The 6arrays"

Phrase: "obtained after hybridization of 6GC B-cell probes"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   770   C0004561:B-cell [Cell]
   767   C0007597:Cell hybridisation [Laboratory Procedure]
   744   C0007634:Cell [Cell]
   744   C0020202:Hybridisation [Genetic Function]
   744   C0182400:Probes [Medical Device]
   744   C1269647:Cell [Cell]
   744   C1300517:Hybridization [Laboratory Procedure]
   744   C1301820:Obtained [Functional Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C1704681:Probe [Gene or Genome]
   711 E C1706701:Obtain [Activity]
   711 E C2347609:Probe [Chemical Viewed Functionally]
   711 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: ","

Phrase: "as well as"

Phrase: "6arrays from 6FL-cell"

Phrase: "probes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "2composite arrays,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510941:Array [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.126: Finally, after global normalization and subtraction of the background, the 2composite arrays were compared using the AtlasImage 1.5software. 

Phrase: "Finally,"

Phrase: "after"

Phrase: "global normalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882115:Normalization [Research Activity]

Phrase: "and"

Phrase: "subtraction of the background,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348589:Subtraction [Phenomenon or Process]

Phrase: "the 2composite arrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510941:Array [Spatial Concept]

Phrase: "were"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the AtlasImage 1.5software."
Processing 00000000.tx.127: Genes were selected if ratios were more than 2or if differences were more than 2000.

Phrase: "Genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "if"

Phrase: "ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0456603:Ratios [Quantitative Concept]
  1000   C1610540:*Ratios [Quantitative Concept]
   966 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "more than 2or"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205172:More [Functional Concept]

Phrase: "if"

Phrase: "differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "more than 2000."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205172:More [Functional Concept]
Processing 00000000.tx.128: Positive values indicate that the transcript is more abundant in FL than GC cells and negative values the opposite. 

Phrase: "Positive values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "indicate"

Phrase: "that"

Phrase: "the transcript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "more abundant in FL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "than GC cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0282491:Germinal Center [Tissue]

Phrase: "and"

Phrase: "negative values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "the opposite."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521805:Opposite [Spatial Concept]
Processing 00000000.tx.129: Shades of gray indicate expression level of a gene (AU), black bars represent expression level more than 10000, gray more than 5000,and white more than 2000.

Phrase: "Shades of gray"

Phrase: "indicate"

Phrase: "expression level of a gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C3244092:expression level [Idea or Concept]
   797   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "(AU"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "black bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "expression level more than 10000,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "gray more than 5000,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0556636:gray [Quantitative Concept]
   770   C1269776:Gray [Qualitative Concept]

Phrase: "and"

Phrase: "white more than 2000."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007457:White [Population Group]
   770   C0043157:White [Population Group]
   770   C0220938:White [Qualitative Concept]
Processing 00000000.tx.130: Also listed along side the gene names is the GenBank accession number. 

Phrase: "Also"

Phrase: "listed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0745732:List [Conceptual Entity]
   966   C3272378:LIST [Intellectual Product]

Phrase: "along side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "the gene names"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1706509:Gene Name [Intellectual Product]
  1000   C1706510:Gene Name [Intellectual Product]
   861   C0027365:Name [Intellectual Product]
   861   C1547383:Name [Intellectual Product]

Phrase: "is"

Phrase: "the GenBank accession number."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1708200:GenBank_Accession_Number [Intellectual Product]
   901   C1510755:Accession Number [Intellectual Product]
           Accession
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]
   827   C1706078:Accession [Activity]
Processing 00000000.tx.131: The genes are grouped according to their function as determined from the literature. 

Phrase: "The genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "grouped according to their function"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   760   C0031843:function [Physiologic Function]
   760   C0439745:Grouped [Spatial Concept]
   760   C0542341:Function [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
   745   C0598132:functional group [Chemical Viewed Functionally]
   726 E C0441833:Group [Idea or Concept]
   726 E C0687744:group [Population Group]
   726 E C1257890:Group [Population Group]
   726 E C1552516:Group [Health Care Related Organization]
   726 E C1705428:Group [Conceptual Entity]
   726 E C1705429:Group [Population Group]

Phrase: "as"

Phrase: "determined from the literature."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0023866:Literature [Intellectual Product]
   770   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
Processing 00000000.tx.132: Radiolabeled probes for hybridization were derived from 2sources of mRNA: GC B cells derived from the tonsils of 6healthy individuals and FL cells isolated from tissues of 6patients with relapsed disease. 

Phrase: "Radiolabeled probes for hybridization"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0182400:Probes [Medical Device]
   737 E C1704681:Probe [Gene or Genome]
   737 E C2347609:Probe [Chemical Viewed Functionally]
   737 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "derived from 2sources of mRNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0335218:Messenger [Professional or Occupational Group]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: ":"

Phrase: "GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "derived from the tonsils of 6healthy individuals"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0040421:Tonsils [Body Part, Organ, or Organ Component]
   748   C0836921:tonsils [Body Part, Organ, or Organ Component]
   748   C1441547:Derived [Qualitative Concept]
   748   C3245521:derived [Idea or Concept]
   714   C0027361:Individual [Population Group]
   714   C0237401:Individual [Human]
   714 E C1280736:Tonsil [Body Part, Organ, or Organ Component]
   714 E C1519547:TONSIL [Tissue]

Phrase: "and"

Phrase: "FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "isolated from tissues of 6patients"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0040300:Tissues [Tissue]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1547928:Tissue [Intellectual Product]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "with relapsed disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0277556:Relapsed Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.133: Six arrays obtained after hybridization of the 6GC B-cell probes were averaged as well as the 6arrays from 6FL probes to create 2composite arrays, respectively. 

Phrase: "Six arrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510941:Array [Spatial Concept]

Phrase: "obtained after hybridization of the 6GC B-cell probes"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   764   C0004561:B-cell [Cell]
   762   C0007597:Cell hybridisation [Laboratory Procedure]
   742   C0007634:Cell [Cell]
   742   C0020202:Hybridisation [Genetic Function]
   742   C0182400:Probes [Medical Device]
   742   C1269647:Cell [Cell]
   742   C1300517:Hybridization [Laboratory Procedure]
   742   C1301820:Obtained [Functional Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   708 E C1704681:Probe [Gene or Genome]
   708 E C1706701:Obtain [Activity]
   708 E C2347609:Probe [Chemical Viewed Functionally]
   708 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "as well as"

Phrase: "the 6arrays from 6FL"

Phrase: "probes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "2composite arrays,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510941:Array [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.134: Finally, after global normalization and subtraction of the background, the 2composite arrays were compared. 

Phrase: "Finally,"

Phrase: "after"

Phrase: "global normalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882115:Normalization [Research Activity]

Phrase: "and"

Phrase: "subtraction of the background,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348589:Subtraction [Phenomenon or Process]

Phrase: "the 2composite arrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510941:Array [Spatial Concept]

Phrase: "were"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.135: The expression of actin and S9 were constant in all 12samples analyzed. 

Phrase: "The expression of actin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "S9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419029:S9 [Gene or Genome]
  1000   C1419753:S9 [Gene or Genome]
  1000   C1861421:S9 [Gene or Genome]

Phrase: "were"

Phrase: "constant in all 12samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1547014:*Constant [Quantitative Concept]
   770   C1948059:Constant [Qualitative Concept]

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.136: Figure 1 summarizes the genes for which the ratio of FL to GC was more than 2or less than 2, or for which the difference was more than 2000or less than 2000. 

Phrase: "Figure 1"

Phrase: "summarizes"

Phrase: "the genes for which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Genes [Gene or Genome]

Phrase: "the ratio of FL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "to GC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Center [Tissue]
   861   C0205099:Center [Spatial Concept]

Phrase: "was"

Phrase: "more than 2or less"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205172:More [Functional Concept]

Phrase: "than 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "or for which"

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "more than 2000or less"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205172:More [Functional Concept]

Phrase: "than 2000."
Processing 00000000.tx.137: Of the 588genes in the cDNA array, 65genes were differentially expressed in FL cells as compared to normal GC B cells, using the above-described criteria. 

Phrase: "Of the 588genes"

Phrase: "in the cDNA array,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0600596:DNA Array [Research Device]
   827   C1510941:Array [Spatial Concept]
   734   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "65genes"

Phrase: "were"

Phrase: "differentially"

Phrase: "expressed in FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "compared to normal GC B cells,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   778   C0004561:B-Cells [Cell]
   778   C0282491:Germinal Center [Tissue]
   757   C0007634:Normal cell [Cell]
           Cells
   757   C1268443:Normal cell [Cell]
   748   C0205099:Center [Spatial Concept]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C1707455:Compared [Activity]
   748   C2347086:% Normal [Quantitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the above-described criteria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.138: Of the 65genes, 37(57%) were increased in FL, whereas 28(43%) were decreased. 

Phrase: "Of the 65genes,"

Phrase: "37"

Phrase: "(57%"

Phrase: ")"

Phrase: "were"

Phrase: "increased in FL,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "whereas"

Phrase: "28"

Phrase: "(43%"

Phrase: ")"

Phrase: "were"

Phrase: "decreased."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.139: The list of genes that were expressed by either FL or GC B cells but did not meet these criteria are listed at http://dfciwww.dfci.harvard.edu/AO/Freedman_Lab/cDNA_array/not_different_expressed.html. 

Phrase: "The list of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0745732:List [Conceptual Entity]
   770   C3272378:LIST [Intellectual Product]

Phrase: "that"

Phrase: "were"

Phrase: "expressed by either FL"

Phrase: "or"

Phrase: "GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "meet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Meet [Idea or Concept]

Phrase: "these criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "are"

Phrase: "listed at http"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1555015:HTTP [Idea or Concept]
   756   C0745732:List [Conceptual Entity]
   756   C3272378:LIST [Intellectual Product]

Phrase: ":"

Phrase: "//dfciwww.dfci.harvard.edu/AO/Freedman_Lab/cDNA_array/not_different_"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   787   C1705242:Different [Qualitative Concept]
   716 E C1705241:*Difference [Quantitative Concept]

Phrase: "expressed.html."
Processing 00000000.tx.140: Real-time quantitative RT-PCR analysis Although differences in gene expression between FL and normal GC B cells were observed with the cDNA array, it was critical to verify these results using another methodology. 

Phrase: "Real-time quantitative RT-PCR analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   897   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   864   C0034746:time reaction [Temporal Concept]
   861   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   835   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0337112:Chain [Manufactured Object]
   793   C0443286:Reaction [Functional Concept]
   793   C0936012:Analysis [Research Activity]
   793   C1114821:Reaction [Clinical Attribute]
   793   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1524024:analysis [Functional Concept]
   793   C1524075:Chain [Idea or Concept]

Phrase: "Although"

Phrase: "differences in gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1519516:Differential Gene Expression [Genetic Function]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "between FL"

Phrase: "and"

Phrase: "normal GC B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   881   C0007634:Normal cell [Cell]
           Cells
   881   C1268443:Normal cell [Cell]
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "observed with the cDNA array,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0600596:DNA Array [Research Device]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1441672:Observed [Functional Concept]
   753   C1510941:Array [Spatial Concept]

Phrase: "it"

Phrase: "was"

Phrase: "critical to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511545:Critical [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "another methodology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0969625:methodology [Intellectual Product]
  1000   C3266812:Methodology [Idea or Concept]
Processing 00000000.tx.141: We monitored the mRNA level of all genes noted to be differentially expressed in the Atlas array, according to the criteria described above by real-time quantitative RT-PCR using SYBR Green 1.20,26 We also monitored Bcl-2, which is increased in the vast majority of FL as compared to normal GC B cells27 as well as 2housekeeping genes (-actin and ribosomal protein S9). 

Phrase: "We"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "the mRNA level of all genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "differentially"

Phrase: "expressed in the Atlas array,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004170:Atlas [Body Part, Organ, or Organ Component]
   760   C0004171:atlas [Intellectual Product,Manufactured Object]
   760   C1510941:Array [Spatial Concept]
   760   C2652343:Atla [Fungus]

Phrase: "according to the criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above by real-time quantitative RT-PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1282910:Above [Spatial Concept]
   742   C1552828:above [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SYBR Green 1.20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0332583:Green [Qualitative Concept]

Phrase: "26"

Phrase: "We also monitored Bcl-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376515:Bcl-2 [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "increased in the vast majority of FL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0680220:majority [Social Behavior]
   748   C0814230:VAST [Intellectual Product]

Phrase: "as"

Phrase: "compared to normal GC B cells27"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0282491:Germinal Center [Tissue]
   748   C0205099:Center [Spatial Concept]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C1707455:Compared [Activity]
   748   C2347086:% Normal [Quantitative Concept]

Phrase: "as well as"

Phrase: "2housekeeping genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "(-actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "ribosomal protein S9"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0073341:ribosomal protein S9 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419753:RIBOSOMAL PROTEIN S9 [Gene or Genome]
           S9
   901   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0035553:Ribosomal [Cell Component]
   827   C1419029:S9 [Gene or Genome]
   827   C1861421:S9 [Gene or Genome]
   755 E C2984240:Ribosome [Functional Concept]

Phrase: ")."
Processing 00000000.tx.142: Results representative of real-time quantitative PCR are shown Figure 2 for Bcl-2, -actin, and ribosomal protein S9. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "representative of real-time quantitative PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1882932:Representative [Activity]
   704   C3179034:Quantitative Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "Figure"

Phrase: "2 for Bcl-2, -"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0376515:Bcl-2 [Gene or Genome]
   770   C0740116:+2 [Quantitative Concept]
   770   C2827735:2+ [Quantitative Concept]
   770   C2981700:2+ [Classification]

Phrase: "actin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "ribosomal protein S9."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0073341:ribosomal protein S9 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419753:RIBOSOMAL PROTEIN S9 [Gene or Genome]
           S9
   901   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0035553:Ribosomal [Cell Component]
   827   C1419029:S9 [Gene or Genome]
   827   C1861421:S9 [Gene or Genome]
   755 E C2984240:Ribosome [Functional Concept]
Processing 00000000.tx.143: The CT value at which the fluorescence reaches the threshold is higher for GC than for FL cells, which is reflective of a lower mRNA content for Bcl-2 in GC B cells. 

Phrase: "The CT value at which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1522609:Value [Quantitative Concept]

Phrase: "the fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "reaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596012:Reaches [Finding]
  1000   C2584321:Reach [Organism Function]

Phrase: "the threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449864:Threshold [Qualitative Concept]

Phrase: "is"

Phrase: "higher for GC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "for FL cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "is"

Phrase: "reflective of a lower mRNA content"

Phrase: "for Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "in GC B cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.144: The CT values obtained for GC or FL for -actin as well as ribosomal S9 protein are the same, indicating that the mRNA content was identical in these 2samples. 

Phrase: "The CT values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "obtained for GC"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0282491:Germinal Center [Tissue]
   770   C0205099:Center [Spatial Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "or"

Phrase: "FL for -actin"

Phrase: "as well as"

Phrase: "ribosomal S9 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "the same,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the mRNA content"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0335218:Messenger [Professional or Occupational Group]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "identical in these 2samples."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.145: The NTCs remained below the threshold, showing that no amplification was observed without template. 

Phrase: "The NTCs"

Phrase: "remained below the threshold,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449864:Threshold [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "no amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "observed without template."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0728990:TEMPLATE [Medical Device]
   790   C1441672:Observed [Functional Concept]
   790   C1514575:Template [Conceptual Entity]
   790   C1705542:Template [Idea or Concept]
Processing 00000000.tx.146: View larger version (130K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(130K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.147: Real-time RT-PCR quantification for Bcl-2, -actin, and S9 ribosomal protein mRNAs levels. 

Phrase: "Real-time RT-PCR quantification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1709793:Quantification [Quantitative Concept]
   735   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]

Phrase: "for Bcl-2, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "actin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "S9 ribosomal protein mRNAs levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   836   C0428479:Protein level [Laboratory or Test Result]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   717   C0073341:S9 ribosomal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.148: Real-time quantitative RT-PCR was performed with appropriate primers for Bcl-2 (A), -actin (B), and S9 ribosomal protein (C) using SYBR Green I dye. 

Phrase: "Real-time quantitative RT-PCR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   918   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   877   C0034746:time reaction [Temporal Concept]
   845   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   795   C0337112:Chain [Manufactured Object]
   795   C0443286:Reaction [Functional Concept]
   795   C1114821:Reaction [Clinical Attribute]
   795   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1524075:Chain [Idea or Concept]

Phrase: "was"

Phrase: "performed with appropriate primers"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0884358:Performed [Functional Concept]
   770   C1548787:Appropriate [Qualitative Concept]
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "(A"

Phrase: ")"

Phrase: ", -"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "S9 ribosomal protein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0073341:S9 ribosomal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0035553:Ribosomal [Cell Component]
   755 E C2984240:Ribosome [Functional Concept]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SYBR Green I dye."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   756   C0386577:SYBR Green I [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.149: Amplification results were visualized using the Sequence Detector 1.7software. 

Phrase: "Amplification results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Sequence Detector 1.7software."
Processing 00000000.tx.150: These are representative plots showing increasing fluorescence (Rn) detected through cycle 40on normal GC B cell or FL cDNA samples. 

Phrase: "These"

Phrase: "are"

Phrase: "representative plots"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "increasing fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Rn)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540639:RN [Gene or Genome]

Phrase: "detected through cycle 40on normal GC B cell"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   764   C0004561:B-cell [Cell]
   764   C0282491:Germinal Center [Tissue]
   762   C0007586:Cell Cycle [Cell Function]
   762   C0007634:Normal cell [Cell]
           Cell
   762   C1155839:Cell Cycle [Cell Function]
   762   C1268443:Normal cell [Cell]
   742   C0205099:Center [Spatial Concept]
   742   C0205307:Normal [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C0442726:Detected [Finding]
   742   C1269647:Cell [Cell]
   742   C1511572:Cycle [Temporal Concept]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "FL cDNA samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.151: NTC represents the negative control amplification (using H20 as template). 

Phrase: "NTC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2755952:NTC [Cell Component]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the negative control amplification"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1517480:Amplification [Molecular Biology Research Technique]
   827   C1521871:Amplification [Phenomenon or Process]
   827   C1705759:Amplification [Cell or Molecular Dysfunction]
   734   C1639518:% negative control [Quantitative Concept]
   734   C1947986:Negative Control [Conceptual Entity]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "H20 as template"

Phrase: ")."
Processing 00000000.tx.152: CT represents the threshold cycle at which fluorescence is first detected above background. 

Phrase: "CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the threshold cycle at which fluorescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449864:Threshold [Qualitative Concept]
   753   C1511572:Cycle [Temporal Concept]

Phrase: "is"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "detected above background."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.153: A higher CT value is indicative of lower mRNA levels (more PCR cycles required to exceed background). 

Phrase: "A higher CT value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "indicative of lower mRNA levels"

Phrase: "(more PCR cycles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1511572:Cycle [Temporal Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exceed"

Phrase: "background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.154: Genes increased in FL Besides the increase of Bcl-2 in FL, relatively few genes have been shown to be increased as compared to normal B cells. 

Phrase: "Genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "increased in FL"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "Besides the increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "of Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "in FL,"

Phrase: "relatively few genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "as"

Phrase: "compared to normal B cells."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0004561:B-Cells [Cell]
   781   C0007634:Normal cell [Cell]
           Cells
   781   C1268443:Normal cell [Cell]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C2347086:% Normal [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.155: Among these genes are those for Pax-5 (PAX5), TNF (TNF) and CXCR4 (SDF-1 receptor).28-30 To confirm the differential expression of the 37genes that were increased in FL cells, we performed real-time quantitative RT-PCR analysis. 

Phrase: "Among these genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "those for Pax-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3542477:PAX [Gene or Genome]

Phrase: "(PAX5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0167636:PAX5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335193:PAX5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "TNF (TNF)"

Phrase: "and"

Phrase: "CXCR4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0250501:CXCR4 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1332823:CXCR4 [Gene or Genome]
  1000   C1707171:CXCR-4 [Gene or Genome]
  1000   C3539513:CXCR4 [Molecular Function]

Phrase: "(SDF-1 receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0250501:SDF-1 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C0218504:SDF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1704964:SDF-1 [Gene or Genome]

Phrase: ").28-30 To"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the differential expression of the 37genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "were"

Phrase: "increased in FL cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "real-time quantitative RT-PCR analysis."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   897   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   864   C0034746:time reaction [Temporal Concept]
   861   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   835   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0337112:Chain [Manufactured Object]
   793   C0443286:Reaction [Functional Concept]
   793   C0936012:Analysis [Research Activity]
   793   C1114821:Reaction [Clinical Attribute]
   793   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1524024:analysis [Functional Concept]
   793   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.156: The CT values were normalized for each gene in all of the samples obtained from the GC B and FL cells as described in "Materials and methods." 

Phrase: "The CT values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "normalized for each gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017337:Gene [Gene or Genome]
   770   C1882115:Normalized [Research Activity]

Phrase: "in all"

Phrase: "of the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "obtained from the GC B"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0282491:Germinal Center [Tissue]
   753   C0205099:Center [Spatial Concept]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "in ""Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.157: The data were analyzed using a 2-sample t test. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 2-sample t test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
Processing 00000000.tx.158: As seen in Table 1, 24genes are listed, 21that were found to be increased in FL using the array (P < .1), and 3genes whose expression was decreased in FL by the array. 

Phrase: "As"

Phrase: "seen in Table 1,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C0205397:Seen [Qualitative Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "24genes"

Phrase: "are"

Phrase: "listed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0745732:List [Conceptual Entity]
   966   C3272378:LIST [Intellectual Product]

Phrase: ","

Phrase: "21that"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "increased in FL"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the array"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510941:Array [Spatial Concept]

Phrase: "(P < .1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "3genes"

Phrase: "whose expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "decreased in FL"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "by the array."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510941:Array [Spatial Concept]
Processing 00000000.tx.159: The difference between the mean of the CT value for FL and the mean of the CT value for GC was calculated (mean CT). 

Phrase: "The difference between the mean of the CT value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "for FL"

Phrase: "and"

Phrase: "the mean of the CT value"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0444504:Mean [Quantitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]

Phrase: "for GC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282491:Germinal Center [Tissue]
   861   C0205099:Center [Spatial Concept]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "(mean CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.160: These 24genes are listed in descending order of their level of expression (mean CT). 

Phrase: "These 24genes"

Phrase: "are"

Phrase: "listed in descending order of their level of expression"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   762   C3244092:expression level [Idea or Concept]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205386:Descending [Qualitative Concept]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547177:Descending [Qualitative Concept]
   742   C1547707:Level [Geographic Area]
   742   C1705175:Order [Intellectual Product]
   742   C1705176:Order [Qualitative Concept]
   742   C1705177:Order [Classification]
   742   C1705178:Order [Activity]
   742   C1882348:Order [Qualitative Concept]
   742   C2946261:Level [Pharmacologic Substance]
   708   C0745732:List [Conceptual Entity]
   708   C3272378:LIST [Intellectual Product]

Phrase: "(mean CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.161: As reported previously, approximately 2.5CT values correspond to a 10-fold increase.26 Consistent with prior reports, we found that Bcl-2, TNF, and Pax-5 were all overexpressed in FL cells.1,13,28,29 In FL cells, several genes encoding for cell cycle regulator proteins were overexpressed including CDK10, p120 (NOL1), p21CIP1 (CDKN1A), and p16INK4A (CDK2A). 

Phrase: "As"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously,"

Phrase: "approximately 2.5CT values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0042295:Values [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]

Phrase: "correspond to a 10-fold increase.26 Consistent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0332290:Consistent [Idea or Concept]
   744   C0332462:Fold [Spatial Concept]
   744   C0442805:Increase [Functional Concept]
   744   C1880834:FOLD [Phenomenon or Process]

Phrase: "with prior reports,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that Bcl-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "TNF,"

Phrase: "and"

Phrase: "Pax-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3542477:PAX [Gene or Genome]

Phrase: "were"

Phrase: "all"

Phrase: "overexpressed in FL cells.1,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1514559:overexpress [Genetic Function]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "13,"

Phrase: "28,"

Phrase: "29 In FL cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "several genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "encoding for cell cycle regulator proteins"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   833   C1325288:cell cycle regulator [Cell Function]
   820   C0243021:Cell Cycle Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0007586:Cell Cycle [Cell Function]
   790   C1155839:Cell Cycle [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0182953:REGULATOR [Medical Device]
   753   C1269647:Cell [Cell]
   753   C1511572:Cycle [Temporal Concept]
   753   C1547699:Encoding [Idea or Concept]
   753   C1704653:Cell [Medical Device]
   753   C1704734:Regulator [Medical Device]
   753   C1704735:Regulator [Conceptual Entity]
   753   C1948049:Cell [Spatial Concept]
   753   C2700640:Encoding [Activity]

Phrase: "were"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "CDK10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332730:CDK10 [Gene or Genome]
  1000   C1333180:CDK10 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "p120"

Phrase: "(NOL1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417754:NOL1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "p21CIP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0249197:p21CIP1 [Gene or Genome]

Phrase: "(CDKN1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249197:CDKN1A [Gene or Genome]
  1000   C0288472:CDKN1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "p16INK4A"

Phrase: "(CDK2A"

Phrase: ")."
Processing 00000000.tx.162: Considering that FL cells are often in G0/G1, it is of interest that regulators of G1 phase p21CIP1 and p16INK4A were overexpressed. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "that FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "often in G0/G1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332183:Often [Temporal Concept]

Phrase: "it"

Phrase: "is of"

Phrase: "interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "that regulators of G1 phase p21CIP1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0182953:regulators [Medical Device]
   719 E C1704734:Regulator [Medical Device]
   719 E C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "p16INK4A"

Phrase: "were"

Phrase: "overexpressed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]
Processing 00000000.tx.163: A large number of transcription factors and DNA binding proteins were preferentially expressed in FL cells including Bsp-1 (MADH1); 

Phrase: "A large number of transcription factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "DNA binding proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0012940:DNA-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   983 E C0812382:DNA-binding protein [Gene or Genome]
   913   C0058610:dna proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1148673:DNA Binding [Genetic Function]

Phrase: "were"

Phrase: "preferentially"

Phrase: "expressed in FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Bsp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   805   C0282359:Bromsulphalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(MADH1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416962:MADH1 [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.164: Id-2 (ID2); 

Phrase: "Id-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   861   C0600091:ID [Intellectual Product]

Phrase: "(ID2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.165: c-Jun (JUN); 

Phrase: "c-Jun (JUN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0162508:c-Jun [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.166: v-erbA (ERBAL2); 

Phrase: "v-erbA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242987:ERBA [Gene or Genome]

Phrase: "(ERBAL2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0812264:ERBAL2 [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.167: ZFX (ZFX); 

Phrase: "ZFX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421578:ZFX [Gene or Genome]

Phrase: "(ZFX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421578:ZFX [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.168: Db1 (ZNF161); 

Phrase: "Db1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823628:DB1 [Gene or Genome]

Phrase: "(ZNF161"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823628:ZNF161 [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.169: Pax-5; 

Phrase: "Pax-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3542477:PAX [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.170: SNF2- (SMARCA2); 

Phrase: "SNF2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335841:SNF2 [Gene or Genome]
  1000   C1335843:SNF2 [Gene or Genome]

Phrase: "(SMARCA2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0246454:Smarca2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335841:SMARCA2 [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.171: and Hsf-1 (HSF1). 

Phrase: "and"

Phrase: "Hsf-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1519740:HSF-1 [Cell]
  1000   C2348945:HSF 1 [Amino Acid, Peptide, or Protein]
   861   C0021760:HSF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1334122:HSF [Gene or Genome]
   861   C1527132:HSF [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(HSF1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415749:HSF1 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.172: There is evidence that Id-2 and Pax-5 are both important in B-cell differentiation. 

Phrase: "There"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that Id-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   861   C0600091:ID [Intellectual Product]

Phrase: "and"

Phrase: "Pax-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3542477:PAX [Gene or Genome]

Phrase: "are"

Phrase: "both important in B-cell differentiation."
Processing 00000000.tx.173: A set of genes that are involved in microenvironmental interactions including cytokines and cytokines receptors were also overexpressed in FL cells including TNF, IL-4R, IL-2R. 

Phrase: "A set of genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1366517:SET gene [Gene or Genome]
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "involved in microenvironmental interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1314939:Involved [Functional Concept]
   737   C1704675:Interaction [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "cytokines receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206552:Receptors, Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "also"

Phrase: "overexpressed in FL cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1514559:overexpress [Genetic Function]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "TNF,"

Phrase: "IL-4R,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1149207:IL-4R [Molecular Function]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "IL-2R."
Processing 00000000.tx.174: Three genes (YY1, Lyn, cyclin B1 [CCNB1]), which had decreased expression in FL cells using the cDNA array, were overexpressed by quantitative RT-PCR with P values of less than .02,.08,and .03,respectively.  

Phrase: "Three genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "(YY1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421565:YY1 [Gene or Genome]

Phrase: "Lyn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812307:LYN [Gene or Genome]
  1000   C1442804:LYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cyclin B1 [CCNB1]"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0385333:Cyclin B1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332695:CYCLIN B1 [Gene or Genome]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "had"

Phrase: "decreased expression in FL cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the cDNA array,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0600596:DNA Array [Research Device]
   827   C1510941:Array [Spatial Concept]
   734   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "overexpressed by quantitative RT-PCR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0337112:Chain [Manufactured Object]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1524075:Chain [Idea or Concept]
   714   C1514559:overexpress [Genetic Function]

Phrase: "with P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "of less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than .02,"

Phrase: ".08,"

Phrase: "and ."

Phrase: "03,"

Phrase: "respectively."
Processing 00000000.tx.175: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.176: Gene expression analysis by real-time quantitative RT-PCR (genes increased in FL) Genes decreased in FL There is relatively little information on genes that are down-regulated in FL cells, as compared to normal B cells. 

Phrase: "Gene expression analysis by real-time quantitative RT-PCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   792   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   775   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]

Phrase: "(genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "increased in FL) Genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017337:Genes [Gene or Genome]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "decreased in FL There"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "is"

Phrase: "relatively little information on genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "that"

Phrase: "are"

Phrase: "down-regulated in FL cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "as"

Phrase: "compared to normal B cells."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0004561:B-Cells [Cell]
   781   C0007634:Normal cell [Cell]
           Cells
   781   C1268443:Normal cell [Cell]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C2347086:% Normal [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.177: We confirmed by RT-PCR the decreased expression in 7of the 28genes noted to be down-regulated in FL cells using the array (P<.1), whereas in 21genes the decrease noted using the array was not confirmed by RT-PCR. 

Phrase: "We"

Phrase: "confirmed by RT-PCR"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   753   C0337112:Chain [Manufactured Object]
   753   C0443286:Reaction [Functional Concept]
   753   C0750484:Confirmed [Idea or Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1524075:Chain [Idea or Concept]
   719 E C1456348:Confirm [Qualitative Concept]

Phrase: "the decreased expression in 7of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the 28genes"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "down-regulated in FL cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the array"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510941:Array [Spatial Concept]

Phrase: "(P<.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "whereas in 21genes"

Phrase: "the decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the array"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510941:Array [Spatial Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "confirmed by RT-PCR."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   753   C0337112:Chain [Manufactured Object]
   753   C0443286:Reaction [Functional Concept]
   753   C0750484:Confirmed [Idea or Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1524075:Chain [Idea or Concept]
   719 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.178: One gene (LFA1), which was increased in FL by array, was found to be decreased by RT-PCR. 

Phrase: "One gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "(LFA1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079717:LFA1 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "increased in FL"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "by array,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510941:Array [Spatial Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "decreased by RT-PCR."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0337112:Chain [Manufactured Object]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1524075:Chain [Idea or Concept]
   719 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.179: Table 2 shows these 8genes in descending order of their level of expression in GC B cells (mean CT). 

Phrase: "Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "these 8genes in descending order of their level of expression"

Phrase: "in GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(mean CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.180: The majority of genes are involved in microenvironmental or cell-cell interactions including MRP14; 

Phrase: "The majority of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "are"

Phrase: "involved in microenvironmental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]

Phrase: "or"

Phrase: "cell-cell interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0007582:cell-cell interaction [Cell Function]
           Interactions, Cell
   793   C1704675:Interaction [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MRP14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054505:MRP14 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1335798:MRP14 [Gene or Genome]
  1000   C1704874:MRP14 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.181: MRP8; 

Phrase: "MRP8"

Phrase: ";"
Processing 00000000.tx.182: CD40; 

Phrase: "CD40"

Phrase: ";"
Processing 00000000.tx.183: thymosin 10(TMSB10); 

Phrase: "thymosin 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040106:Thymosin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1527153:Thymosin [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "(TMSB10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420786:TMSB10 [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.184: and DBI (DBI). 

Phrase: "and"

Phrase: "DBI (DBI"

Phrase: ")."
Processing 00000000.tx.185: Consistent with the low proliferative index of FL cells, the cell cycle regulator p55CDC (CDC20) had decreased expression in the FL cells.  

Phrase: "Consistent with the low proliferative index of FL cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the cell cycle regulator p55CDC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1413256:p55CDC [Gene or Genome]
   812   C3539866:p55CDC [Amino Acid, Peptide, or Protein]
   812   C3541310:p55CDC [Gene or Genome]
   756   C1325288:cell cycle regulator [Cell Function]

Phrase: "(CDC20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413256:CDC20 [Gene or Genome]

Phrase: ")"

Phrase: "had"

Phrase: "decreased expression in the FL cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.186: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.187: Gene expression analysis by real-time quantitative RT-PCR (genes decreased in FL) Validation sample We conducted a small validation study of the 32genes that were significantly different in their expression levels. 

Phrase: "Gene expression analysis by real-time quantitative RT-PCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   792   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   775   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]

Phrase: "(genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "decreased in FL) Validation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1519941:Validation [Research Activity]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "We"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "a small validation study of the 32genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0681836:validation study [Intellectual Product,Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C1519941:Validation [Research Activity]
   748   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "were"

Phrase: "significantly different in their expression levels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.188: Three additional FL samples were studied by RT-PCR only. 

Phrase: "Three additional FL samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "studied by RT-PCR only."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0205171:Only [Quantitative Concept]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1524075:Chain [Idea or Concept]
   748   C1720467:Only [Intellectual Product]
   714   C0557651:Study [Manufactured Object]
   714   C2603343:Study [Research Activity]
Processing 00000000.tx.189: Of the 24genes found to be overexpressed in FL cells by RT-PCR, 15were confirmed to be overexpressed in FL cells compared to GC cells in this small validation sample. 

Phrase: "Of the 24genes"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "overexpressed in FL cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1514559:overexpress [Genetic Function]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by RT-PCR,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1524075:Chain [Idea or Concept]

Phrase: "15were"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "overexpressed in FL cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1514559:overexpress [Genetic Function]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "compared to GC cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0282491:Germinal Center [Tissue]
   760   C0007634:Cells [Cell]
   760   C0205099:Center [Spatial Concept]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in this small validation sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.190: Of the 8genes that had decreased expression in FL cells, 5were confirmed to be significantly decreased in the 3additional cases. 

Phrase: "Of the 8genes"

Phrase: "that"

Phrase: "had"

Phrase: "decreased expression in FL cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "5were"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "significantly"

Phrase: "decreased in the 3additional cases."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.191: An asterisk in Tables 1 and 2 indicates these genes.  

Phrase: "An asterisk in Tables 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2945706:asterisk [Conceptual Entity]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "indicates"

Phrase: "these genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.192: Discussion Top Abstract Introduction Materials and methods Results Discussion References Follicular lymphomas have been hypothesized to be neoplastic transformations of normal GC-B cells. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Follicular lymphomas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0024301:Lymphomas, Follicular [Neoplastic Process]
   861   C0024299:Lymphomas [Neoplastic Process]
   861   C0439682:Follicular [Qualitative Concept]
   861   C1571705:Follicular [Body Part, Organ, or Organ Component]

Phrase: "have"

Phrase: "been"

Phrase: "hypothesized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "neoplastic transformations of normal GC-B cells."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0007621:Transformations, Neoplastic Cell [Neoplastic Process]
           neoplastic transformations
   767   C0597032:Neoplastic cells [Cell]
   744   C0040682:Transformations [Cell Function]
           cell transformation
   744   C1709160:Neoplastic [Qualitative Concept]
   734   C1510411:Cell Transformation [Pathologic Function]
       E   Transformation
   711 E C1705163:Transformation [Research Activity]
Processing 00000000.tx.193: This was supported first by morphology, and then by virtue of the expression of various cell surface antigens.31,32 However the finding that FL cells possess in essentially all cases the Bcl-2/IgH rearrangement and overexpression of Bcl-2 protein provided clear distinction from normal GC B cells. 

Phrase: "This"

Phrase: "was"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "first by morphology,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0205435:First [Quantitative Concept]
   790   C0332437:Morphology [Qualitative Concept]
   790   C0543482:morphology [Spatial Concept]
   790   C0700329:Morphology, NOS [Finding]
   790   C0700619:Morphology [Biomedical Occupation or Discipline]
   790   C1279901:First [Qualitative Concept]

Phrase: "and"

Phrase: "then by virtue of the expression of various cell surface antigens.31,"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   770   C0003339:Cell Surface Antigens [Immunologic Factor]
           Surface Antigens
   766   C0699040:Surface of cell [Cell Component]
           Cell surface
   736   C0003320:Antigens [Immunologic Factor]
   736   C0007634:Cell [Cell]
   736   C0042764:Virtue [Idea or Concept]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   736   C0205148:Surface [Spatial Concept]
   736   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   736   C0450355:31 [Intellectual Product]
   736   C1269647:Cell [Cell]
   736   C1704653:Cell [Medical Device]
   736   C1883708:Then [Temporal Concept]
   736   C1948049:Cell [Spatial Concept]
   715   C2334846:Virtual surface [Spatial Concept]

Phrase: "32 However"

Phrase: "the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "possess in essentially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0850310:possess [Mental or Behavioral Dysfunction]
   790   C3154893:Possess [Idea or Concept]

Phrase: "all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the Bcl-2/IgH rearrangement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511695:Rearrangement [Genetic Function]

Phrase: "and"

Phrase: "overexpression of Bcl-2 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "clear distinction from normal GC B cells."
Processing 00000000.tx.194: In the present report we have compared the gene expression profile of FL cells to normal tonsillar GC B cells. 

Phrase: "In the present report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the gene expression profile of FL cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C1449575:gene expression profile [Laboratory Procedure]
   814   C1956267:Profile, Gene Expression [Quantitative Concept]
   748   C1979963:Profile [Laboratory Procedure]
   748   C2003903:Profile [Functional Concept]

Phrase: "to normal tonsillar GC B cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   878   C0007634:Normal cell [Cell]
           Cells
   878   C1268443:Normal cell [Cell]
   827   C0004561:B-Cells [Cell]
   827   C0282491:Germinal Center [Tissue]
   799   C0205099:Center [Spatial Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.195: Based on the evidence that Bcl-2/IgH rearrangement and overexpression of Bcl-2 is necessary but not sufficient to induce FL, we hypothesized that additional alterations in gene expression may contribute to the malignant phenotype. 

Phrase: "Based on the evidence"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0332120:Evidence [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that Bcl-2/IgH rearrangement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511695:Rearrangement [Genetic Function]

Phrase: "and"

Phrase: "overexpression of Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "necessary"

Phrase: "but"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "FL,"

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that additional alterations in gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0017263:Gene Expression Alteration [Genetic Function]
   767   C0596611:Gene Alteration [Genetic Function]
   719   C1515926:Alteration [Idea or Concept]

Phrase: "may"

Phrase: "contribute to the malignant phenotype."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0031437:Phenotype [Organism Attribute]
   760   C0205282:Malignant [Qualitative Concept]
   760   C0334590:MALIGNANT [Neoplastic Process]
   760   C1285572:Phenotype [Laboratory Procedure]
   760   C1533592:MALIGNANT [Neoplastic Process]
   760   C1880177:Contribute [Activity]
Processing 00000000.tx.196: Our objective was to identify genes that were differentially expressed in the malignant cells and their normal cellular counterparts using a cDNA array and confirm expression using real-time quantitative RT-PCR as a second platform. 

Phrase: "Our objective"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018017:Objective [Intellectual Product]
  1000   C1571702:Objective [Qualitative Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "were"

Phrase: "differentially"

Phrase: "expressed in the malignant cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0334227:Malignant cells [Cell]
   806   C2698007:Malignant Cells, NOS [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C0205282:Malignant [Qualitative Concept]
   760   C0334590:MALIGNANT [Neoplastic Process]
   760   C1533592:MALIGNANT [Neoplastic Process]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "their normal cellular counterparts"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cDNA array"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0600596:DNA Array [Research Device]
   827   C1510941:Array [Spatial Concept]
   734   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "real-time quantitative RT-PCR as a second platform."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   825   C3179034:Quantitative Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   809   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   775   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   754   C0034746:Reaction Time [Temporal Concept]
   738   C0337112:Chain [Manufactured Object]
   738   C0443286:Reaction [Functional Concept]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.197: For a limited number of genes the results of quantitative PCR differed from the array data. 

Phrase: "For a limited number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "the results of quantitative PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1709795:Quantitative Result [Finding]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "differed from the array data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1510941:Array [Spatial Concept]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]
Processing 00000000.tx.198: This was unexpected, but emphasizes the need to confirm array data using a second methodology. 

Phrase: "This"

Phrase: "was"

Phrase: "unexpected,"

Phrase: "but"

Phrase: "emphasizes"

Phrase: "the need to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027552:Need [Qualitative Concept]
   861   C0686904:need [Functional Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "array data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a second methodology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0969625:methodology [Intellectual Product]
   861   C3266812:Methodology [Idea or Concept]
Processing 00000000.tx.199: We identified a series of genes that were either overexpressed or underexpressed in FL cells as compared to normal GC B cells. 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a series of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "that"

Phrase: "were"

Phrase: "either"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "or"

Phrase: "underexpressed in FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "compared to normal GC B cells."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   778   C0004561:B-Cells [Cell]
   778   C0282491:Germinal Center [Tissue]
   757   C0007634:Normal cell [Cell]
           Cells
   757   C1268443:Normal cell [Cell]
   748   C0205099:Center [Spatial Concept]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C1707455:Compared [Activity]
   748   C2347086:% Normal [Quantitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.200: A number of these genes are known to be important in normal and malignant B cells and may help explain certain aspects of the pathophysiology of FL. 

Phrase: "A number of these genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important in normal"

Phrase: "and"

Phrase: "malignant B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0334227:Malignant cells [Cell]
   913   C2698007:Malignant Cells, NOS [Laboratory Procedure]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "may"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "explain"

Phrase: "certain aspects of the pathophysiology of FL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.201: Because all patients had relapsed disease, our data may not apply to FL cells isolated from untreated patients. 

Phrase: "Because"

Phrase: "all patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "relapsed disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0277556:Relapsed Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "apply to FL cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0185125:Apply [Health Care Activity]
   770   C1632850:Apply [Functional Concept]
   770   C1879355:Apply [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "isolated from untreated patients."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205409:Isolated [Functional Concept]
   770   C0332155:untreated [Finding]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.202: Furthermore, it is possible that some of the alterations in gene expression were related to prior cytotoxic therapy. 

Phrase: "Furthermore,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "some of the alterations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]
   737   C1515926:Alteration [Idea or Concept]

Phrase: "in gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "related to prior cytotoxic therapy."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   806   C0677881:Cytotoxic Therapy [Therapeutic or Preventive Procedure]
           Cytotoxic
   797   C0332152:Prior to [Temporal Concept]
           Prior
   797   C1514463:Prior Therapy [Clinical Attribute]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1363945:Therapy [Finding]
   760   C1511636:cytotoxic [Functional Concept]
   760   C2826257:PRIOR [Event]
   726 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.203: The localization of certain of these genes at sites of known chromosomal abnormalities in FL may provide further evidence for their role in the malignant transformation. 

Phrase: "The localization of certain of these genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0008630:Gene Localization [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "at sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "of known chromosomal abnormalities"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   901   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "in FL"

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "further evidence for their role"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "in the malignant transformation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040682:Transformation [Cell Function]
   861   C1510411:Transformation [Pathologic Function]
   861   C1705163:Transformation [Research Activity]
Processing 00000000.tx.204: The genes that had the greatest CT values and the most statistically significant differences in expression were BCL2, BSP-1, MRP8, and MRP14. 

Phrase: "The genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "had"

Phrase: "the greatest CT values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "the most statistically significant differences in expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "BCL2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376515:BCL2 [Gene or Genome]
  1000   C0597712:BCL2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "BSP-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   805   C0282359:Bromsulphalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "MRP8,"

Phrase: "and"

Phrase: "MRP14."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054505:MRP14 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1335798:MRP14 [Gene or Genome]
  1000   C1704874:MRP14 [Gene or Genome]
Processing 00000000.tx.205: Observing overexpression of Bcl-2 in FL cells served as a control for this study. 

Phrase: "Observing"

Phrase: "overexpression of Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "served as a control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "for this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.206: Bsp-1, also known as Smad1, is involved in transforming growth factor- (TGF-) and bone morphogenetic proteins (BMPs) signaling.33,34 It is unknown what function Bsp-1 has in B cells, although TGF- has effects on human and murine B cells. 

Phrase: "Bsp-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   805   C0282359:Bromsulphalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "also"

Phrase: "known as Smad1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205309:Known [Qualitative Concept]
   790   C1414988:SMAD1 [Gene or Genome]
   790   C1416962:SMAD1 [Gene or Genome]

Phrase: "is"

Phrase: "involved in transforming growth factor-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1314939:Involved [Functional Concept]
   760   C1510411:Transforming [Pathologic Function]
   760   C1521761:Factor [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2827422:Factor [Conceptual Entity]
   760   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "bone morphogenetic proteins (BMPs)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]

Phrase: "signaling.33,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
   827 E C1710082:Signal [Phenomenon or Process]

Phrase: "34"

Phrase: "It"

Phrase: "is"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "what"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "Bsp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   805   C0282359:Bromsulphalein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "has in B cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0004561:B-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   770   C3539897:Has [Qualitative Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "although"

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "has"

Phrase: "effects on human"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "murine B cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.207: The major effect of TGF- is inhibiting DNA synthesis and inducing cell cycle arrest, and in some B-cell lines, apoptosis.35 The overexpression of Bcl-2 in FL cells may prevent apoptosis as a consequence of TGF-. 

Phrase: "The major effect of TGF-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0205164:Major [Qualitative Concept]
   748   C0220844:growth [Physiologic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2348382:Effect [Qualitative Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "DNA synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598312:DNA Synthesis [Genetic Function]
  1000   C1328870:DNA synthesis [Laboratory Procedure]
  1000   C1817262:DNA synthesis [Genetic Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "inducing cell cycle arrest,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1155873:Cell Cycle Arrest [Cell Function]
   923   C1516332:Cell Cycle Arrest [Cell Function]
   812   C0237477:Arrest [Temporal Concept]
   812   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "and in some B-cell lines,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0004561:B-cell [Cell]
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1515981:And [Idea or Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "apoptosis.35"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "The overexpression of Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "in FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "apoptosis as a consequence of TGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162638:Apoptosis [Cell Function]

Phrase: "."
Processing 00000000.tx.208: In the B-cell line RL, which has t(14;18), TGF- treatment leads to an increase in hypophosphorylated Rb and a decrease in mutant p53 levels.36 In murine B cells, TGF- caused G1 arrest through up-regulation of p27Kip1, whereas in other cell types TGF- up-regulated p21Cip (CDKN1A).35,37 Overexpression of Bsp-1 may promote increased sensitivity of FL cells to effects of TGF- and contribute to the hypoproliferative nature of these cells. 

Phrase: "In the B-cell line RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1419337:RL [Gene or Genome]
   812   C3539667:RL [Gene or Genome]

Phrase: "which"

Phrase: "has"

Phrase: "t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";18"

Phrase: ")"

Phrase: ","

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "leads to an increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0442805:Increase [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in hypophosphorylated Rb"

Phrase: "and"

Phrase: "a decrease in mutant p53 levels.36"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "In murine B cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "caused G1 arrest through up-regulation of p27Kip1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1517342:G1 Arrest [Molecular Function]
   744   C0237477:Arrest [Temporal Concept]
   744   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "whereas in other cell types TGF-"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   800   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0449475:Cell types [Intellectual Product]
   767   C0007595:Cell Growth [Cell Function]
   744   C0007634:Cell [Cell]
       E   Cell Type
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C0332307:Types [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1510411:Transforming [Pathologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   711 E C1547052:*Type [Quantitative Concept]

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "p21Cip"

Phrase: "(CDKN1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249197:CDKN1A [Gene or Genome]
  1000   C0288472:CDKN1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ").35,"

Phrase: "37 Overexpression of Bsp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "increased sensitivity of FL cells"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1881189:INCREASED SENSITIVITY [Phenomenon or Process]
   806   C2346484:INCREASED SENSITIVITY [Phenomenon or Process]
           SENSITIVITY
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of TGF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0332285:Of [Spatial Concept]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "contribute to the hypoproliferative nature of these cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0007634:Cells [Cell]
   744   C0349590:Nature [Idea or Concept]
   744   C1262865:Nature [Functional Concept]
   744   C1880177:Contribute [Activity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.209: MRP8 and MRP14, also known as migration inhibitory factor-related proteins 8and 14,are members of the S100 family, which are reported to be expressed in myelomonocytic cells.38 These proteins associate with the cytoskeleton, but are also secreted products. 

Phrase: "MRP8"

Phrase: "and"

Phrase: "MRP14,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054505:MRP14 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1335798:MRP14 [Gene or Genome]
  1000   C1704874:MRP14 [Gene or Genome]

Phrase: "also"

Phrase: "known as migration inhibitory factor-related proteins 8and 14,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   852   C0054505:Migration Inhibitory Factor-Related Protein 14 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0024429:Migration Inhibitory Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205309:Known [Qualitative Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C0600210:Migration [Social Behavior]
   742   C1521761:Factor [Functional Concept]
   742   C1533574:Migration [Physiologic Function]
   742   C1881827:MIGRATION [Phenomenon or Process]
   742   C2827422:Factor [Conceptual Entity]
   742   C3463820:Inhibitory [Activity]
   708 E C0163712:Relate [Organic Chemical]

Phrase: "are"

Phrase: "members of the S100 family,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0086282:Family Members [Family Group]
   781 E C1611821:Family Member [Intellectual Product]
   760   C0680022:members [Population Group]
   726 E C2698041:Member [Professional or Occupational Group]

Phrase: "which"

Phrase: "are"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "expressed in myelomonocytic cells.38"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "These proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associate with the cytoskeleton,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0010853:Cytoskeleton [Cell Component]
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]
   770   C1748451:Cytoskeleton [Cell Component]

Phrase: "but"

Phrase: "are"

Phrase: "also secreted products."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.210: MRPs regulate adhesion through 2 integrin39; 

Phrase: "MRPs"

Phrase: "regulate"

Phrase: "adhesion through 2 integrin39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.211: however, their precise function remains unknown. 

Phrase: "however,"

Phrase: "their precise function remains"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.212: Expression in normal GC B cells, but not in FL cells, may be important in the adhesion of normal GC cells. 

Phrase: "Expression in normal GC B cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "not in FL cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1518422:Not [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "important in the adhesion of normal GC cells."
Processing 00000000.tx.213: In addition the low level of MRP8 and MRP14 in FL cells may explain the relative absence of monocytes in neoplastic GCs as compared to that found in normal GCs.40 Several transcription factors/regulators and DNA binding proteins were overexpressed in FL cells. 

Phrase: "In addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the low level of MRP8"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205251:low [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299352:Low [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C1550472:low [Idea or Concept]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "MRP14 in FL cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0054505:MRP14 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1335798:MRP14 [Gene or Genome]
   770   C1704874:MRP14 [Gene or Genome]

Phrase: "may"

Phrase: "explain"

Phrase: "the relative absence of monocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in neoplastic GCs"

Phrase: "as"

Phrase: "compared to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "found in normal GCs.40 Several transcription factors/regulators"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   764   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040649:Transcription [Genetic Function]
   742   C0150312:Found [Quantitative Concept]
   742   C0182953:regulators [Medical Device]
   742   C0205307:Normal [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C0439509:/40 [Temporal Concept]
   742   C2347086:% Normal [Quantitative Concept]
   708 E C0243095:Find [Finding]
   708   C1521761:Factor [Functional Concept]
   708 E C1704734:Regulator [Medical Device]
   708 E C1704735:Regulator [Conceptual Entity]
   708   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "DNA binding proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0012940:DNA-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   983 E C0812382:DNA-binding protein [Gene or Genome]
   913   C0058610:dna proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1148673:DNA Binding [Genetic Function]

Phrase: "were"

Phrase: "overexpressed in FL cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1514559:overexpress [Genetic Function]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.214: Among these were Pax-5 and Id-2, both of which have important roles in B-cell development and differentiation.29,41-44 Pax-5, also known as B-cell-specific activator protein (BSAP), is a DNA binding protein. 

Phrase: "Among these"

Phrase: "were"

Phrase: "Pax-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3542477:PAX [Gene or Genome]

Phrase: "and"

Phrase: "Id-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   861   C0600091:ID [Intellectual Product]

Phrase: "both of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "have"

Phrase: "important roles in B-cell development"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "differentiation.29,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "41-44 Pax-5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3542477:PAX [Gene or Genome]

Phrase: "also"

Phrase: "known as B-cell-specific activator protein (BSAP),"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   897   C0167636:B-Cell-Specific Activator Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0004561:B-cell [Cell]
   774   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205309:Known [Qualitative Concept]
   748   C0205369:Specific [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1552740:specific [Intellectual Product]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "a DNA binding protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0012940:DNA Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0812382:DNA-binding protein [Gene or Genome]
   902   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.215: Pax-5 expression is restricted to B cells, the testis in adults, and the brain and liver in the fetus. 

Phrase: "Pax-5 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "restricted to B cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0004561:B-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0443288:Restricted [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "the testis in adults,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039597:Testis [Body Part, Organ, or Organ Component]
   770   C1278981:Testis [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "liver in the fetus."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.216: In B-cell ontogeny, Pax-5 mRNA is expressed from the pro-B-cell stage through mature B cells, decreasing in plasma cells. 

Phrase: "In B-cell ontogeny,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516356:Cell Ontogeny [Cell Function]
   827   C0018270:ontogeny [Organism Function]
   827   C1621967:Ontogeny [Organism Function]
   734   C0004561:B-cell [Cell]

Phrase: "Pax-5 mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0335218:Messenger [Professional or Occupational Group]

Phrase: "is"

Phrase: "expressed from the pro-B-cell stage"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C1955926:Pro-B-Cell [Cell]
   778   C0004561:B-cell [Cell]
   778   C1292769:pro b [Neoplastic Process]
   774   C0441781:Stage B [Intellectual Product]
   748   C0007634:Cell [Cell]
   748   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205390:Stage [Temporal Concept]
   748   C1269647:Cell [Cell]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2987124:PRO [Intellectual Product]

Phrase: "through mature B cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C1513019:Mature B-Cell [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "decreasing in plasma cells."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0032112:Plasma Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0032105:Plasma [Body Substance]
   770   C0442797:Decreasing [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C3282337:Cells [Cell]
   737 E C0392756:Decrease [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.217: Mice lacking Pax-5 have B-cell maturation arrest at the pre-B-cell stage. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "Pax-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3542477:PAX [Gene or Genome]

Phrase: "have"

Phrase: "B-cell maturation arrest at the pre-B-cell stage."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0333951:Maturation arrest [Pathologic Function]
   760   C1516349:Cell Maturation [Cell Function]
   739   C0237477:Arrest [Temporal Concept]
   739   C0392351:arrest [Governmental or Regulatory Activity]
   739   C0678723:Maturation [Organism Function]
   739   C0870861:maturation [Phenomenon or Process]
   739   C1254042:Maturation [Physiologic Function]
Processing 00000000.tx.218: Pax-5 regulates expression of several B-cell-specific genes including CD19, the tyrosine kinase Blk, and pre-B-cell-specific surrogate light chain genes.45 Pax-5 localizes to 9p13 and has deregulated expression in lymphoplasmacytic lymphomas and some cases of diffuse large cell lymphoma with t(9;14).46,47 Our studies are consistent with a previous report that the majority of cases of FL overexpress Pax-5 protein.29 It is unclear what role Pax-5 plays in FL; 

Phrase: "Pax-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3542477:PAX [Gene or Genome]

Phrase: "regulates"

Phrase: "expression of several B-cell-specific genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0017262:Gene Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "CD19,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540683:CD19 [Laboratory Procedure]

Phrase: "the tyrosine kinase Blk,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1332419:BLK [Gene or Genome]
   734   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "pre-B-cell-specific surrogate light chain genes.45 Pax-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C3542477:PAX [Gene or Genome]

Phrase: "localizes to 9p13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0392752:localize [Spatial Concept]
   790   C1515496:9p13 [Cell Component]

Phrase: "and"

Phrase: "has"

Phrase: "deregulated expression in lymphoplasmacytic lymphomas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "some cases of diffuse large cell lymphoma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "with t(9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";14"

Phrase: ").46,"

Phrase: "47"

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "consistent with a previous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the majority of cases of FL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "Pax-5 protein.29"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C3542477:PAX [Gene or Genome]

Phrase: "It"

Phrase: "is"

Phrase: "unclear"

Phrase: "what role Pax-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3542477:PAX [Gene or Genome]

Phrase: "plays in FL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032214:Play [Daily or Recreational Activity]
   790   C0600138:Plays [Finding]

Phrase: ";"
Processing 00000000.tx.219: however, overexpression in splenic B cells and cell lines enhances proliferation and modulates p53 expression.48 Similar to Pax-5, Id-2 has been shown to be important in B-cell development. 

Phrase: "however,"

Phrase: "overexpression in splenic B cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "p53 expression.48 Similar to Pax-5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "Id-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   861   C0600091:ID [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important in B-cell development."
Processing 00000000.tx.220: Id proteins are helix-loop-helix transcription regulators that play an important role in hematopoiesis.49 Id proteins bind to other helix-loop-helix-bearing transcription factors, inhibiting their function.50 In mice, Id-2 is expressed in pro-B cells and decreases during differentiation.51 In normal peripheral blood mononuclear cells, Id-2 mRNA levels decrease with mitogen stimulation.50 Id-2 plays a critical role in lymphoid tissue development because Id-2/ mice lack lymph nodes and Peyer patches, but have normal splenic architecture with T cells and B cells.45 Overexpression of Id-2 causes a block in normal murine T-cell differentiation.52 Therefore, the overexpression of Id-2 in FL cells may regulate proliferation or contribute to the maturation arrest in these tumor cells. 

Phrase: "Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "helix-loop-helix transcription regulators"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0182953:regulators [Medical Device]
   771 E C1704734:Regulator [Medical Device]
   771 E C1704735:Regulator [Conceptual Entity]
   717   C0282642:helix loop helix [Spatial Concept]

Phrase: "that"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in hematopoiesis.49 Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "bind to other helix-loop-helix-bearing transcription factors,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   790   C0282642:helix loop helix [Spatial Concept]
   764   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0018882:Helix [Eukaryote]
   742   C0040649:Transcription [Genetic Function]
   742   C0229304:Helix [Body Part, Organ, or Organ Component]
   742   C0419518:Loop [Medical Device]
   742   C0445022:Loop [Spatial Concept]
   742   C1145667:Bind [Activity]
   742   C1167622:bind [Molecular Function]
   742   C1704689:Bearing [Medical Device]
   742   C1704821:Helix [Spatial Concept]
   742   C1705682:Helix [Anatomical Structure]
   708 E C0004897:Bear [Mammal]
   708   C1521761:Factor [Functional Concept]
   708   C2827422:Factor [Conceptual Entity]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "their function.50 In mice,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "Id-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   861   C0600091:ID [Intellectual Product]

Phrase: "is"

Phrase: "expressed in pro-B cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C1955926:Pro-B-Cells [Cell]
   806   C0004561:B-Cells [Cell]
   806   C1292769:pro b [Neoplastic Process]
   760   C0007634:Cells [Cell]
   760   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2987124:PRO [Intellectual Product]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "decreases during differentiation.51"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007589:Differentiation [Cell Function]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "In normal peripheral blood mononuclear cells,"
Meta Candidates (Total=26; Excluded=12; Pruned=0; Remaining=14)
   937   C1321301:Peripheral Blood Mononuclear Cells [Cell]
   881   C0007634:Normal cell [Cell]
           Cells
   881   C1268443:Normal cell [Cell]
   872   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   840   C0229664:peripheral blood [Body Substance]
           Blood
   840   C0806987:Mononuclear cells [Cell]
   808 E C2328697:Hemal cell [Cell]
   804   C0005767:Blood [Tissue]
   804   C0005768:blood [Body Substance]
   804   C0205100:Peripheral [Spatial Concept]
   804   C1513475:Mononuclear [Clinical Attribute]
   804   C3282337:Cells [Cell]
   798 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   733 E C0333275:Bloody [Qualitative Concept]
   721 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   721 E C0392895:Bloods [Population Group]
   721 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   721 E C1511228:VESSEL, BLOOD [Tissue]
   704 E C1558950:VASCULAR [Finding]
   704 E C1801960:Vascular [Qualitative Concept]

Phrase: "Id-2 mRNA levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "decrease with mitogen stimulation.50 Id-2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   748   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0026249:Mitogen [Pharmacologic Substance]
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]
   748   C0600091:ID [Intellectual Product]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a critical role in lymphoid tissue development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "because"

Phrase: "Id-2/ mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0068319:ID-2 [Amino Acid, Peptide, or Protein]

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "lymph nodes"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
  1000   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   966 E C0440747:LYMPH NODE [Tissue]
   966 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   861   C0024202:Lymph [Body Substance]
   861   C0746922:nodes [Body Part, Organ, or Organ Component]
   827 E C1706163:Node [Conceptual Entity]
   827 E C2697524:Node [Conceptual Entity]
   827 E C2700445:Node [Plant]
   777 E C0443268:Nodal [Spatial Concept]
   777 E C1417752:NODAL [Gene or Genome]
   755 E C0449725:Nodality [Spatial Concept]

Phrase: "and"

Phrase: "Peyer patches,"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
  1000   C0031272:Peyer's Patches [Body Part, Organ, or Organ Component]
  1000   C1267588:Peyer's patches [Body Part, Organ, or Organ Component]
   861   C0994894:Patches [Medical Device]
   827 E C0332461:Patch [Finding]
   827 E C0445403:Patch [Biomedical or Dental Material]
   827 E C0991556:Patch [Medical Device]
   827 E C1305400:Patch [Medical Device]
   827 E C1533128:Patch [Biomedical or Dental Material]
   827 E C1706366:{Patch} [Quantitative Concept]
   827 E C1707974:Patch [Biomedical or Dental Material]
   777 E C0205413:Patchy [Qualitative Concept]

Phrase: "but"

Phrase: "have"

Phrase: "normal splenic architecture with T cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003737:Architecture [Occupation or Discipline]

Phrase: "and"

Phrase: "B cells.45 Overexpression of Id-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a block in normal murine T-cell differentiation.52 Therefore,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0028778:Block [Pathologic Function]
   739   C0332206:Block [Functional Concept]
   739   C1533157:Block [Substance]
   739   C1706084:Block [Geographic Area]
   739   C2828370:Block [Quantitative Concept]

Phrase: "the overexpression of Id-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "in FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "regulate"

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "or"

Phrase: "contribute to the maturation arrest"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0333951:Maturation arrest [Pathologic Function]
   760   C0237477:Arrest [Temporal Concept]
   760   C0392351:arrest [Governmental or Regulatory Activity]
   760   C0678723:Maturation [Organism Function]
   760   C0870861:maturation [Phenomenon or Process]
   760   C1254042:Maturation [Physiologic Function]
   760   C1880177:Contribute [Activity]
   704 E C0311403:Inhibited [Qualitative Concept]
   704 E C3463820:Inhibiting [Activity]

Phrase: "in these tumor cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.221: Identification of the target genes that are regulated by Pax-5 and Id-2 in FL cells may provide important insights into understanding the growth pattern and maturation arrest of these cells. 

Phrase: "Identification of the target genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "regulated by Pax-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C3542477:PAX [Gene or Genome]

Phrase: "and"

Phrase: "Id-2 in FL cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   760   C0007634:Cells [Cell]
   760   C0600091:ID [Intellectual Product]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "important insights into understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0233820:insights [Mental Process]

Phrase: "the growth pattern"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156245:Growth pattern [Finding]
  1000   C1623229:growth pattern [Cell Function]
   861   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "maturation arrest of these cells."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0333951:Maturation arrest [Pathologic Function]
   781   C1516349:Cell Maturation [Cell Function]
   760   C0237477:Arrest [Temporal Concept]
   760   C0392351:arrest [Governmental or Regulatory Activity]
   760   C0678723:Maturation [Organism Function]
   760   C0870861:maturation [Phenomenon or Process]
   760   C1254042:Maturation [Physiologic Function]
   704 E C0311403:Inhibited [Qualitative Concept]
   704 E C3463820:Inhibiting [Activity]
Processing 00000000.tx.222: The FL cells reside in a GC microenvironment within lymphoid tissues and in the marrow in association with other lymphohematopoietic and stromal cells.53 Evidence indicates that interactions of FL cells with components of the microenvironment modulate the growth and survival of the malignant cells.54 FL cells had increased mRNA expression of 2cytokine receptors: IL-2R and IL-4R. 

Phrase: "The FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "reside in a GC microenvironment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0282491:Germinal Center [Tissue]
   753   C0205099:Center [Spatial Concept]
   753   C2982691:Reside [Activity]

Phrase: "within lymphoid tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0024296:Tissues, Lymphoid [Tissue]
   861   C0040300:Tissues [Tissue]
   861   C1518071:Lymphoid [Qualitative Concept]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "and in the marrow"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0086590:Marrow [Food]
   770   C0376152:Marrow [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
   770   C1546708:Marrow [Intellectual Product]
   715 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   715 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   715 E C1550278:Medullary [Body Part, Organ, or Organ Component]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with other lymphohematopoietic"

Phrase: "and"

Phrase: "stromal cells.53 Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that interactions of FL cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0007582:Interactions, Cell [Cell Function]
   726   C1704675:Interaction [Functional Concept]

Phrase: "with components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "of the microenvironment"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "survival of the malignant cells.54 FL cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0007620:Cell Survival [Cell Function]
   744   C0038952:Survival [Activity]
   744   C0220921:survival [Functional Concept]

Phrase: "had"

Phrase: "increased mRNA expression of 2cytokine receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0040649:RNA Expression [Genetic Function]
   757   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "IL-2R"

Phrase: "and"

Phrase: "IL-4R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1149207:IL-4R [Molecular Function]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]
Processing 00000000.tx.223: The IL2RG chain mediates signaling from IL-2 as well as IL-4, IL-7, and IL-15.55-57 Furthermore, there are often large numbers of T cells expressing CD40L (CD154), IL-2, and IL-4 in normal and malignant GCs.58,59 Survival of FL cells in vitro is enhanced by IL-4 in association with stimulation through CD40.19,60 Therefore IL-4 production by T cells and overexpression of the IL-4 receptor on FL cells may be important for their viability in vivo. 

Phrase: "The IL2RG chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "signaling from IL-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037083:Signaling [Cell Function]
   770   C3537152:signaling [Biologic Function]

Phrase: "as well as"

Phrase: "IL-4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "IL-7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "IL-15.55-57 Furthermore,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0254610:IL-15 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1149222:IL-15 [Molecular Function]
   840   C1334105:IL-15 [Gene or Genome]
   804   C0020898:IL [Geographic Area]
   804   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0022271:IL [Geographic Area]
   804   C0450382:55 [Intellectual Product]

Phrase: "there"

Phrase: "are"

Phrase: "often large numbers of T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "expressing"

Phrase: "CD40L"

Phrase: "(CD154"

Phrase: ")"

Phrase: ","

Phrase: "IL-2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021756:Interleukin-2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0879590:INTERLEUKIN 2 [Gene or Genome]
  1000   C1522405:Interleukin-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IL-4 in normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020898:IL [Geographic Area]
   770   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "malignant GCs.58,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205282:Malignant [Qualitative Concept]
   827   C0334590:MALIGNANT [Neoplastic Process]
   827   C1533592:MALIGNANT [Neoplastic Process]

Phrase: "59 Survival of FL cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007620:Cell Survival [Cell Function]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "is"

Phrase: "enhanced by IL-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020898:IL [Geographic Area]
   770   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0022271:IL [Geographic Area]
   770   C2349975:Enhanced [Activity]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "through CD40.19,"

Phrase: "60 Therefore IL-4 production by T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C1819457:IL-4 production [Organism Function]
   744   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "overexpression of the IL-4 receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "on FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "important for their viability"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.224: Increased numbers of CD40L+ T cells in malignant GCs may be able to compensate for the lower expression of CD40 on FL cells as compared to normal GC B cells.13 As reported previously, TNF mRNA was overexpressed by FL cells.28 TNF can serve as an autocrine growth factor for normal B cells, although TNF has not been shown to stimulate proliferation of FL cells in vitro. 

Phrase: "Increased numbers of CD40L+ T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in malignant GCs"

Phrase: "may"

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "compensate for the lower expression of CD40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205432:compensate [Qualitative Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "on FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "compared to normal GC B cells.13"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C0004561:B-Cells [Cell]
   770   C0282491:Germinal Center [Tissue]
   750   C0007634:Normal cell [Cell]
           Cells
   750   C1268443:Normal cell [Cell]
   744   C0205099:Center [Spatial Concept]
   744   C0205307:Normal [Qualitative Concept]
   744   C0439166:% normal [Quantitative Concept]
   744   C1707455:Compared [Activity]
   744   C2347086:% Normal [Quantitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "As"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously,"

Phrase: "TNF mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0335218:Messenger [Professional or Occupational Group]

Phrase: "was"

Phrase: "overexpressed by FL cells.28 TNF"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719   C1514559:overexpress [Genetic Function]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "serve as an autocrine growth factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0596138:Autocrine [Organ or Tissue Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "for normal B cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0004561:B-Cells [Cell]
   896   C0007634:Normal cell [Cell]
           Cells
   896   C1268443:Normal cell [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "although"

Phrase: "TNF"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "proliferation of FL cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0596290:Cell Proliferation [Cell Function]
   770   C0334094:Proliferation [Pathologic Function]
   770   C1514485:Proliferation [Functional Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.225: TNF family members and their receptors play a central role in the generation and maintenance of the structure of lymphoid tissues, the development of GCs, and follicular dendritic cells (FDCs).61 A potentially important function of FL-derived TNF may be in the creation and maintenance of the tumor cell microenvironment, and functional FDCs, which may assist in the support of tumor cell viability and their recruitment within specific areas of the body. 

Phrase: "TNF family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "their receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a central role in the generation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "maintenance of the structure of lymphoid tissues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1817201:tissue maintenance [Organism Function]
   748   C0024501:Maintenance [Activity]

Phrase: "the development of GCs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "follicular dendritic cells (FDCs).61"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   923   C0242245:Dendritic Cells, Follicular [Cell]
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C0439682:Follicular [Qualitative Concept]
   812   C1571705:Follicular [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "A potentially important function of FL-derived TNF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: "may"

Phrase: "be in the creation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441513:Creation [Therapeutic or Preventive Procedure]
   770   C1706214:Creation [Activity]
   770   C2987476:Be [Conceptual Entity]

Phrase: "and"

Phrase: "maintenance of the tumor cell microenvironment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1516348:Cell Maintenance [Cell Function]
   753   C0024501:Maintenance [Activity]

Phrase: "and"

Phrase: "functional FDCs,"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   923   C0242245:Dendritic Cells, Follicular [Cell]
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C0439682:Follicular [Qualitative Concept]
   812   C1571705:Follicular [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "may"

Phrase: "assist in the support of tumor cell viability"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   770   C0007620:Cell Viability [Cell Function]
   770   C0431085:Tumor cell [Cell]
   770   C0597032:Tumor Cell [Cell]
   767   C1300991:Tumor viability [Clinical Attribute]
   744   C0007634:Cell [Cell]
   744   C0018896:assist [Social Behavior]
   744   C0027651:Tumor [Neoplastic Process]
   744   C0183683:Support [Medical Device]
   744   C0443348:viability [Qualitative Concept]
   744   C0557034:assist [Health Care Activity]
   744   C1269647:Cell [Cell]
   744   C1521721:Support [Conceptual Entity]
   744   C1578706:Tumor [Intellectual Product]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "their recruitment within specific areas of the body."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2949735:Recruitment [Activity]
Processing 00000000.tx.226: One problem with comparing gene expression of normal and neoplastic tissues is the difficulty of determining whether the signal is originating from the tumor cells or from associated normal cells. 

Phrase: "One problem with comparing gene expression of normal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033213:Problem [Finding]

Phrase: "and"

Phrase: "neoplastic tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "the difficulty of determining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1299586:Difficulty [Finding]

Phrase: "whether"

Phrase: "the signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "originating from the tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0431085:Tumor cells [Cell]
   773 E C0597032:Tumor Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0027651:Tumor [Neoplastic Process]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "or from associated normal cells."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   781   C0699040:cell associated [Cell Component]
   773   C0007634:Normal cell [Cell]
           Cells
   773   C1268443:Normal cell [Cell]
   760   C0205307:Normal [Qualitative Concept]
   760   C0332281:Associated [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C2347086:% Normal [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.227: Within normal tonsils and tissue involved with FL, there are many normal cellular constituents (ie, fibroblasts, monocytes, T, NK, endothelial cells, and FDCs). 

Phrase: "Within normal tonsils"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0040421:Tonsils [Body Part, Organ, or Organ Component]
   861   C0836921:tonsils [Body Part, Organ, or Organ Component]
   827 E C1280736:Tonsil [Body Part, Organ, or Organ Component]
   827 E C1519547:TONSIL [Tissue]

Phrase: "and"

Phrase: "tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "involved with FL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]

Phrase: "there"

Phrase: "are"

Phrase: "many normal cellular constituents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0729650:Constituents [Substance]

Phrase: "("

Phrase: "ie"

Phrase: ","

Phrase: "fibroblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "monocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026473:Monocytes [Cell]

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "NK,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2709199:Natural killer [Cell]
   861   C0205296:Natural [Functional Concept]
   861   C1336644:KILLER [Gene or Genome]
   861   C1705132:KILLER [Gene or Genome]

Phrase: "endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "FDCs"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0242245:Dendritic Cells, Follicular [Cell]
   901   C0011306:Dendritic Cells [Cell]
   867 E C0003315:Dendritic cell [Cell]
   867 E C1511762:Dendritic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0011305:Dendritic [Cell Component]
   827   C0439640:Dendritic [Qualitative Concept]
   827   C0439682:Follicular [Qualitative Concept]
   827   C1571705:Follicular [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.228: Although the microenvironment in FL may in fact differ from that of normal lymphoid tissues, in this study we only sought to examine gene expression in the B cells. 

Phrase: "Although"

Phrase: "the microenvironment in FL"

Phrase: "may in fact"

Phrase: "differ from that of normal lymphoid tissues,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0024296:Tissues, Lymphoid [Tissue]
   757   C0040300:Normal Tissue [Tissue]
           Tissues
   757   C0332441:Normal tissue [Finding]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C1518071:Lymphoid [Qualitative Concept]
   748   C2347086:% Normal [Quantitative Concept]
   714 E C1547928:Tissue [Intellectual Product]

Phrase: "in this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "gene expression in the B cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017262:Gene Expression [Genetic Function]
   767   C1861886:CELL Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.229: The GC B cells used in this study were representative of a total population, rather than separated into centroblasts or centrocytes. 

Phrase: "The GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "representative of a total population,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "rather than"

Phrase: "separated into centroblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   756   C1517735:Centroblast [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "centrocytes."
Processing 00000000.tx.230: The phenotype of the GC B cells used was CD38+, CD44 ,and surface IgD. 

Phrase: "The phenotype of the GC B cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0427385:Cell phenotype [Laboratory Procedure]
   750   C1318444:Cell phenotype [Organism Attribute]
   744   C0031437:Phenotype [Organism Attribute]
   744   C1285572:Phenotype [Laboratory Procedure]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "CD38+,"

Phrase: "CD44 ,"

Phrase: "and"

Phrase: "surface IgD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2754970:surface IgD [Cell Component]
   861   C0020843:IgD [Amino Acid, Peptide, or Protein]
   861   C0205148:Surface [Spatial Concept]
   861   C0577612:IGD [Laboratory Procedure]
Processing 00000000.tx.231: Within the total population, the expression of CD77 is associated with the more proliferative centroblasts, whereas CD38+ GC B cells that lack CD77 are more reflective of centrocytes.62 CD77 has been reported to have variable expression on FL cells.63 However, despite the potential heterogeneity of different tonsillar B-cell preparations, when the gene expression of the various samples of GC B cells was examined, they were remarkably homogeneous. 

Phrase: "Within the total population,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3258257:Total population [Quantitative Concept]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "the expression of CD77"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "associated with the more proliferative centroblasts,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0334094:Proliferative [Pathologic Function]
   719 E C0750490:Associate [Idea or Concept]
   719   C1517735:Centroblast [Body Part, Organ, or Organ Component]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "whereas"

Phrase: "CD38+ GC B cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   881   C0945928:CD38+ cell [Cell]
   840   C0004561:B-Cells [Cell]
   840   C0282491:Germinal Center [Tissue]
   804   C0007634:Cells [Cell]
   804   C0205099:Center [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "CD77"

Phrase: "are"

Phrase: "more reflective of centrocytes.62 CD77"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "variable expression on FL cells.63 However,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1868500:Variable expression [Finding]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "despite the potential heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "of different tonsillar B-cell preparations,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   823   C0920433:cell preparation [Laboratory Procedure]
   771   C0455052:Preparation [Health Care Activity]
   771   C1521827:Preparation [Functional Concept]

Phrase: "when"

Phrase: "the gene expression of the various samples of GC B cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017262:Gene Expression [Genetic Function]
   736   C0017337:Gene [Gene or Genome]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1861886:CELL Gene [Gene or Genome]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "they"

Phrase: "were"

Phrase: "remarkably homogeneous."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881065:Homogeneous [Qualitative Concept]
Processing 00000000.tx.232: The finding that cell cycle regulatory proteins that are involved in G1 arrest, p21CIP1 and p16INK4A, were overexpressed in FL cells is consistent with their low proliferative nature.64 Moreover, p55CDC, which is also required for normal cell division, was underexpressed in FL cells.13,65 An alternative interpretation is that the GC B cells we purified were predominantly centroblasts with a high proliferation rate and low levels of these CDK inhibitors. 

Phrase: "The finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that cell cycle regulatory proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0243021:Cell-Cycle Regulatory Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cell Cycle Proteins
   861   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "involved in G1 arrest,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1517342:G1 Arrest [Molecular Function]
   770   C0237477:Arrest [Temporal Concept]
   770   C0392351:arrest [Governmental or Regulatory Activity]
   770   C1314939:Involved [Functional Concept]

Phrase: "p21CIP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0249197:p21CIP1 [Gene or Genome]

Phrase: "and"

Phrase: "p16INK4A,"

Phrase: "were"

Phrase: "overexpressed in FL cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1514559:overexpress [Genetic Function]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "consistent with their low proliferative nature.64 Moreover,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "p55CDC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1413256:p55CDC [Gene or Genome]
  1000   C3539866:p55CDC [Amino Acid, Peptide, or Protein]
  1000   C3541310:p55CDC [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "also"

Phrase: "required for normal cell division,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0007590:Cell division [Cell Function]
   806   C0007634:Normal cell [Cell]
           Cell
   806   C1268443:Normal cell [Cell]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1293097:Division [Therapeutic or Preventive Procedure]
   760   C1514873:Required [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2347086:% Normal [Quantitative Concept]
   760   C2919030:Division [Organization]
   760   C2919031:Division [Activity]

Phrase: "was"

Phrase: "underexpressed in FL cells.13,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "An alternative interpretation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0459471:Interpretation [Intellectual Product]
   861   C3173575:Interpretation [Clinical Attribute]

Phrase: "is"

Phrase: "that"

Phrase: "the GC B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "were"

Phrase: "predominantly centroblasts with a high proliferation rate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1517735:Centroblast [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "low levels of these CDK inhibitors."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.233: Follicular lymphomas have been compared to normal GC B cells using oligonucleotide microarrays.13 Seventeen of the 32genes we confirmed by RT-PCR to be differentially expressed were present on the microarray used by Alizadeh et al.13 Despite a different technical approach, a number of the genes that we found to be overexpressed in FL cells were also increased in the array analysis by Alizadeh et al. 

Phrase: "Follicular lymphomas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0024301:Lymphomas, Follicular [Neoplastic Process]
   861   C0024299:Lymphomas [Neoplastic Process]
   861   C0439682:Follicular [Qualitative Concept]
   861   C1571705:Follicular [Body Part, Organ, or Organ Component]

Phrase: "have"

Phrase: "been"

Phrase: "compared to normal GC B cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   778   C0004561:B-Cells [Cell]
   778   C0282491:Germinal Center [Tissue]
   757   C0007634:Normal cell [Cell]
           Cells
   757   C1268443:Normal cell [Cell]
   748   C0205099:Center [Spatial Concept]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C1707455:Compared [Activity]
   748   C2347086:% Normal [Quantitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oligonucleotide microarrays.13 Seventeen of the 32genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0600597:Oligonucleotide Microarrays [Medical Device,Research Device]
   748   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   714   C1709016:Microarray [Manufactured Object]

Phrase: "we"

Phrase: "confirmed by RT-PCR to"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1524075:Chain [Idea or Concept]
   714 E C1456348:Confirm [Qualitative Concept]

Phrase: "be"

Phrase: "differentially"

Phrase: "expressed"

Phrase: "were"

Phrase: "present on the microarray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "used by Alizadeh et al.13"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:Used by [Finding]
           used
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "Despite a different technical approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "a number of the genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "overexpressed in FL cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1514559:overexpress [Genetic Function]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "increased in the array analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1510941:Array [Spatial Concept]
   760   C1524024:analysis [Functional Concept]

Phrase: "by Alizadeh et al."
Processing 00000000.tx.234: These include BCL2, BSP1, JUN, IL4R, IL-2R, Lyn, and SNF-2a. 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "BCL2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376515:BCL2 [Gene or Genome]
  1000   C0597712:BCL2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "BSP1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416962:BSP1 [Gene or Genome]
  1000   C2677154:BSP1 [Gene or Genome]

Phrase: "JUN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "IL4R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0123771:IL4R [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1149207:IL-4R [Molecular Function]
  1000   C1334118:IL4R [Gene or Genome]

Phrase: "IL-2R,"

Phrase: "Lyn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812307:LYN [Gene or Genome]
  1000   C1442804:LYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "SNF-2a."
Processing 00000000.tx.235: In addition, 2genes (p55CDC, CD40), which we found to have decreased expression in FL cells, were also decreased in the study of Alizadeh et al.13 In contrast, 2genes that we found to be increased in FL cells were decreased in the Alizadeh13 study (p16INK4A and CCN1B). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "2genes"

Phrase: "(p55CDC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1413256:p55CDC [Gene or Genome]
  1000   C3539866:p55CDC [Amino Acid, Peptide, or Protein]
  1000   C3541310:p55CDC [Gene or Genome]

Phrase: "CD40"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "decreased expression in FL cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "also"

Phrase: "decreased in the study of Alizadeh et al.13"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0205216:Decreased [Quantitative Concept]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C0557651:Study [Manufactured Object]
   742   C2603343:Study [Research Activity]
   708 E C0547047:Decrease [Quantitative Concept]

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "2genes"

Phrase: "that"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "increased in FL cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "decreased in the Alizadeh13 study"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "(p16INK4A"

Phrase: "and"

Phrase: "CCN1B"

Phrase: ")."
Processing 00000000.tx.236: In addition to the t(14;18) translocation, additional cytogenetic abnormalities have been described in FL.66-72 Additional chromosomal abnormalities involving, for example, p53, play a central role in the progression of FL. 

Phrase: "In addition to the t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";18"

Phrase: ")"

Phrase: "translocation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040715:Translocation [Cell or Molecular Dysfunction]
  1000   C2987521:Translocation [Activity]

Phrase: "additional cytogenetic abnormalities"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0008625:Cytogenetic Abnormalities [Cell or Molecular Dysfunction]
   901   C0008626:Cytogenetic Abnormalities [Disease or Syndrome]
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "described in FL.66-72 Additional chromosomal abnormalities"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   770   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   744   C0000768:Abnormalities [Congenital Abnormality]
   744   C0000769:abnormalities [Functional Concept]
   744   C0008633:Chromosomal [Cell Component]
   744   C1524062:Additional [Functional Concept]
   744   C1552738:described [Idea or Concept]
   711 E C1704258:Abnormality [Finding]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: ","

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "p53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a central role in the progression of FL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.237: These additional abnormalities are likely to be important in the development of the disease, because Bcl-2/IgH is necessary but not sufficient for tumor development. 

Phrase: "These additional abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "important in the development of the disease,"

Phrase: "because"

Phrase: "Bcl-2/IgH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017351:IGH [Gene or Genome]
   734   C0376515:Bcl-2 [Gene or Genome]

Phrase: "is"

Phrase: "necessary"

Phrase: "but"

Phrase: "not sufficient for tumor development."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205410:Sufficient [Qualitative Concept]
Processing 00000000.tx.238: These changes include gains and losses of chromosomal material that can either lead to an increased or a decreased expression of other genes. 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "gains"

Phrase: "and"

Phrase: "losses of chromosomal material"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C1516519:Chromosomal Loss [Cell or Molecular Dysfunction]
   767 E C0598174:chromosome loss [Genetic Function]
   737   C1517945:Loss [Quantitative Concept]

Phrase: "that"

Phrase: "can"

Phrase: "either"

Phrase: "lead to an increased"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C0861064:increased lead [Finding]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "a decreased expression of other genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.239: In this study we found a number of genes that were deregulated and localized to sites of known genetic abnormalities observed in FL (Table 3). 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "deregulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880287:Deregulated [Activity]

Phrase: "and"

Phrase: "localized to sites of known genetic abnormalities"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   775   C0449689:Site of origin [Spatial Concept]
   762   C0262496:Genetic Abnormality [Finding]
   762   C1704257:Genetic Abnormality [Finding]
   762   C2945843:Site of [Qualitative Concept]
   748   C0000768:Abnormalities [Congenital Abnormality]
   748   C0000769:abnormalities [Functional Concept]
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0205145:Sites [Spatial Concept]
   748   C0205309:Known [Qualitative Concept]
   748   C0314603:Genetic [Functional Concept]
   748   C0392752:Localized [Spatial Concept]
   720 E C0744356:GENITAL ABNORMALITY [Finding]
   714 E C1515974:Site [Body Location or Region]
   714 E C1704258:Abnormality [Finding]
   714 E C2825164:Site [Spatial Concept]

Phrase: "observed in FL (Table 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0039224:Table [Manufactured Object]
   760   C1441672:Observed [Functional Concept]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.240: For example, p21CIP1 and TNF, assigned to 6p21.1 and 6p21.3, respectively, are located within high-level DNA amplifications on band 6p21.71 MRP8, MRP14, and TDPX2 genes are located within commonly seen chromosome 1breakpoints 1q21-22 and 1p22-36, respectively.66,69  View this table: [in this window] [in a new window]  Table 3. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "p21CIP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0249197:p21CIP1 [Gene or Genome]

Phrase: "and"

Phrase: "TNF,"

Phrase: "assigned to 6p21.1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1521535:6p21.1 [Cell Component]
   770   C1516050:Assigned [Functional Concept]
   770   C1521533:6p21 [Cell Component]
   770   C1552601:assigned [Intellectual Product]

Phrase: "and"

Phrase: "6p21.3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521539:6p21.3 [Cell Component]
   861   C1521533:6p21 [Cell Component]

Phrase: "respectively,"

Phrase: "are"

Phrase: "located within high-level DNA amplifications"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0683230:amplification dna [Genetic Function]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205250:High [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1299351:High [Qualitative Concept]
   753   C1547707:Level [Geographic Area]
   753   C2700149:HIGH [Intellectual Product]
   753   C2946261:Level [Pharmacologic Substance]
   719   C1517480:Amplification [Molecular Biology Research Technique]
   719   C1521871:Amplification [Phenomenon or Process]
   719   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "on band 6p21.71 MRP8,"

Phrase: "MRP14,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054505:MRP14 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1335798:MRP14 [Gene or Genome]
  1000   C1704874:MRP14 [Gene or Genome]

Phrase: "and"

Phrase: "TDPX2 genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1420676:TDPX2 gene [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "located within commonly"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "chromosome 1breakpoints 1q21-22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0008665:Chromosome 22 [Cell Component]
   812   C0008633:Chromosome [Cell Component]
   812   C1520988:1q21 [Cell Component]

Phrase: "and"

Phrase: "1p22-36,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520943:1p22 [Cell Component]

Phrase: "respectively.66,"

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.241: Chromosomal localization of differentially expressed genes in FL In conclusion, we have identified a number of genes that are differentially expressed in FL cells and their normal counterparts, GC B cells, using a combination of gene array technology and quantitative PCR analysis. 

Phrase: "Chromosomal localization of differentially expressed genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0008630:Gene Localization [Laboratory Procedure,Molecular Biology Research Technique]
   754   C1657114:chromosome localisation [Biologic Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in FL"

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "differentially"

Phrase: "expressed in FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "their normal counterparts,"

Phrase: "GC B cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a combination of gene array technology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "quantitative PCR analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   937   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
Processing 00000000.tx.242: These studies focused on only the normal and neoplastic B cells by using highly purified cells without contaminating cells from the associated microenvironment. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "focused on only"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205171:Only [Quantitative Concept]
   790   C0205234:Focused [Spatial Concept]
   790   C1285542:focused [Functional Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "neoplastic B cells by"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0004561:B-Cells [Cell]
   819   C0597032:Neoplastic cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "highly purified cells without contaminating cells"

Phrase: "from the associated microenvironment."
Processing 00000000.tx.243: Several of the genes identified are involved in regulating the cell cycle, and their overexpression in FL cells is consistent with their low proliferative state. 

Phrase: "Several of the genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439064:Several [Quantitative Concept]
   770   C0443302:Several [Quantitative Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "are"

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "regulating"

Phrase: "the cell cycle,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "their overexpression in FL cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "consistent with their low proliferative state."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.244: The observation that a number of transcription factors overexpressed by FL cells, particularly Pax-5 and Id-2, have a central role in normal B-cell development, may lead to better understanding of the regulation of other genes involved in the pathogenesis and pathophysiology of this disease. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "a number of transcription factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "overexpressed by FL cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1514559:overexpress [Genetic Function]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "particularly Pax-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3542477:PAX [Gene or Genome]

Phrase: "and"

Phrase: "Id-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   861   C0600091:ID [Intellectual Product]

Phrase: "have"

Phrase: "a central role in normal B-cell development,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "may"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "understanding of the regulation of other genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0017263:genes regulation [Genetic Function]
   748   C0017337:Genes [Gene or Genome]
   748   C0162340:Understanding [Mental Process]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "involved in the pathogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
   770   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "pathophysiology of this disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031847:pathophysiology [Functional Concept]
   770   C0277785:Pathophysiology [Qualitative Concept]
Processing 00000000.tx.245: In addition to insights into the biology of FL, comparing gene expression in normal B cells and FL cells may lead to the identification of potential targets as well as antigens for immunotherapeutic strategies.  

Phrase: "In addition to insights"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233820:insights [Mental Process]

Phrase: "into the biology"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005532:Biology [Biomedical Occupation or Discipline]
   928 E C0205460:Biologic [Qualitative Concept]
   928 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "of FL,"

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "gene expression in normal B cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017262:Gene Expression [Genetic Function]
   767   C1861886:CELL Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "FL cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "lead to the identification of potential targets"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0020792:Identification [Mental Process]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0205396:Identification [Qualitative Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3245505:Potential [Qualitative Concept]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   714   C1521840:Target [Functional Concept]
   714   C2986546:TARGET [Diagnostic Procedure]

Phrase: "as well as"

Phrase: "antigens for immunotherapeutic strategies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003320:Antigens [Immunologic Factor]
Processing 00000000.tx.246: Footnotes Submitted October 10,2000; 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "Submitted October 10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515023:Submitted [Functional Concept]

Phrase: "2000"

Phrase: ";"
Processing 00000000.tx.247: accepted August 23,2001. 

Phrase: "accepted August 23,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450348:23 [Quantitative Concept]
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2001."
Processing 00000000.tx.248: Supported in part by National Institutes of Health grants CA55207 and CA66996, and the Norman Hirschfield Foundation. 

Phrase: "Supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by National Institutes of Health grants CA55207"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "and"

Phrase: "CA66996,"

Phrase: "and"

Phrase: "the Norman Hirschfield Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.249: H.H. was supported by the Cure for Lymphoma Foundation. 

Phrase: "H.H."

Phrase: "was"

Phrase: "supported by the Cure"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1521721:Supported [Conceptual Entity]
   770   C1880198:Cure [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "for Lymphoma Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.250: The publication costs of this article were defrayed in part by page charge payment. 

Phrase: "The publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]

Phrase: "costs of this article"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010186:Cost [Quantitative Concept]
   770   C0220812:Costs [Quantitative Concept]
   770   C1706852:Article [Intellectual Product]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by page charge payment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220808:payment [Quantitative Concept]
   827   C0680264:payment [Quantitative Concept]
Processing 00000000.tx.251: Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18U.S.C. section 1734. 

Phrase: "Therefore,"

Phrase: "and"

Phrase: "solely to"

Phrase: "indicate"

Phrase: "this fact,"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C. section 1734."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0205155:Section [Spatial Concept]
   804   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   804   C1522472:Section [Substance]
   804   C1552923:Section [Quantitative Concept]
   804   C1705191:Section [Physical Object]
Processing 00000000.tx.252: Reprints: Arnold S.

Phrase: "Reprints"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3273171:Reprint [Intellectual Product]

Phrase: ":"

Phrase: "Arnold S."
Processing 00000000.tx.253: Freedman, Department of Adult Oncology, Dana-Farber Cancer Institute, 44Binney St, Boston, MA 02115; 

Phrase: "Freedman,"

Phrase: "Department of Adult Oncology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Dana-Farber Cancer Institute,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1511716:Dana-Farber Cancer Institute [Health Care Related Organization]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "44Binney St,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02115"

Phrase: ";"
Processing 00000000.tx.254: e-mail: arnold_freedman{at}dfci.harvard.edu .  References Top Abstract Introduction Materials and methods Results Discussion References 1. 

Phrase: "e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "arnold_freedman{at}dfci.harvard.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.255: Yunis J, Oken M, Kaplan M, Ensrud K, Howe R, Theologides A. 

Phrase: "Yunis J,"

Phrase: "Oken M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kaplan M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ensrud K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Howe R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Theologides A."
Processing 00000000.tx.256: Distinctive chromosomal abnormalities in histology, subtypes of non-Hodgkin's lymphomas. 

Phrase: "Distinctive chromosomal abnormalities in histology,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   806   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "subtypes of non-Hodgkin's lymphomas."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449560:subtypes [Classification]
Processing 00000000.tx.257: N Engl J Med. 

Phrase: "N Engl J Med."
Processing 00000000.tx.258: 1982;307:1231-1236[Abstract]. 

Phrase: "1982"

Phrase: ";307"

Phrase: ":"

Phrase: "1231-1236"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.259: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.260: McDonnell TJ, Deane N, Platt FM, et al. bcl-2-immunoglobulin transgenic mice demonstrated extended B cell survival and follicular lymphoproliferation. 

Phrase: "McDonnell TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Deane N,"

Phrase: "Platt FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "et al. bcl-2-immunoglobulin transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0025936:Mice, Transgenic [Mammal]
   795   C0003069:Transgenic [Animal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "demonstrated"

Phrase: "extended B cell survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007620:Cell Survival [Cell Function]
   812   C0038952:Survival [Activity]
   812   C0220921:survival [Functional Concept]

Phrase: "and"

Phrase: "follicular lymphoproliferation."
Processing 00000000.tx.261: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.262: 1989;57:79-88[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1989"

Phrase: ";57"

Phrase: ":"

Phrase: "79-88"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.263: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.264: McDonnell TJ, Korsmeyer SJ. 

Phrase: "McDonnell TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Korsmeyer SJ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]
Processing 00000000.tx.265: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14:18). 

Phrase: "Progression from lymphoid hyperplasia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]

Phrase: "to high-grade malignant lymphoma"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0079740:Lymphoma, High-Grade [Neoplastic Process]
   861   C0024299:Lymphoma, Malignant [Neoplastic Process]
           Lymphoma
   812   C0205282:Malignant [Qualitative Concept]
   812   C0334590:MALIGNANT [Neoplastic Process]
   812   C1533592:MALIGNANT [Neoplastic Process]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "transgenic for the t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003069:Transgenic [Animal]

Phrase: ":"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.266: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.267: 1991;349:254-256[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1991"

Phrase: ";349"

Phrase: ":"

Phrase: "254-256"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.268: 4. 

Phrase: "4."
Processing 00000000.tx.269: Limpens J, Stad R, Vos C, et al. 

Phrase: "Limpens J,"

Phrase: "Stad R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Vos C,"

Phrase: "et al."
Processing 00000000.tx.270: Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. 

Phrase: "Lymphoma-associated translocation t(14"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0024299:Lymphoma [Neoplastic Process]
   804   C0040715:Translocation [Cell or Molecular Dysfunction]
   804   C0332281:Associated [Qualitative Concept]
   804   C2987521:Translocation [Activity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: ";18"

Phrase: ")"

Phrase: "in blood B cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0005773:Blood Cells [Cell]
   901   C0004561:B-Cells [Cell]
   869 E C2328697:Hemal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "of normal individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.271: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.272: 1995;85:2528-2536[Abstract/Free FullText]. 

Phrase: "1995"

Phrase: ";85"

Phrase: ":"

Phrase: "2528-2536"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.273: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.274: Paltiel O, Zelenets A, Sverdlin I, Gordon L, Ben-Yehuda D. 

Phrase: "Paltiel O,"

Phrase: "Zelenets A,"

Phrase: "Sverdlin I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gordon L,"

Phrase: "Ben-Yehuda D."
Processing 00000000.tx.275: Translocation t(14;18) in healthy individuals: preliminary study of its association with family history and agricultural exposure. 

Phrase: "Translocation t(14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]

Phrase: ";18"

Phrase: ")"

Phrase: "in healthy individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: ":"

Phrase: "preliminary study of its association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439611:Preliminary [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "with family history"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0241889:Family history [Finding]
  1000   C1705495:Family History [Idea or Concept]
   861   C0015576:Family [Family Group]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1704727:Family [Conceptual Entity]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C0241888:Familial [Functional Concept]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "and"

Phrase: "agricultural exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.276: Ann Oncol. 

Phrase: "Ann Oncol."
Processing 00000000.tx.277: 2000;11:78-80. 

Phrase: "2000"

Phrase: ";11"

Phrase: ":"

Phrase: "78-80."
Processing 00000000.tx.278: 6. 

Phrase: "6."
Processing 00000000.tx.279: Aster J, Kobayashi Y, Shiota M, Mori S, Sklar J. 

Phrase: "Aster J,"

Phrase: "Kobayashi Y,"

Phrase: "Shiota M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mori S,"

Phrase: "Sklar J."
Processing 00000000.tx.280: Detection of the t(14:18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. 

Phrase: "Detection of the t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "18"

Phrase: ")"

Phrase: "at similar frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "in hyperplastic lymphoid tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0024296:Tissues, Lymphoid [Tissue]
   827   C0040300:Tissues [Tissue]
   827   C1518071:Lymphoid [Qualitative Concept]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "from American"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596070:American [Population Group]

Phrase: "and"

Phrase: "Japanese patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.281: Am J Pathol. 

Phrase: "Am"

Phrase: "J Pathol."
Processing 00000000.tx.282: 1992;141:291-299[Abstract]. 

Phrase: "1992"

Phrase: ";141"

Phrase: ":"

Phrase: "291-299"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.283: 7. 

Phrase: "7."
Processing 00000000.tx.284: Liu Y, Hernandez A, Shibata D, Cortopassi G. 

Phrase: "Liu Y,"

Phrase: "Hernandez A,"

Phrase: "Shibata D,"

Phrase: "Cortopassi G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.285: BCL-2 translocation frequency rises with age in humans. 

Phrase: "BCL-2 translocation frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0376249:frequency [Quantitative Concept]
   812   C0439603:Frequency [Temporal Concept]
   812   C0871396:Frequency [Quantitative Concept]
   812   C1561548:Frequency [Qualitative Concept]
   812   C1705502:Frequency [Quantitative Concept]
   756   C1516130:BCL-2 Translocation [Cell or Molecular Dysfunction]
   741 E C0332183:Frequent [Temporal Concept]

Phrase: "rises with age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.286: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.287: 1994;91:8910-8914[Abstract]. 

Phrase: "1994"

Phrase: ";91"

Phrase: ":"

Phrase: "8910-8914"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.288: 8. 

Phrase: "8."
Processing 00000000.tx.289: Price CGA, Meerabux J, Murtagh S, et al. 

Phrase: "Price CGA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539168:CGA [Disease or Syndrome]

Phrase: "Meerabux J,"

Phrase: "Murtagh S,"

Phrase: "et al."
Processing 00000000.tx.290: The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. 

Phrase: "The significance of circulating cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";18"

Phrase: ")"

Phrase: "in long remission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0544452:Remission [Finding]
   861   C0687702:remission [Neoplastic Process]

Phrase: "from follicular lymphoma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0024301:Lymphoma, Follicular [Neoplastic Process]
   861   C0024299:Lymphoma [Neoplastic Process]
   861   C0439682:Follicular [Qualitative Concept]
   861   C1571705:Follicular [Body Part, Organ, or Organ Component]
Processing 00000000.tx.291: J Clin Oncol. 

Phrase: "J Clin Oncol."
Processing 00000000.tx.292: 1991;9:1527-1532[Abstract]. 

Phrase: "1991"

Phrase: ";9"

Phrase: ":"

Phrase: "1527-1532"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.293: 9. 

Phrase: "9."
Processing 00000000.tx.294: Perou CM, Srlie T, Eisen MB, et al. 

Phrase: "Perou CM,"

Phrase: "Srlie T,"

Phrase: "Eisen MB,"

Phrase: "et al."
Processing 00000000.tx.295: Molecular portraits of human breast tumours. 

Phrase: "Molecular portraits of human breast tumours."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0376644:Portraits [Intellectual Product]
   753   C0936090:Portraits [Intellectual Product]
Processing 00000000.tx.296: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.297: 2000;406:747-752[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "2000"

Phrase: ";406"

Phrase: ":"

Phrase: "747-752"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.298: 10. 

Phrase: "10."
Processing 00000000.tx.299: Wellmann A, Thieblemont C, Pittaluga S, et al. 

Phrase: "Wellmann"

Phrase: "A,"

Phrase: "Thieblemont C,"

Phrase: "Pittaluga S,"

Phrase: "et al."
Processing 00000000.tx.300: Detection of differentially expressed genes in lymphoma using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. 

Phrase: "Detection of differentially expressed genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in lymphoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024299:Lymphoma [Neoplastic Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cDNA arrays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0600596:DNA Arrays [Research Device]
   793   C1510941:Array [Spatial Concept]
   734   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "identification of clusterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "as a new diagnostic marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1511876:Diagnostic Marker [Clinical Attribute]
   827   C0005516:Marker [Clinical Attribute]

Phrase: "for anaplastic large-cell lymphomas."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0206180:Lymphomas, Anaplastic Large-Cell [Neoplastic Process]
   890   C0024302:Large cell lymphoma [Neoplastic Process]
   890   C0079744:Lymphoma, Large-Cell [Neoplastic Process]
   886   C1321546:Anaplastic Lymphoma [Neoplastic Process]
   875   C1515964:Anaplastic Cell [Cell]
   844   C0883208:cell lymphoma [Cell]
   812   C0007634:Cell [Cell]
   812   C0024299:Lymphomas [Neoplastic Process]
   812   C0205618:Anaplastic [Qualitative Concept]
   812   C0549177:Large [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   741 E C0002793:Anaplasia [Neoplastic Process]
Processing 00000000.tx.301: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.302: 2000;96:398-404[Abstract/Free FullText]. 

Phrase: "2000"

Phrase: ";96"

Phrase: ":"

Phrase: "398-404"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.303: 11. 

Phrase: "11."
Processing 00000000.tx.304: Bittner M, Meltzer P, Chen Y, et al. 

Phrase: "Bittner M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Meltzer P,"

Phrase: "Chen Y,"

Phrase: "et al."
Processing 00000000.tx.305: Molecular classification of cutaneous malignant melanoma by gene expression profiling. 

Phrase: "Molecular classification of cutaneous malignant melanoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C2698629:Skin Classification [Intellectual Product]
   753   C0008902:Classification [Classification]
   753   C0008903:classification [Functional Concept]
   753   C0678229:classification [Occupational Activity]

Phrase: "by gene expression profiling."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752248:Gene Expression Profiling [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C1449575:Gene Expression Profiling [Laboratory Procedure]
   983 E C1956267:Profile, Gene Expression [Quantitative Concept]
   901   C1513400:Expression Profiling [Molecular Biology Research Technique]
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]
   734   C0017262:Gene Expression [Genetic Function]
Processing 00000000.tx.306: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.307: 2000;406:536-540[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "2000"

Phrase: ";406"

Phrase: ":"

Phrase: "536-540"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.308: 12. 

Phrase: "12."
Processing 00000000.tx.309: Walker J, Rigley K. 

Phrase: "Walker J,"

Phrase: "Rigley K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.310: Gene expression profiling in human peripheral blood mononuclear cells using high-density filter-based cDNA microarrays. 

Phrase: "Gene expression profiling in human peripheral blood mononuclear cells"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0752248:Gene Expression Profiling [Laboratory Procedure,Molecular Biology Research Technique]
   790   C1449575:Gene Expression Profiling [Laboratory Procedure]
   773 E C1956267:Profile, Gene Expression [Quantitative Concept]
   764   C1513400:Expression Profiling [Molecular Biology Research Technique]
   708   C1979963:Profile [Laboratory Procedure]
   708   C2003903:Profile [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "high-density filter-based cDNA microarrays."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   883   C1709016:High-Density Microarray [Manufactured Object]
           Microarray
   818   C0600596:DNA Microarrays [Research Device]
   801 E C1522053:DNA Microarray [Molecular Biology Research Technique]
Processing 00000000.tx.311: J Immunol Methods. 

Phrase: "J Immunol Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.312: 2000;239:167-179[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "2000"

Phrase: ";239"

Phrase: ":"

Phrase: "167-179"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.313: 13. 

Phrase: "13."
Processing 00000000.tx.314: Alizadeh AA, Eisen MB, Davis ER, et al. 

Phrase: "Alizadeh AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Eisen MB,"

Phrase: "Davis ER,"

Phrase: "et al."
Processing 00000000.tx.315: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. 

Phrase: "Distinct types of diffuse large B-cell lymphoma"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   782   C0449475:Type of cell [Intellectual Product]
           Cell types
   750 E C0007634:Cell Type [Cell]
   744   C0332307:Types [Qualitative Concept]
   711 E C1547052:*Type [Quantitative Concept]
   703   C0079744:Diffuse Large B-Cell Lymphoma [Neoplastic Process]
   703   C2699777:Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [Neoplastic Process]

Phrase: "identified by gene expression profiling."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0752248:Gene Expression Profiling [Laboratory Procedure,Molecular Biology Research Technique]
   862   C1449575:Gene Expression Profiling [Laboratory Procedure]
   845 E C1956267:Profile, Gene Expression [Quantitative Concept]
   806   C0017262:Gene Expression [Genetic Function]
   806   C1513400:Expression Profiling [Molecular Biology Research Technique]
   760   C0017337:Gene [Gene or Genome]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]
Processing 00000000.tx.316: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.317: 2000;403:503-511[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "2000"

Phrase: ";403"

Phrase: ":"

Phrase: "503-511"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.318: 14. 

Phrase: "14."
Processing 00000000.tx.319: Shim C, Zhang W, Rhee CH, Lee J-H. 

Phrase: "Shim C,"

Phrase: "Zhang W,"

Phrase: "Rhee CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Lee J-H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.320: Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. 

Phrase: "Profiling of differentially expressed genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]

Phrase: "in human primary cervical cancer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   875   C1306459:primary cancer [Finding]
           Cancer
   861   C0007847:Cervical Cancer [Neoplastic Process]
   861   C0302592:Cervical Cancer [Neoplastic Process]
   861   C3539064:Cervical Cancer [Intellectual Product]
   812   C0006826:Cancer [Neoplastic Process]
   812   C0027530:Cervical [Body Location or Region]
   812   C0205064:Cervical [Spatial Concept]
   812   C0998265:Cancer [Eukaryote]

Phrase: "by complementary DNA expression array."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0600596:DNA Array [Research Device]
   812   C1510941:Array [Spatial Concept]
Processing 00000000.tx.321: Clin Cancer Res. 

Phrase: "Clin Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]
Processing 00000000.tx.322: 1998;4:3045-3050[Abstract]. 

Phrase: "1998"

Phrase: ";4"

Phrase: ":"

Phrase: "3045-3050"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.323: 15. 

Phrase: "15."
Processing 00000000.tx.324: Khan J, Simon R, Bittner M, et al. 

Phrase: "Khan J,"

Phrase: "Simon R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bittner M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.325: Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. 

Phrase: "Gene expression profiling of alveolar rhabdomyosarcoma"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0752248:Gene Expression Profiling [Laboratory Procedure,Molecular Biology Research Technique]
   833   C1449575:Gene Expression Profiling [Laboratory Procedure]
   816 E C1956267:Profile, Gene Expression [Quantitative Concept]
   790   C1513400:Expression Profiling [Molecular Biology Research Technique]
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "with cDNA microarrays."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0600596:DNA Microarrays [Research Device]
   884 E C1522053:DNA Microarray [Molecular Biology Research Technique]
   793   C1709016:Microarray [Manufactured Object]
   734   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.326: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.327: 1998;58:5009-5013[Abstract]. 

Phrase: "1998"

Phrase: ";58"

Phrase: ":"

Phrase: "5009-5013"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.328: 16. 

Phrase: "16."
Processing 00000000.tx.329: Backert S, Gelos M, Kobalz U, et al. 

Phrase: "Backert S,"

Phrase: "Gelos M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kobalz U,"

Phrase: "et al."
Processing 00000000.tx.330: Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array. 

Phrase: "Differential gene expression in colon carcinoma cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C1519516:Differential Gene Expression [Genetic Function]
   778   C0017262:Gene Expression [Genetic Function]
   757   C1861886:CELL Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "detected with a cDNA array."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0600596:DNA Array [Research Device]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442726:Detected [Finding]
   753   C1510941:Array [Spatial Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.331: Int J Cancer. 

Phrase: "Int J Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.332: 1999;82:868-874[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1999"

Phrase: ";82"

Phrase: ":"

Phrase: "868-874"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.333: 17. 

Phrase: "17."
Processing 00000000.tx.334: Clark E, Golub T, Lander E, Hynes R. 

Phrase: "Clark E,"

Phrase: "Golub T,"

Phrase: "Lander E,"

Phrase: "Hynes R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.335: Genomic analysis of metastasis reveals an essential role for RhoC. 

Phrase: "Genomic analysis of metastasis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "an essential role for RhoC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.336: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.337: 2000;406:532-535[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "2000"

Phrase: ";406"

Phrase: ":"

Phrase: "532-535"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.338: 18. 

Phrase: "18."
Processing 00000000.tx.339: Wang T, Hopkins D, Schmidt C, et al. 

Phrase: "Wang T,"

Phrase: "Hopkins D,"

Phrase: "Schmidt C,"

Phrase: "et al."
Processing 00000000.tx.340: Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis. 

Phrase: "Identification of genes differentially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "over-expressed in lung squamous cell carcinoma"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   853   C0149782:lung squamous cell carcinoma [Neoplastic Process]
   814   C0007137:Squamous cell carcinoma [Neoplastic Process]
           Carcinoma, Squamous
   778   C0221910:Squamous cell [Cell]
   774   C0684249:CARCINOMA LUNG [Neoplastic Process]
   774   C1518174:Carcinoma Cell [Cell]
   748   C0007097:Carcinoma [Neoplastic Process]
   748   C0007634:Cell [Cell]
   748   C0024109:Lung [Body Part, Organ, or Organ Component]
   748   C0205136:Over [Spatial Concept]
   748   C0819757:LUNG [Tissue]
   748   C1182670:Squamous [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1278908:Lung [Body Part, Organ, or Organ Component]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "combination of cDNA subtraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "microarray analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1449575:Microarray Analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.341: Oncogene. 

Phrase: "Oncogene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]
Processing 00000000.tx.342: 2000;19:1519-1528[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "2000"

Phrase: ";19"

Phrase: ":"

Phrase: "1519-1528"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.343: 19. 

Phrase: "19."
Processing 00000000.tx.344: Ghia P, Boussiotis V, Schultze J, et al. 

Phrase: "Ghia P,"

Phrase: "Boussiotis V,"

Phrase: "Schultze J,"

Phrase: "et al."
Processing 00000000.tx.345: Unbalanced expression of Bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. 

Phrase: "Unbalanced expression of Bcl-2 family proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in follicular lymphoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0024301:Lymphoma, Follicular [Neoplastic Process]
   861   C0024299:Lymphoma [Neoplastic Process]
   861   C0439682:Follicular [Qualitative Concept]
   861   C1571705:Follicular [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "contribution of CD40 signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "in promoting survival."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
Processing 00000000.tx.346: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.347: 1998;91:244-251[Abstract/Free FullText]. 

Phrase: "1998"

Phrase: ";91"

Phrase: ":"

Phrase: "244-251"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.348: 20. 

Phrase: "20."
Processing 00000000.tx.349: Nakao M, Janssen JWG, Flohr T, Bartram CR. 

Phrase: "Nakao M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Janssen JWG,"

Phrase: "Flohr T,"

Phrase: "Bartram CR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]
Processing 00000000.tx.350: Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by light cycler technology. 

Phrase: "Rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "reliable quantification of minimal residual disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantification [Quantitative Concept]

Phrase: "in acute lymphoblastic leukemia"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0023449:Acute lymphoblastic leukaemia [Neoplastic Process]
           Lymphoblastic leukaemia
  1000   C1961102:Lymphoblastic Leukemia, Acute [Neoplastic Process]
           Lymphoblastic Leukemia
  1000   C3542401:Acute Lymphoblastic Leukemia [Intellectual Product]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023448:Lymphoblastic leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0229613:lymphoblastic [Cell]
   755 E C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rearranged immunoglobulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "and"

Phrase: "T-cell receptor loci by light cycler technology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.351: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.352: 2000;60:3281-3289[Abstract/Free FullText]. 

Phrase: "2000"

Phrase: ";60"

Phrase: ":"

Phrase: "3281-3289"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.353: 21. 

Phrase: "21."
Processing 00000000.tx.354: Gibson U, Heid C, Williams P. 

Phrase: "Gibson U,"

Phrase: "Heid C,"

Phrase: "Williams P."
Processing 00000000.tx.355: A novel method for real time quantitative RT-PCR. 

Phrase: "A novel method for real time quantitative RT-PCR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0025663:Method [Intellectual Product]
   738   C0449851:Method [Functional Concept]
   738   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.356: Genome Res. 

Phrase: "Genome Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.357: 1996;6:995-1001[Abstract]. 

Phrase: "1996"

Phrase: ";6"

Phrase: ":"

Phrase: "995-1001"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.358: 22. 

Phrase: "22."
Processing 00000000.tx.359: Liu Y, Barthelemy C, de Bouteiller O, Arpin C, Durand I, Banchereau J. 

Phrase: "Liu Y,"

Phrase: "Barthelemy C,"

Phrase: "de Bouteiller O,"

Phrase: "Arpin C,"

Phrase: "Durand I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Banchereau J."
Processing 00000000.tx.360: Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid upregulation of B7-1 and B7-2. 

Phrase: "Memory B cells from human tonsils"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   820   C0682638:b cells memory [Cell]
   790   C0004561:B-Cells [Cell]
   783   C0312737:Memory cells [Cell]
   783   C0427861:Human cells [Laboratory or Test Result]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "colonize"

Phrase: "mucosal epithelium"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014609:Epithelium [Tissue]
   789 E C0221908:Epithelial [Qualitative Concept]

Phrase: "and"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "antigen to T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   865   C0487637:T-cell Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003320:Antigen [Immunologic Factor]

Phrase: "by rapid upregulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041904:Up-Regulation [Cell Function,Molecular Function]
   861   C0162493:Up-Regulation [Genetic Function]

Phrase: "of B7-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0104998:B7-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366561:B7-1 [Gene or Genome]
  1000   C1705431:B7-1 [Gene or Genome]

Phrase: "and"

Phrase: "B7-2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413243:B7-2 [Gene or Genome]
  1000   C2698599:B7-2 [Gene or Genome]
Processing 00000000.tx.361: Immunity. 

Phrase: "Immunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020964:Immunity [Physiologic Function]
   928 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.362: 1995;2:239-248[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1995"

Phrase: ";2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "239-248"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.363: 23. 

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.364: Anderson KC, Bates MP, Slaughenhoupt BL, et al. 

Phrase: "Anderson KC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022575:kc [Disease or Syndrome]
   861   C1705783:KC [Gene or Genome]

Phrase: "Bates"

Phrase: "MP,"

Phrase: "Slaughenhoupt BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "et al."
Processing 00000000.tx.365: Expression of human B cell associated antigens on leukemias and lymphomas: a model of B cell differentiation. 

Phrase: "Expression of human B cell associated antigens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "on leukemias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023418:LEUKEMIAS, NOS [Neoplastic Process]

Phrase: "and"

Phrase: "lymphomas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024299:Lymphomas [Neoplastic Process]

Phrase: ":"

Phrase: "a model of B cell differentiation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.366: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.367: 1984;63:1424-1431[Abstract]. 

Phrase: "1984"

Phrase: ";63"

Phrase: ":"

Phrase: "1424-1431"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.368: 24. 

Phrase: "24."
Processing 00000000.tx.369: Jaffe ES, Shevach EM, Frank MM, Bered CW, Green I. 

Phrase: "Jaffe ES,"

Phrase: "Shevach EM,"

Phrase: "Frank MM,"

Phrase: "Bered CW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]

Phrase: "Green I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.370: Nodular lymphoma: evidence for origin from follicular B lymphocytes. 

Phrase: "Nodular lymphoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024301:Lymphoma, Nodular [Neoplastic Process]
   861   C0024299:Lymphoma [Neoplastic Process]
   861   C0205297:Nodular [Qualitative Concept]

Phrase: ":"

Phrase: "evidence for origin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "from follicular B lymphocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0004561:B-Lymphocytes [Cell]
   827   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.371: N Engl J Med. 

Phrase: "N Engl J Med."
Processing 00000000.tx.372: 1974;290:814-819. 

Phrase: "1974"

Phrase: ";290"

Phrase: ":"

Phrase: "814-819."
Processing 00000000.tx.373: 25. 

Phrase: "25."
Processing 00000000.tx.374: Cossman J, Neckers LM, Jones T, Hsu SM, Jaffe ES. 

Phrase: "Cossman J,"

Phrase: "Neckers LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Jones T,"

Phrase: "Hsu SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Jaffe ES."
Processing 00000000.tx.375: Low grade lymphomas: expression of developmentally regulated B cell antigens. 

Phrase: "Low grade lymphomas"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079747:Lymphomas, Low-Grade [Neoplastic Process]
   827   C0024299:Lymphomas [Neoplastic Process]
   734   C1282907:Low grade [Qualitative Concept]

Phrase: ":"

Phrase: "expression of developmentally regulated B cell antigens."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.376: Am J Pathol. 

Phrase: "Am"

Phrase: "J Pathol."
Processing 00000000.tx.377: 1984;115:117-124[Abstract]. 

Phrase: "1984"

Phrase: ";115"

Phrase: ":"

Phrase: "117-124"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.378: 26. 

Phrase: "26."
Processing 00000000.tx.379: Donovan JW, Ladetto M, Zou G, et al. 

Phrase: "Donovan JW,"

Phrase: "Ladetto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zou G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.380: Immumoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia. 

Phrase: "Immumoglobulin heavy-chain consensus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0376298:Consensus [Social Behavior]

Phrase: "probes for real-time PCR quantification of residual disease"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   820   C1709846:Real-Time Polymerase Chain Reaction [Molecular Biology Research Technique]
   775   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   756   C0543478:Residual Disease [Neoplastic Process]
   756   C1550177:Real Time [Idea or Concept]
   754   C0034746:Reaction Time [Temporal Concept]
   738   C0012634:Disease [Disease or Syndrome]
   738   C0040223:Time [Temporal Concept]
   738   C0182400:Probe [Medical Device]
   738   C0237400:Real [Qualitative Concept]
   738   C0337112:Chain [Manufactured Object]
   738   C0443286:Reaction [Functional Concept]
   738   C1114821:Reaction [Clinical Attribute]
   738   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1524075:Chain [Idea or Concept]
   738   C1609982:Residual [Qualitative Concept]
   738   C1704681:Probe [Gene or Genome]
   738   C1709793:Quantification [Quantitative Concept]
   738   C2347609:Probe [Chemical Viewed Functionally]
   738   C3272377:REAL [Intellectual Product]
   738   C3536729:Probe [Manufactured Object]
   738   C3541383:Time [Temporal Concept]

Phrase: "in acute lymphoblastic leukemia."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0023449:Acute lymphoblastic leukaemia [Neoplastic Process]
           Lymphoblastic leukaemia
  1000   C1961102:Lymphoblastic Leukemia, Acute [Neoplastic Process]
           Lymphoblastic Leukemia
  1000   C3542401:Acute Lymphoblastic Leukemia [Intellectual Product]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023448:Lymphoblastic leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0229613:lymphoblastic [Cell]
   755 E C1167770:Lymphoblasts [Laboratory Procedure]
Processing 00000000.tx.381: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.382: 2000;95:2651-2658[Abstract/Free FullText]. 

Phrase: "2000"

Phrase: ";95"

Phrase: ":"

Phrase: "2651-2658"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.383: 27. 

Phrase: "27."
Processing 00000000.tx.384: Tsujimoto Y, Cossman J, Jaffe E, Croce C. 

Phrase: "Tsujimoto Y,"

Phrase: "Cossman J,"

Phrase: "Jaffe E,"

Phrase: "Croce C."
Processing 00000000.tx.385: Involvement of bcl-2 gene in human follicular lymphoma. 

Phrase: "Involvement of bcl-2 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in human follicular lymphoma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0024301:Lymphoma, Follicular [Neoplastic Process]
   827   C0024299:Lymphoma [Neoplastic Process]
   827   C0439682:Follicular [Qualitative Concept]
   827   C1571705:Follicular [Body Part, Organ, or Organ Component]
Processing 00000000.tx.386: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.387: 1985;228:1440-1443[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1985"

Phrase: ";228"

Phrase: ":"

Phrase: "1440-1443"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.388: 28. 

Phrase: "28."
Processing 00000000.tx.389: Salles G, Bienvenu J, Bastion Y, et al. 

Phrase: "Salles G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bienvenu J,"

Phrase: "Bastion Y,"

Phrase: "et al."
Processing 00000000.tx.390: Elevated circulating levels of TNF and its p55 receptor are associated with an adverse prognosis in lymphoma patients. 

Phrase: "Elevated circulating levels of TNF"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0175630:Circulating [Functional Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "its p55 receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "associated with an adverse prognosis"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0033325:Prognosis [Health Care Activity]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in lymphoma patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.391: Br J Hematol. 

Phrase: "Br J Hematol."
Processing 00000000.tx.392: 1996;93:352-359[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1996"

Phrase: ";93"

Phrase: ":"

Phrase: "352-359"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.393: 29. 

Phrase: "29."
Processing 00000000.tx.394: Krenacs L, Himmelmann A, Quintanilla-Martinez L, et al. 

Phrase: "Krenacs L,"

Phrase: "Himmelmann A,"

Phrase: "Quintanilla-Martinez L,"

Phrase: "et al."
Processing 00000000.tx.395: Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. 

Phrase: "Transcription factor B-cell-specific activator protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0167636:B-Cell-Specific Activator Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C1336776:Transcription Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(BSAP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0167636:B-Cell-Specific Activator Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0004561:B-cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0205369:Specific [Qualitative Concept]
   804   C1269647:Cell [Cell]
   804   C1552740:specific [Intellectual Product]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "is"

Phrase: "differentially"

Phrase: "expressed in B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0004561:B-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and in subsets of B-cell lymphomas."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0079731:B-Cell Lymphomas [Neoplastic Process]
   804   C0079004:B-Cell Subsets [Intellectual Product]
   778   C0004561:B-cell [Cell]
   762   C0883208:cell lymphoma [Cell]
   748   C0007634:Cell [Cell]
   748   C0024299:Lymphomas [Neoplastic Process]
   748   C1269647:Cell [Cell]
   748   C1515981:And [Idea or Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714   C1515021:Subset [Classification]
Processing 00000000.tx.396: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.397: 1998;92:1308-1316[Abstract/Free FullText]. 

Phrase: "1998"

Phrase: ";92"

Phrase: ":"

Phrase: "1308-1316"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.398: 30. 

Phrase: "30."
Processing 00000000.tx.399: Corcione A, Ottonello L, Tortolina G, et al. 

Phrase: "Corcione A,"

Phrase: "Ottonello L,"

Phrase: "Tortolina G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.400: Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells. 

Phrase: "Stromal cell-derived factor-1 as a chemoattractant"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   869   C0218504:Stromal Cell-Derived Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   869   C1332817:STROMAL CELL-DERIVED FACTOR 1 [Gene or Genome]
   770   C0162597:Stromal cell [Cell]
   767   C0960756:factor A [Organic Chemical]
   744   C0007634:Cell [Cell]
   744   C1269647:Cell [Cell]
   744   C1441547:Derived [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C3245521:derived [Idea or Concept]
   735 E C0596291:stroma cell [Cell Component]

Phrase: "for follicular center lymphoma B cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   867   C0079731:lymphoma b-cell [Neoplastic Process]
   853   C0883208:Lymphoma cells [Cell]
   853   C2697951:Lymphoma Cells [Laboratory Procedure]
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.401: J Natl Cancer Inst. 

Phrase: "J Natl Cancer Inst."
Processing 00000000.tx.402: 2000;92:628-635[Abstract/Free FullText]. 

Phrase: "2000"

Phrase: ";92"

Phrase: ":"

Phrase: "628-635"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.403: 31. 

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.404: Stein H, Gerdes J, Mason DY. 

Phrase: "Stein H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gerdes J,"

Phrase: "Mason DY."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2826182:DY [Temporal Concept]
Processing 00000000.tx.405: The normal and malignant germinal centre. 

Phrase: "The normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "malignant germinal centre."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0282491:Germinal Center [Tissue]
   827   C0205099:Center [Spatial Concept]
Processing 00000000.tx.406: Clin Haematol. 

Phrase: "Clin Haematol."
Processing 00000000.tx.407: 1982;11:531-559[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1982"

Phrase: ";11"

Phrase: ":"

Phrase: "531-559"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.408: 32. 

Phrase: "32."
Processing 00000000.tx.409: Harris N, Jaffe E, Stein H, et al. 

Phrase: "Harris N,"

Phrase: "Jaffe E,"

Phrase: "Stein H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.410: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. 

Phrase: "A revised European-American classification of lymphoid neoplasms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0920604:classification neoplasm [Intellectual Product]
   744   C0008902:Classification [Classification]
   744   C0008903:classification [Functional Concept]
   744   C0678229:classification [Occupational Activity]

Phrase: ":"

Phrase: "a proposal from the International Lymphoma Study Group."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1555306:proposal [Idea or Concept]
   744   C1948033:Proposal [Intellectual Product]
Processing 00000000.tx.411: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.412: 1994;84:1361-1392[Free FullText]. 

Phrase: "1994"

Phrase: ";84"

Phrase: ":"

Phrase: "1361-1392"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.413: 33. 

Phrase: "33."
Processing 00000000.tx.414: Yue J, Frey RS, Mulder KM. 

Phrase: "Yue J,"

Phrase: "Frey RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Mulder KM."
Processing 00000000.tx.415: Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGF. 

Phrase: "Cross-talk between the Smad1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0010357:Crosstalk [Molecular Function]
   806   C2986468:Cross-talk [Cell Function]
   760   C0037817:Talk [Organism Function]
   760   C0234856:talk [Daily or Recreational Activity]
   760   C0600118:talk [Finding]
   760   C2828360:Cross [Conceptual Entity]

Phrase: "and"

Phrase: "Ras/MEK signaling pathways for TGF."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   809   C1514731:Ras Signaling Pathway [Molecular Function]
   783   C0037080:pathways signaling [Molecular Function]
   773 E C0037083:signaling pathway [Cell Function]
   773 E C0086982:Signaling Pathway [Molecular Function]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.416: Oncogene. 

Phrase: "Oncogene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]
Processing 00000000.tx.417: 1999;18:2033-2037[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1999"

Phrase: ";18"

Phrase: ":"

Phrase: "2033-2037"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.418: 34. 

Phrase: "34."
Processing 00000000.tx.419: Kretzschmar M, Liu F, Hata A, Doody J, Massagu J. 

Phrase: "Kretzschmar M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Liu F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Hata A,"

Phrase: "Doody J,"

Phrase: "Massagu J."
Processing 00000000.tx.420: The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. 

Phrase: "The TGF-beta family mediator Smad1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C1414988:SMAD1 [Gene or Genome]
   795   C1416962:SMAD1 [Gene or Genome]
   710   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "phosphorylated"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "and"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "functionally by the BMP receptor kinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0289417:Receptor, BMP [Amino Acid, Peptide, or Protein,Receptor]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0279266:BMP [Therapeutic or Preventive Procedure]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.421: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.422: 1997;11:984-995[Abstract]. 

Phrase: "1997"

Phrase: ";11"

Phrase: ":"

Phrase: "984-995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.423: 35. 

Phrase: "35."
Processing 00000000.tx.424: Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T. 

Phrase: "Kamesaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nishizawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Michaud GY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018408:GY [Geographic Area]
   861   C0556636:Gy [Quantitative Concept]

Phrase: "Cossman J,"

Phrase: "Kiyono T."
Processing 00000000.tx.425: TGF-beta 1induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. 

Phrase: "TGF-beta 1induces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the cyclin-dependent kinase inhibitor p27Kip1 mRNA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C0335218:Messenger [Professional or Occupational Group]
   710   C0919418:Cyclin-Dependent Kinase Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1152568:cyclin dependent kinase inhibitor [Molecular Function]
   710   C1511576:Cyclin-Dependent Kinase Inhibitor [Pharmacologic Substance]

Phrase: "and"

Phrase: "protein in murine B cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.426: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.427: 1998;160:770-777[Abstract/Free FullText]. 

Phrase: "1998"

Phrase: ";160"

Phrase: ":"

Phrase: "770-777"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.428: 36. 

Phrase: "36."
Processing 00000000.tx.429: Beckwith M, Ruscetti FW, Sing GK, Urba WJ, Longo DL. 

Phrase: "Beckwith M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ruscetti FW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332292:FW [Functional Concept]
   861   C2986896:FW [Idea or Concept]

Phrase: "Sing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037173:SING [Geographic Area]
  1000   C0234857:sing [Individual Behavior]

Phrase: "GK,"

Phrase: "Urba WJ,"

Phrase: "Longo DL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]
Processing 00000000.tx.430: Anti-IgM induces transforming growth factor-beta sensitivity in a human B-lymphoma cell line: inhibition of growth is associated with a downregulation of mutant p53. 

Phrase: "Anti-IgM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0051980:anti-IgM [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "transforming growth factor-beta sensitivity in a human B-lymphoma cell line"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   736   C0036667:Sensitivity [Quantitative Concept]
   736   C0312418:Sensitivity [Mental Process]
   736   C0427965:Sensitivity [Finding]
   736   C1511883:Sensitivity [Quantitative Concept]
   736   C1522640:Sensitivity [Qualitative Concept]
   736   C2346484:SENSITIVITY [Phenomenon or Process]
   736   C2349185:Sensitivity [Qualitative Concept]

Phrase: ":"

Phrase: "inhibition of growth"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C2249823:inhibition of growth [Organism Function]
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "is"

Phrase: "associated with a downregulation of mutant p53."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0013081:Down-Regulation [Cell Function,Molecular Function]
   748   C0079419:P53 [Gene or Genome]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1705526:p53 [Gene or Genome]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.431: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.432: 1995;85:2461-2470[Abstract/Free FullText]. 

Phrase: "1995"

Phrase: ";85"

Phrase: ":"

Phrase: "2461-2470"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.433: 37. 

Phrase: "37."
Processing 00000000.tx.434: Yue J, Buard A, Mulder KM. 

Phrase: "Yue J,"

Phrase: "Buard A,"

Phrase: "Mulder KM."
Processing 00000000.tx.435: Blockade of TGFb3 up-regulation of p27Kip1 and p21Cip1 by expression of RasN17 in epithelial cells. 

Phrase: "Blockade of TGFb3 up-regulation of p27Kip1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332206:Blockade [Functional Concept]
   748   C3540676:Blockade [Pharmacologic Substance]

Phrase: "and"

Phrase: "p21Cip1 by expression of RasN17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0249197:p21CIP1 [Gene or Genome]

Phrase: "in epithelial cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0014597:Epithelial Cells [Cell]
  1000   C1273342:Epithelial Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0221908:Epithelial [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.436: Oncogene. 

Phrase: "Oncogene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]
Processing 00000000.tx.437: 1998;17:47-55[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1998"

Phrase: ";17"

Phrase: ":"

Phrase: "47-55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.438: 38. 

Phrase: "38."
Processing 00000000.tx.439: Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. 

Phrase: "Rammes"

Phrase: "A,"

Phrase: "Roth J,"

Phrase: "Goebeler M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Klempt M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hartmann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sorg C."
Processing 00000000.tx.440: Myeloid-related protein MRP8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel tubulin-dependent pathway. 

Phrase: "Myeloid-related protein MRP8"

Phrase: "and"

Phrase: "MRP14,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054505:MRP14 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1335798:MRP14 [Gene or Genome]
  1000   C1704874:MRP14 [Gene or Genome]

Phrase: "calcium-binding proteins of the S100 family,"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   823   C0027758:S100 Calcium Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           S100 Protein Family
           S100 Proteins
   814   C0006732:Calcium-Binding Proteins [Amino Acid, Peptide, or Protein,Receptor]
   789   C3272083:S100 protein binding [Molecular Function]
           S100 binding
   780 E C1822659:calcium binding protein [Gene or Genome]
   778   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1516144:Calcium Binding [Molecular Function]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C0805431:Calcium/Protein [Quantitative Concept]
   757   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0006726:Calcium [Inorganic Chemical]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C2936886:Calcium [Pharmacologic Substance]

Phrase: "are"

Phrase: "secreted by activated monocytes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0026473:Monocytes [Cell]
   770   C1327616:Secreted [Cell Function]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "via a novel tubulin-dependent pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.441: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.442: 1997;272:9496-9502[Abstract/Free FullText]. 

Phrase: "1997"

Phrase: ";272"

Phrase: ":"

Phrase: "9496-9502"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.443: 39. 

Phrase: "39."
Processing 00000000.tx.444: Newton R, Hogg N. 

Phrase: "Newton R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hogg N."
Processing 00000000.tx.445: The human S100 protein MRP-14 is a novel activator of the beta 2integrin Mac-1 on neutrophils. 

Phrase: "The human S100 protein MRP-14"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   853   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0027758:S-100 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0086418:Human [Human]
   804   C1441165:S-100 [Immunologic Factor]
   804   C3273837:S100 [Gene or Genome]
   804   C3274824:S100 [Gene or Genome]

Phrase: "is"

Phrase: "a novel activator of the beta 2integrin Mac-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1419349:activator 1 [Gene or Genome]

Phrase: "on neutrophils."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027950:Neutrophils [Cell]
   916 E C0746885:neutrophilic [Cell Function]
   893 E C0151683:Neutrophilia [Finding]
Processing 00000000.tx.446: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.447: 1998;160:1427-1435[Abstract/Free FullText]. 

Phrase: "1998"

Phrase: ";160"

Phrase: ":"

Phrase: "1427-1435"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.448: 40. 

Phrase: "40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.449: Suh YK, Shabaik A, Meurer WT, Shin SS. 

Phrase: "Suh YK,"

Phrase: "Shabaik A,"

Phrase: "Meurer WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: "Shin SS."
Processing 00000000.tx.450: Lymphoid cell aggregates: a useful clue in the fine-needle aspiration diagnosis of follicular lymphoma. 

Phrase: "Lymphoid cell aggregates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0031272:Lymphoid aggregate [Body Part, Organ, or Organ Component]
   896   C0229653:Lymphoid aggregate [Body Part, Organ, or Organ Component]
   827   C0205418:aggregates [Qualitative Concept]
   734   C0086574:Lymphoid cell [Cell]

Phrase: ":"

Phrase: "a useful clue in the fine-needle aspiration diagnosis of follicular lymphoma."
Processing 00000000.tx.451: Diagn Cytopathol. 

Phrase: "Diagn Cytopathol."
Processing 00000000.tx.452: 1997;17:467-471[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1997"

Phrase: ";17"

Phrase: ":"

Phrase: "467-471"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.453: 41. 

Phrase: "41."
Processing 00000000.tx.454: Barberis A, Widenhorn K, Vitelli L, Busslinger M. 

Phrase: "Barberis A,"

Phrase: "Widenhorn K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Vitelli L,"

Phrase: "Busslinger M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.455: A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. 

Phrase: "A novel B-cell lineage-specific transcription factor present at early"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0150312:Present [Quantitative Concept]
   738   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "not late"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "stages of differentiation."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0007589:Differentiation [Cell Function]
   790   C0205390:Stage [Temporal Concept]
   790   C1300072:Stage [Clinical Attribute]
   790   C1306673:Stage [Qualitative Concept]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.456: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.457: 1990;4:849-859[Abstract]. 

Phrase: "1990"

Phrase: ";4"

Phrase: ":"

Phrase: "849-859"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.458: 42. 

Phrase: "42."
Processing 00000000.tx.459: Sun X. 

Phrase: "Sun X."
Processing 00000000.tx.460: Constitutive expression of the Id1 gene impairs mouse B cell development. 

Phrase: "Constitutive expression of the Id1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "impairs"

Phrase: "mouse B cell development."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C1511002:B-Cell Development [Cell Function]
   923   C3158362:B cell development [Cell Function]
   861   C0815089:cell development [Cell Function]
   812   C0243107:development [Physiologic Function]
   812   C0678723:Development [Organism Function]
   812   C1527148:Development [Functional Concept]
   756   C1522109:Mouse B Cell [Cell]
   741 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.461: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.462: 1994;79:893-900[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1994"

Phrase: ";79"

Phrase: ":"

Phrase: "893-900"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.463: 43. 

Phrase: "43."
Processing 00000000.tx.464: Yokota Y, Mansouri A, Mori S, et al. 

Phrase: "Yokota Y,"

Phrase: "Mansouri A,"

Phrase: "Mori S,"

Phrase: "et al."
Processing 00000000.tx.465: Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. 

Phrase: "Development of peripheral lymphoid organs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0242290:organ development [Biologic Function]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "natural killer cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
  1000   C2363836:Natural Killer Cells [Laboratory Procedure]
   901   C0022686:Killer Cells [Cell]
   901   C2709199:Natural killer [Cell]
   827   C0007634:Cells [Cell]
   827   C0205296:Natural [Functional Concept]
   827   C1336644:KILLER [Gene or Genome]
   827   C1705132:KILLER [Gene or Genome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "depends on the helix-loop-helix inhibitor Id2."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0282642:helix loop helix [Spatial Concept]
   744   C0018882:Helix [Eukaryote]
   744   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0229304:Helix [Body Part, Organ, or Organ Component]
   744   C0419518:Loop [Medical Device]
   744   C0445022:Loop [Spatial Concept]
   744   C0725813:depend [Medical Device]
   744   C1334077:ID2 [Gene or Genome]
   744   C1704821:Helix [Spatial Concept]
   744   C1705682:Helix [Anatomical Structure]
   744   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.466: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.467: 1999;397:702-706[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1999"

Phrase: ";397"

Phrase: ":"

Phrase: "702-706"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.468: 44. 

Phrase: "44."
Processing 00000000.tx.469: Nutt SL, Heavey B, Rolink AG, Busslinger M. 

Phrase: "Nutt SL,"

Phrase: "Heavey B,"

Phrase: "Rolink AG,"

Phrase: "Busslinger M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.470: Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. 

Phrase: "Commitment to the B-lymphoid lineage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0870312:commitment [Mental Process]

Phrase: "depends on the transcription factor Pax5."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   820   C0167636:PAX5 Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           PAX5
   790   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0040649:Transcription [Genetic Function]
   753   C0725813:depend [Medical Device]
   753   C1335193:PAX5 [Gene or Genome]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.471: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.472: 1999;401:556-562[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1999"

Phrase: ";401"

Phrase: ":"

Phrase: "556-562"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.473: 45. 

Phrase: "45."
Processing 00000000.tx.474: Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M. 

Phrase: "Urbanek P,"

Phrase: "Wang ZQ,"

Phrase: "Fetka I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Wagner EF,"

Phrase: "Busslinger M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.475: Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. 

Phrase: "Complete block of early B cell differentiation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0028778:Block [Pathologic Function]
   748   C0332206:Block [Functional Concept]
   748   C1533157:Block [Substance]
   748   C1706084:Block [Geographic Area]
   748   C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "altered patterning of the posterior midbrain"

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "Pax5/BSAP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   947   C0167636:B-Cell-Specific Activator Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0004561:B-cell [Cell]
   799   C0007634:Cell [Cell]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0205369:Specific [Qualitative Concept]
   799   C1269647:Cell [Cell]
   799   C1552740:specific [Intellectual Product]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.476: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.477: 1994;79:901-912[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1994"

Phrase: ";79"

Phrase: ":"

Phrase: "901-912"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.478: 46. 

Phrase: "46."
Processing 00000000.tx.479: Offit K, Parsa N, Jhanwar S, Filippa D, Wachtel M, Chaganti R. 

Phrase: "Offit K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Parsa N,"

Phrase: "Jhanwar S,"

Phrase: "Filippa D,"

Phrase: "Wachtel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Chaganti R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.480: Clusters of chromosome 9aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma. 

Phrase: "Clusters of chromosome 9aberrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1555715:Cluster [Idea or Concept]
   737   C1704332:Cluster [Quantitative Concept]

Phrase: "are"

Phrase: "associated with clinico-pathologic subsets of non-Hodgkin's lymphoma."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0024305:Lymphoma, Non-Hodgkin [Neoplastic Process]
   790   C2700512:LYMPHOMA, NON-HODGKIN [Gene or Genome]
   790   C3539720:Non-Hodgkin Lymphoma [Intellectual Product]
   764   C0019829:Hodgkin Lymphoma [Neoplastic Process]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C3541281:Hodgkin Lymphoma [Intellectual Product]
   742   C0024299:Lymphoma [Neoplastic Process]
   742   C1518422:Non [Functional Concept]
   742   C1521733:Pathologic [Functional Concept]
   708 E C0750490:Associate [Idea or Concept]
   708   C1515021:Subset [Classification]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.481: Genes Chromosom Cancer. 

Phrase: "Genes Chromosom Cancer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0919437:genes cancer [Gene or Genome]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.482: 1993;7:1-7[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";7"

Phrase: ":"

Phrase: "1-7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.483: 47. 

Phrase: "47."
Processing 00000000.tx.484: Iida S, Rao P, Ueda R, Chaganti R. 

Phrase: "Iida S,"

Phrase: "Rao P,"

Phrase: "Ueda R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Chaganti R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.485: Chromosomal rearrangement of the PAX-5 locus in lymphoplastmacytic lymphoma with t(9;14)(p13;q32). 

Phrase: "Chromosomal rearrangement of the PAX-5 locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1515001:Chromosomal Rearrangement [Cell or Molecular Dysfunction]
   748   C1511695:Rearrangement [Genetic Function]

Phrase: "in lymphoplastmacytic lymphoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024299:Lymphoma [Neoplastic Process]

Phrase: "with t(9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";14"

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ";q32"

Phrase: ")."
Processing 00000000.tx.486: Leuk Lymphoma. 

Phrase: "Leuk Lymphoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024299:Lymphoma [Neoplastic Process]
Processing 00000000.tx.487: 1999;34:25-33[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1999"

Phrase: ";34"

Phrase: ":"

Phrase: "25-33"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.488: 48. 

Phrase: "48."
Processing 00000000.tx.489: Stuart ET, Haffner R, Oren M, Gruss P. 

Phrase: "Stuart ET, Haffner R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: "Oren M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gruss P."
Processing 00000000.tx.490: Loss of p53 function through PAX-mediated transcriptional repression. 

Phrase: "Loss of p53 function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "through PAX-mediated transcriptional repression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0920533:Transcriptional Repression [Genetic Function]
   812   C0035143:Repression [Mental Process]
Processing 00000000.tx.491: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.492: 1995;14:5638-5645[Abstract]. 

Phrase: "1995"

Phrase: ";14"

Phrase: ":"

Phrase: "5638-5645"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.493: 49. 

Phrase: "49."
Processing 00000000.tx.494: Cooper CL, Brady G, Bilia F, Iscove NN, Quesenberry PJ. 

Phrase: "Cooper CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Brady G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bilia F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Iscove NN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1850406:NN [Disease or Syndrome]

Phrase: "Quesenberry PJ."
Processing 00000000.tx.495: Expression of the Id family helix-loop-helix regulators during growth and development in the hematopoietic system. 

Phrase: "Expression of the Id family helix-loop-helix regulators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "during growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "development in the hematopoietic system."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1744604:system development [Biologic Function]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.496: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.497: 1997;89:3155-3165[Abstract/Free FullText]. 

Phrase: "1997"

Phrase: ";89"

Phrase: ":"

Phrase: "3155-3165"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.498: 50. 

Phrase: "50."
Processing 00000000.tx.499: Ishiguro A, Spirin K, Shiohara M, et al. 

Phrase: "Ishiguro"

Phrase: "A,"

Phrase: "Spirin K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Shiohara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.500: Expression of Id2 and Id3 mRNA in human lymphocytes. 

Phrase: "Expression of Id2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Id3 mRNA in human lymphocytes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0335218:Messenger [Professional or Occupational Group]
Processing 00000000.tx.501: Leuk Res. 

Phrase: "Leuk Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.502: 1995;19:989-996[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1995"

Phrase: ";19"

Phrase: ":"

Phrase: "989-996"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.503: 51. 

Phrase: "51."
Processing 00000000.tx.504: Sun X, Copeland N, Jenkins N, Baltimore D. 

Phrase: "Sun X,"

Phrase: "Copeland N,"

Phrase: "Jenkins N,"

Phrase: "Baltimore D."
Processing 00000000.tx.505: Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. 

Phrase: "Id proteins Id1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1415855:ID1 [Gene or Genome]
   734   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Id2 selectively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1334077:ID2 [Gene or Genome]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "DNA binding by one class of helix-loop-helix proteins."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   777   C0012940:DNA-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   761 E C0812382:DNA-binding protein [Gene or Genome]
   760   C1148673:DNA Binding [Genetic Function]
   757   C0058610:dna proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1516509:DNA Loop [Cell Component]
   741 E C0033618:Protein Binding [Molecular Function]
   739   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
Processing 00000000.tx.506: Mol Cell Biol. 

Phrase: "Mol Cell Biol."
Processing 00000000.tx.507: 1991;11:5603-5611[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1991"

Phrase: ";11"

Phrase: ":"

Phrase: "5603-5611"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.508: 52. 

Phrase: "52."
Processing 00000000.tx.509: Morrow MA, Mayer EW, Perez CA, Adlam M, Siu G. 

Phrase: "Morrow MA,"

Phrase: "Mayer EW,"

Phrase: "Perez CA,"

Phrase: "Adlam M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Siu G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.510: Overexpression of the helix-loop-helix protein Id2 blocks T cell development at multiple stages. 

Phrase: "Overexpression of the helix-loop-helix protein Id2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "T cell development at multiple stages."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1515126:T-Cell Development [Cell Function]
   790   C0815089:cell development [Cell Function]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
   748   C0870411:Developmental stages [Temporal Concept]
Processing 00000000.tx.511: Mol Immunol. 

Phrase: "Mol Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.512: 1999;36:491-503[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1999"

Phrase: ";36"

Phrase: ":"

Phrase: "491-503"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.513: 53. 

Phrase: "53."
Processing 00000000.tx.514: Freedman A, Munro J, Morimoto C, et al. 

Phrase: "Freedman A,"

Phrase: "Munro J,"

Phrase: "Morimoto C,"

Phrase: "et al."
Processing 00000000.tx.515: Follicular non-Hodgkin's lymphoma cell adhesion to normal and neoplastic germinal centers involves VLA-4 and VCAM-1. 

Phrase: "Follicular non-Hodgkin's lymphoma cell adhesion to normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007577:Cell Adhesion [Cell Function]
   744   C0001511:Adhesion [Pathologic Function]
   744   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "neoplastic germinal centers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0282491:Germinal Centers [Tissue]
   827   C0205099:centers [Spatial Concept]

Phrase: "involves"

Phrase: "VLA-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0209606:VLA-4 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "VCAM-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0078056:VCAM-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           VCAM
Processing 00000000.tx.516: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.517: 1992;79:206-212[Abstract]. 

Phrase: "1992"

Phrase: ";79"

Phrase: ":"

Phrase: "206-212"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.518: 54. 

Phrase: "54."
Processing 00000000.tx.519: Ghia P, Caligaris-Cappio F. 

Phrase: "Ghia P,"

Phrase: "Caligaris-Cappio F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.520: The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms. 

Phrase: "The indispensable role of microenvironment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the natural history"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0175860:Natural History [Occupation or Discipline]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0205296:Natural [Functional Concept]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "of low-grade B-cell neoplasms."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C0079731:B-cell neoplasm [Neoplastic Process]
   804   C0027651:NEOPLASMS, NOS [Neoplastic Process]
   771 E C2981607:NEOPLASM [Intellectual Product]
Processing 00000000.tx.521: Adv Cancer Res. 

Phrase: "Adv Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]
Processing 00000000.tx.522: 2000;79:157-173[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "2000"

Phrase: ";79"

Phrase: ":"

Phrase: "157-173"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.523: 55. 

Phrase: "55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.524: Kondo M, Takeshita T, Ishii N, et al. 

Phrase: "Kondo M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Takeshita T,"

Phrase: "Ishii N,"

Phrase: "et al."
Processing 00000000.tx.525: Sharing of the interleukin-2 (IL-2) receptor chain between receptors for IL-2 and IL-4. 

Phrase: "Sharing of the interleukin-2 (IL-2) receptor chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0237876:Sharing [Social Behavior]

Phrase: "between receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "for IL-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021756:Interleukin-2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0879590:INTERLEUKIN 2 [Gene or Genome]
  1000   C1522405:Interleukin-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IL-4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]
Processing 00000000.tx.526: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.527: 1993;262:1874-1877[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";262"

Phrase: ":"

Phrase: "1874-1877"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.528: 56. 

Phrase: "56."
Processing 00000000.tx.529: Noguchi M, Nakamura Y, Russell SM, et al. 

Phrase: "Noguchi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nakamura Y,"

Phrase: "Russell SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "et al."
Processing 00000000.tx.530: Interleukin-2 receptor chain: a functional component of the interleukin-7 receptor. 

Phrase: "Interleukin-2 receptor chain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   756   C0034819:Interleukin 2 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   756   C1101536:Interleukin 2 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   708   C0206553:Interleukin Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: ":"

Phrase: "a functional component of the interleukin-7 receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1179435:Functional Component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.531: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.532: 1993;262:1877-1880[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";262"

Phrase: ":"

Phrase: "1877-1880"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.533: 57. 

Phrase: "57."
Processing 00000000.tx.534: Russell SM, Keegan AD, Harada N, et al. 

Phrase: "Russell SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Keegan AD,"

Phrase: "Harada N,"

Phrase: "et al."
Processing 00000000.tx.535: Interleukin-2 receptor chain: a functional component of the interleukin-4 receptor. 

Phrase: "Interleukin-2 receptor chain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   756   C0034819:Interleukin 2 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   756   C1101536:Interleukin 2 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   708   C0206553:Interleukin Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: ":"

Phrase: "a functional component of the interleukin-4 receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1179435:Functional Component [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.536: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.537: 1993;262:1880-1883[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";262"

Phrase: ":"

Phrase: "1880-1883"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.538: 58. 

Phrase: "58."
Processing 00000000.tx.539: Butch A, Chung G, Hoffmann J, Nahm M. 

Phrase: "Butch"

Phrase: "A,"

Phrase: "Chung G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Hoffmann J,"

Phrase: "Nahm M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.540: Cytokine expression by germinal center cells. 

Phrase: "Cytokine expression by germinal center cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.541: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.542: 1993;150:39-47[Abstract/Free FullText]. 

Phrase: "1993"

Phrase: ";150"

Phrase: ":"

Phrase: "39-47"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.543: 59. 

Phrase: "59."
Processing 00000000.tx.544: Carbone A, Gloghini A, Gruss HJ, Pinto A. 

Phrase: "Carbone A,"

Phrase: "Gloghini A,"

Phrase: "Gruss HJ,"

Phrase: "Pinto A."
Processing 00000000.tx.545: CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. 

Phrase: "CD40 ligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0167627:CD40 Ligand [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1539082:CD40 LIGAND [Gene or Genome]
   861   C0023688:Ligand [Chemical]

Phrase: "is"

Phrase: "constitutively"

Phrase: "expressed in a subset of T cell lymphomas"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0079772:T-Cell Lymphomas [Neoplastic Process]
   793   C0080202:T-Cell Subset [Cell]
   770   C0039194:T-cell [Cell]
   754   C0883208:cell lymphoma [Cell]
   744   C0007634:Cell [Cell]
   744   C0024299:Lymphomas [Neoplastic Process]
   744   C1269647:Cell [Cell]
   744   C1515021:Subset [Classification]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "and on the microenvironmental reactive T cells of follicular lymphomas"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   764   C0079772:cell lymphomas t [Neoplastic Process]
   760   C0024301:Lymphomas, Follicular [Neoplastic Process]
   760   C0039194:T-Cells [Cell]
   741   C0883208:Lymphoma cells [Cell]
   741   C2697951:Lymphoma Cells [Laboratory Procedure]
   739   C0007634:Cells [Cell]
   739   C0024299:Lymphomas [Neoplastic Process]
   739   C0205332:Reactive [Qualitative Concept]
   739   C0439682:Follicular [Qualitative Concept]
   739   C1515981:And [Idea or Concept]
   739   C1571705:Follicular [Body Part, Organ, or Organ Component]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
   705   C1707328:Cell Microenvironment [Idea or Concept]

Phrase: "and"

Phrase: "Hodgkin's disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0019829:Hodgkin Disease [Neoplastic Process]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.546: Am J Pathol. 

Phrase: "Am"

Phrase: "J Pathol."
Processing 00000000.tx.547: 1995;147:912-922[Abstract]. 

Phrase: "1995"

Phrase: ";147"

Phrase: ":"

Phrase: "912-922"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.548: 60. 

Phrase: "60."
Processing 00000000.tx.549: Johnson P, Watt S, Betts D, et al. 

Phrase: "Johnson P,"

Phrase: "Watt S,"

Phrase: "Betts D,"

Phrase: "et al."
Processing 00000000.tx.550: Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. 

Phrase: "Isolated follicular lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "resistant to apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332325:Resistant to [Functional Concept]
           Resistant
   790   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "grown"

Phrase: "in vitro in the CD40/stromal cell system."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021135:In Vitro [Intellectual Product]
   770   C1533691:in vitro [Qualitative Concept]
           vitro
   770   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.551: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.552: 1993;82:1848-1857[Abstract]. 

Phrase: "1993"

Phrase: ";82"

Phrase: ":"

Phrase: "1848-1857"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.553: 61. 

Phrase: "61."
Processing 00000000.tx.554: Mackay F, Browning J. 

Phrase: "Mackay F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Browning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J."
Processing 00000000.tx.555: Turning off follicular dendritic cells. 

Phrase: "Turning off follicular dendritic cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0541749:turning [Finding]
Processing 00000000.tx.556: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.557: 1998;395:26-27[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1998"

Phrase: ";395"

Phrase: ":"

Phrase: "26-27"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.558: 62. 

Phrase: "62."
Processing 00000000.tx.559: Wiels J, Mangeney M, Tetaud C, Tursz T. 

Phrase: "Wiels J,"

Phrase: "Mangeney M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tetaud C,"

Phrase: "Tursz T."
Processing 00000000.tx.560: Sequential shifts in the three major glycosphingolipid are associated with B cell differentiation. 

Phrase: "Sequential shifts in the three major glycosphingolipid"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0333051:shifts [Functional Concept]
   714 E C2347509:Shift [Phenomenon or Process]

Phrase: "are"

Phrase: "associated with B cell differentiation."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   862   C1511002:B-Cell Differentiation [Cell Function]
   806   C0004561:B-cell [Cell]
   806   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0699040:cell associated [Cell Component]
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2945687:Differentiation [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.561: Int Immunol. 

Phrase: "Int Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.562: 1991;3:1289-1300[Abstract]. 

Phrase: "1991"

Phrase: ";3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1289-1300"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.563: 63. 

Phrase: "63."
Processing 00000000.tx.564: LaCasse E, Bray M, Patterson B, et al. 

Phrase: "LaCasse E,"

Phrase: "Bray M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Patterson B,"

Phrase: "et al."
Processing 00000000.tx.565: Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34+ hematopoietic stem cells: implication for ex vivo tumor purging and autologous stem cell transplantation. 

Phrase: "Shiga-like toxin-1 receptor on human breast cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   810   C0142216:Shiga-like toxin receptor [Lipid,Receptor]
   781   C0061338:Shiga toxin receptor [Immunologic Factor,Lipid,Receptor]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "lymphoma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024299:Lymphoma [Neoplastic Process]

Phrase: "and"

Phrase: "myeloma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026764:Myeloma [Neoplastic Process]
  1000   C3538749:Myeloma [Intellectual Product]

Phrase: "and"

Phrase: "absence from CD34+ hematopoietic stem cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: ":"

Phrase: "implication for ex vivo tumor purging"

Phrase: "and"

Phrase: "autologous stem cell transplantation."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C1831743:Autologous Stem Cell Transplantation [Therapeutic or Preventive Procedure]
   923   C1504389:Stem Cell Transplantation [Therapeutic or Preventive Procedure]
   902   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   861   C0038250:Stem cell [Cell]
   861   C0206153:Cell Transplantation [Therapeutic or Preventive Procedure]
   812   C0007634:Cell [Cell]
   812   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   812   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   812   C0040733:transplantation [Functional Concept]
   812   C0242767:Stem [Plant]
   812   C0439859:Autologous [Qualitative Concept]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.566: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.567: 1999;94:2901-2910[Abstract/Free FullText]. 

Phrase: "1999"

Phrase: ";94"

Phrase: ":"

Phrase: "2901-2910"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.568: 64. 

Phrase: "64."
Processing 00000000.tx.569: Sherr CJ, Roberts JM. 

Phrase: "Sherr CJ,"

Phrase: "Roberts JM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]
Processing 00000000.tx.570: CDK inhibitors: positive and negative regulators of G1-phase progression. 

Phrase: "CDK inhibitors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   966   C1152568:CDK inhibitor [Molecular Function]
   966   C1511576:CDK Inhibitor [Pharmacologic Substance]
   861   C0243045:CDK [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1150557:CDK [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ":"

Phrase: "positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "negative regulators of G1-phase progression."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0182953:regulators [Medical Device]
   753   C0205160:Negative [Qualitative Concept]
   753   C1513916:Negative [Finding]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   719 E C1704734:Regulator [Medical Device]
   719 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.571: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.572: 1999;13:1501-1512[Free FullText]. 

Phrase: "1999"

Phrase: ";13"

Phrase: ":"

Phrase: "1501-1512"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.573: 65. 

Phrase: "65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]
Processing 00000000.tx.574: Weinstein J, Karim J, Geschwind DH, Nelson SF, Krumm J, Sakamoto KM. 

Phrase: "Weinstein J,"

Phrase: "Karim J,"

Phrase: "Geschwind DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Nelson SF,"

Phrase: "Krumm J,"

Phrase: "Sakamoto KM."
Processing 00000000.tx.575: Genomic organization, 5' flanking enhancer region, and chromosomal assignment of the cell cycle gene, p55Cdc. 

Phrase: "Genomic organization,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "5' flanking enhancer region,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   923   C0949645:5' Flanking Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   902   C1883644:5' Region [Nucleotide Sequence]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "chromosomal assignment of the cell cycle gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1516050:Assignment [Functional Concept]

Phrase: "p55Cdc."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1413256:p55CDC [Gene or Genome]
  1000   C3539866:p55CDC [Amino Acid, Peptide, or Protein]
  1000   C3541310:p55CDC [Gene or Genome]
Processing 00000000.tx.576: Mol Genet Metab. 

Phrase: "Mol Genet Metab."
Processing 00000000.tx.577: 1998;64:52-57[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1998"

Phrase: ";64"

Phrase: ":"

Phrase: "52-57"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.578: 66. 

Phrase: "66."
Processing 00000000.tx.579: Offit K, Wong G, Filippa DA, Tao Y, Chaganti RSK. 

Phrase: "Offit K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Wong G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Filippa DA,"

Phrase: "Tao Y,"

Phrase: "Chaganti RSK."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1419742:RSK [Gene or Genome]
   861   C1419743:RSK [Gene or Genome]
   861   C1419744:RSK [Gene or Genome]
   861   C3540564:RSK [Gene or Genome]
Processing 00000000.tx.580: Cytogenetic analysis of 434consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. 

Phrase: "Cytogenetic analysis of 434consecutively ascertained specimens of non-Hodgkin's lymphoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0752095:Cytogenetic Analysis [Molecular Biology Research Technique]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "clinical correlations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.581: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.582: 1991;77:1508-1515[Abstract]. 

Phrase: "1991"

Phrase: ";77"

Phrase: ":"

Phrase: "1508-1515"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.583: 67. 

Phrase: "67."
Processing 00000000.tx.584: Juneja S, Lukeis R, Tan L, et al. 

Phrase: "Juneja S,"

Phrase: "Lukeis R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Tan L,"

Phrase: "et al."
Processing 00000000.tx.585: Cytogenetic analysis of 147cases of non-Hodgkin's lymphoma: non-random chromosomal abnormalities and histological correlations. 

Phrase: "Cytogenetic analysis of 147cases of non-Hodgkin's lymphoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0752095:Cytogenetic Analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "non-random chromosomal abnormalities"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   861   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   812   C0000768:Abnormalities [Congenital Abnormality]
   812   C0000769:abnormalities [Functional Concept]
   779 E C1704258:Abnormality [Finding]
   729 E C0205161:Abnormal [Qualitative Concept]
   729 E C2347472:% Abnormal [Quantitative Concept]
   729 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "and"

Phrase: "histological correlations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.586: Br J Haematol. 

Phrase: "Br J Haematol."
Processing 00000000.tx.587: 1990;76:231-237[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1990"

Phrase: ";76"

Phrase: ":"

Phrase: "231-237"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.588: 68. 

Phrase: "68."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]
Processing 00000000.tx.589: Yano T, Jaffe ES, Longo DL, Raffeld M. 

Phrase: "Yano T,"

Phrase: "Jaffe ES,"

Phrase: "Longo DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Raffeld M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.590: MYC rearrangements in histologically progressed follicular lymphomas. 

Phrase: "MYC rearrangements in histologically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511695:Rearrangements [Genetic Function]

Phrase: "progressed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272688:progressed [Functional Concept]
   966 E C1280477:Progress [Functional Concept]

Phrase: "follicular lymphomas."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0024301:Lymphomas, Follicular [Neoplastic Process]
   861   C0024299:Lymphomas [Neoplastic Process]
   861   C0439682:Follicular [Qualitative Concept]
   861   C1571705:Follicular [Body Part, Organ, or Organ Component]
Processing 00000000.tx.591: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.592: 1992;80:758-766[Abstract]. 

Phrase: "1992"

Phrase: ";80"

Phrase: ":"

Phrase: "758-766"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.593: 69. 

Phrase: "69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]
Processing 00000000.tx.594: Whang-Peng J, Knutsen T, Jaffe ES, et al. 

Phrase: "Whang-Peng J,"

Phrase: "Knutsen T,"

Phrase: "Jaffe ES,"

Phrase: "et al."
Processing 00000000.tx.595: Sequential analysis of 43patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. 

Phrase: "Sequential analysis of 43patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "with non-Hodgkin's lymphoma"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024305:Lymphoma, Non-Hodgkin [Neoplastic Process]
  1000   C2700512:LYMPHOMA, NON-HODGKIN [Gene or Genome]
  1000   C3539720:Non-Hodgkin Lymphoma [Intellectual Product]
   901   C0019829:Hodgkin Lymphoma [Neoplastic Process]
   901   C3541281:Hodgkin Lymphoma [Intellectual Product]
   827   C0024299:Lymphoma [Neoplastic Process]
   827   C1518422:Non [Functional Concept]

Phrase: ":"

Phrase: "clinical correlations with cytogenetic, histologic, immunophenotyping,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "molecular studies."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0947630:studies [Laboratory Procedure]
   861   C1521991:Molecular [Qualitative Concept]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   789 E C0567416:Molecule [Substance]
Processing 00000000.tx.596: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.597: 1995;85:203-216[Abstract/Free FullText]. 

Phrase: "1995"

Phrase: ";85"

Phrase: ":"

Phrase: "203-216"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.598: 70. 

Phrase: "70."
Processing 00000000.tx.599: Johansson B, Mertens F, Mitelman F. 

Phrase: "Johansson B,"

Phrase: "Mertens F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Mitelman F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.600: Cytogenetic evolution patterns in non-Hodgkin's lymphoma. 

Phrase: "Cytogenetic evolution patterns in non-Hodgkin's lymphoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Patterns [Spatial Concept]
Processing 00000000.tx.601: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.602: 1995;86:3905-3914[Abstract/Free FullText]. 

Phrase: "1995"

Phrase: ";86"

Phrase: ":"

Phrase: "3905-3914"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.603: 71. 

Phrase: "71."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]
Processing 00000000.tx.604: Bentz M, Werner CA, Dhner H, et al. 

Phrase: "Bentz M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Werner CA,"

Phrase: "Dhner H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.605: High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. 

Phrase: "High incidence of chromosomal imbalances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "and"

Phrase: "gene amplifications in the classical follicular variant of follicle center lymphoma."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0017256:Gene Amplification [Genetic Function]
   739   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   704   C1517480:Amplification [Molecular Biology Research Technique]
   704   C1521871:Amplification [Phenomenon or Process]
Processing 00000000.tx.606: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.607: 1996;88:1437-1444[Abstract/Free FullText]. 

Phrase: "1996"

Phrase: ";88"

Phrase: ":"

Phrase: "1437-1444"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.608: 72. 

Phrase: "72."
Processing 00000000.tx.609: Elenitoba-Johnson KSJ, Gascoyne RD, Lim MS, Chhanabai M, Jaffe ES, Raffeld M. 

Phrase: "Elenitoba-Johnson KSJ,"

Phrase: "Gascoyne RD,"

Phrase: "Lim MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Chhanabai M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Jaffe ES,"

Phrase: "Raffeld M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.610: Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. 

Phrase: "Homozygous deletions at chromosome 9p21"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   824   C2966436:9p21 chromosome deletion [Finding]
   797   C0008628:Deletions, Chromosome [Cell or Molecular Dysfunction]
   760   C1880274:Deletions [Activity]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "p16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525037:p16 [Gene or Genome]

Phrase: "and"

Phrase: "p15"

Phrase: "are"

Phrase: "associated with histologic progression"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C3274677:Histologic Progression [Pathologic Function]
   770   C0205462:Histologic [Functional Concept]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in follicle center lymphoma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024301:Follicle Center Lymphoma [Neoplastic Process]
           Lymphoma, Follicular
   827   C0024299:Lymphoma [Neoplastic Process]
Processing 00000000.tx.611: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.612: 1998;91:4677-4685[Abstract/Free FullText].  

Phrase: "1998"

Phrase: ";91"

Phrase: ":"

Phrase: "4677-4685"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.613: 2002 by The American Society of Hematology.

Phrase: "2002 by The American Society of Hematology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1515949:American Society of Hematology [Professional Society]
   748   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   748   C0037455:society [Organization]
   748   C0200627:HEMATOLOGY [Laboratory Procedure]
   748   C0596070:American [Population Group]

